Sentence,class,file
2012. http://www.nice.org.uk/guidance/ta220/resources/ta220-psoriatic-arthritis- golimumab-costing-statement2 .,Non-OADS,/arxiv_data1/oa_pdf/11/2e/12325_2015_Article_233.PMC4569679.pdf
http://www.eumusc.net/myUploadData/ﬁles/ Musculoskeletal%20Health%20in%20Europe%20Report%20v5.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/2e/12325_2015_Article_233.PMC4569679.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by- nc/4.0/ ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/aa/0d/12325_2015_Article_234.PMC4569680.pdf
2015. http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm.,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/12325_2015_Article_234.PMC4569680.pdf
2015. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/SGLT2_ inhibitors/human_referral_prac_000052.jsp&mid= WC0b01ac05805c516f .,Non-OADS,/arxiv_data1/oa_pdf/aa/0d/12325_2015_Article_234.PMC4569680.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/0b/rjv109.PMC4569838.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/24/ofv124.PMC4569839.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/77/3e/cardiovascmed-04-02-25679.PMC4569886.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)STIM1 in the progression and metastasis of CRC Z Zhang et al 4820 Oncogene (2015) 4808 –4820 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/d8/12/onc2014404a.PMC4569941.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)miR-206 suppresses lymphangiogenesis in PDAC I Keklikoglou et al 4878 Oncogene (2015) 4867 –4878 © 2015 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c4/38/onc2014408a.PMC4569942.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/35/e9/cardiovascmed-04-02-27205.PMC4570004.pdf
"Moreover, identiﬁcation of active CD8CTIL subsets could lead to efforts to selectively expand these T cells prior to infusion into patients, which has a high potential © Cara L Haymaker, Richard C Wu, Krit Ritthipichai, Chantale Bernatchez, Marie-Andr /C19ee Forget, Jie Qing Chen, Hui Liu, Ena Wang, Francesco Marincola, Patrick Hwu, and Laszlo G Radvanyi*Correspondence to: Laszlo G Radvanyi; Email: laszlo.radvanyi@lionbio.comSubmitted: 10/31/2014; Revised: 01/16/2015; Accepted: 01/29/2015 http://dx.doi.org/10.1080/2162402X.2015.1014246 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
The microarray data have been deposited into the NCBI GEO database (Accession #GSE43260; http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc DGSE43260).,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Clin Oncol 2005; 23:2346-57; PMID:15800326; http://dx.doi.org/10.1200/JCO.2005.00.240 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Clin Cancer Res 2012; 18:6758-70; PMID:23032743; http://dx.doi.org/10.1158/1078- 0432.CCR-12-1177 3.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Clin Cancer Res 2010; 16:2646-55; PMID:20406835; http://dx.doi.org/10.1158/1078- 0432.CCR-10-0041 4.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Nat Immunol 2003; 4:670-9; PMID:12796776; http://dx.doi.org/10.1038/ni944 6.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Clin Invest 2010; 120:157-67; PMID:20038811; http://dx.doi.org/10.1172/JCI40070 7.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Cancer Res 2012; 72:887-96; PMID:22205715; http://dx.doi.org/10.1158/0008-5472.CAN-11-2637 8.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Biochem Biophys Res Commun 2006; 345:1440-5; PMID:16725108; http://dx.doi.org/10.1016/j.bbrc.2006.05.036 9.,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Front Immunol 2013; 4:455; PMID:24391639; http://dx.doi.org/ 10.3389/ﬁmmu.2013.0045512.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
PLoS One 2012; 7:e30852; PMID:22347406; http://dx.doi.org/10.1371/journal.pone.0030852 13.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Blood 2009; 113:4575-85; PMID:19204323;http://dx.doi.org/10.1182/blood-2008-10-185223 14.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Curr Opin Immunol 2009; 21:291-7;PMID:19497720; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Nat Rev Immunol 2007; 7:155- 61; PMID:17220916; http://dx.doi.org/10.1038/nri2014 16.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Nat Rev Cancer 2002; 2:850-61; PMID:12415255; http://dx.doi.org/10.1038/nrc928 17.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Immunol 2011; 186:4200-12; PMID:21383243; http://dx.doi.org/10.4049/jimmunol.1001783 18.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Immunol 2005; 175:5895-903; PMID: 16237082; http://dx.doi.org/10.4049/jimmunol.175.9.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Immunol 2010; 184:452-65; PMID:19949105; http://dx.doi.org/10.4049/jimmunol.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Trends Immunol 2009; 30:306-12; PMID:19540809; http://dx.doi.org/10.1016/j.it.2009.,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Exp Med 1997; 186:1965-74; PMID:9396765; http://dx.doi.org/10.1084/jem.186.12.1965 22.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Immunology 2009; 126:458-65; PMID:19278419; http://dx.doi.org/ 10.1111/j.1365-2567.2008.03027.x 23.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Int Immunol 2006; 18:1197-209;PMID:16772372; http://dx.doi.org/10.1093/intimm/ dxl060 24.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Nat Immunol 2005; 6:472-80; PMID:15834410; http://dx.doi.org/10.1038/ ni1193 25.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Immunity 1995; 3:273-82; PMID:7552993; http://dx.doi.org/10.1016/1074-7613(95)90113-2 26.,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Clin Invest 2011; 121:2350-60;PMID:21555851; http://dx.doi.org/10.1172/ JCI46102 27.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Immunity 2007; 27:670-84; PMID:17950003; http://dx.doi.org/ 10.1016/j.immuni.2007.09.006 28.,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Annu Rev Immunol 2004;22:745-63; PMID:15032595; http://dx.doi.org/ 10.1146/annurev.immunol.22.012703.104702 29.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Immunology 2011; 134:17-32;PMID:21711350; http://dx.doi.org/10.1111/j.1365- 2567.2011.03470.x 30.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Clin Cancer Res 2011; 17:4550-7; PMID:21498393; http://dx.doi.org/10.1158/1078-0432.CCR-11-0116 31.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Immunol 2005;175:1566-74; PMID:16034095; http://dx.doi.org/ 10.4049/jimmunol.175.3.1566 33.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Eur J Cancer 2009; 45:228-47; PMID:19097774; http://dx.doi.org/10.1016/j.ejca.2008.10.026 34.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Clin Cancer Res 2009; 15:7412-20; PMID:19934295; http://dx.doi.org/10.1158/1078-0432.CCR-09-1624 35.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Immunol 2007; 178:6073-82; PMID:17475832; http://dx.doi.org/ 10.4049/jimmunol.178.10.6073 e1014246-14 Volume 4 Issue 8 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Dev Cell 2002; 3:607-8; PMID:12431365; http://dx.doi.org/ 10.1016/S1534-5807(02)00328-3 38.,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Nat Rev Immunol 2006; 6:671-81; PMID:16932752; http://dx.doi.org/10.1038/nri1917 39.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Blood 2006; 107:4449-57; PMID:16469873; http://dx.doi.org/10.1182/blood-2005-06-2519 40.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
"Blood 2012; 120:3455-65; PMID:22968455; http://dx.doi.org/10.1182/blood- 2012-03-416867 4 1 .B l a c k b u r nS D ,S h i nH ,H a i n i n gW N ,Z o uT , Workman CJ, Polley A, Betts MR, Freeman GJ,Vignali DA, Wherry EJ.",Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Coregulation of CD8 CT cell exhaustion by multiple inhibitory receptors dur- i n gc h r o n i cv i r a li n f e c t i o n .N a tI m m u n o l2 0 0 9 ; 10:29-37; PMID:19043418; http://dx.doi.org/10.1038/ni.1679 42.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.Blood 2009; 114:4099-107; PMID:19706884; http://dx.doi.org/10.1182/blood-2009-04-217604 43.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
PLoS One 2013; 8:e77991; PMID:24205056; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Immunol 2009; 182:1509-17;PMID:19155498; http://dx.doi.org/10.4049/ jimmunol.182.3.1509 45.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
J Exp Med 2011; 208:797-809; PMID:21402741; http://dx.doi.org/10.1084/jem.,Non-OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
Proc Natl Acad Sci 2009; 106:6244-9; PMID:19332782; http://dx.doi.org/10.1073/ pnas.0902115106 47.,OADS,/arxiv_data1/oa_pdf/d7/00/koni-04-08-1014246.PMC4570103.pdf
"6 © Wendy WJ Unger, Christian T Mayer, Steef Engels, Christina Hesse, Maurizio Perdicchio, Franz Puttur, Ingeborg Streng-Ouwehand, Manja Litjens, Ha kan Kalay, Luciana Berod, Tim Sparwasser, and Yvette van Kooyk*Correspondence to: Yvette van Kooyk; Email: y.vankooyk@vumc.nlSubmitted: 04/17/2014; Revised: 09/24/2014; Accepted: 09/25/2014 http://dx.doi.org/10.4161/21624011.2014.970462 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Nat Rev Immunol 2008; 8:247-58; PMID:18323851; http://dx.doi.org/10.1038/nri2274 2.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Target Oncol2012; 7:15-28; PMID:22327882; http://dx.doi.org/ 10.1007/s11523-012-0208-y 3.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Int J Cancer 2010; 127:759-67; PMID:20518016; http://dx.doi.org/10.1002/ijc.25429 4.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Immunity 2013; 39:1-10; PMID:23890059; http://dx.doi.org/10.1016/j.immuni.2013.07.012 5.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Tuning microenvironments: induction of regulatory T cells by dendritic cells.Immunity 2008; 29: 362-71.; PMID:18799144; http://dx.doi.org/10.1016/j.immuni.2008.08.005 6.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Front Immunol 2012;3:183; PMID:22783257; http://dx.doi.org/10.3389/ ﬁmmu.2012.00183 7.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Nat Med 2004; 10:942-9; PMID:15322536; http://dx.doi.org/ 10.1038/nm1093 8.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Cancer Res 2009; 69:3995-4000; PMID:19383912; http://dx.doi.org/10.1158/0008-5472.CAN-08-3804 9.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Cancer Res 2011; 71:736-46; PMID:21156649; http://dx.doi.org/10.1158/0008-5472.CAN-10-1797 10.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Curr Opin Immunol 2013; 25:277-83; PMID:23619309;http://dx.doi.org/10.1016/j.coi.2013.03.007 11.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
JClin Oncol 2008; 26:2292-8; PMID:18467720; http://dx.doi.org/10.1200/JCO.2007.13.316512.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Cancer Res 2006; 66: 4943-51; PMID:16651452; http://dx.doi.org/10.1158/0008-5472.CAN-05-3396 13.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
N Engl J Med 2011; 364:2119-27; PMID:21631324; http://dx.doi.org/10.1056/NEJMoa1012863 14.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Clin Oncol 2003; 21:1562-73; PMID:12697882; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Front Immu- nol 2012; 3:13; PMID:22566899; http://dx.doi.org/ 10.3389/ﬁmmu.2012.00013 17.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Immunol 2002; 168:2118-26;PMID:11859097; http://dx.doi.org/10.4049/ jimmunol.168.5.2118 18.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Immunother 2007; 30:715-26; PMID:17893564; http://dx.doi.org/10.1097/CJI.0b013e318135472c 19.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Blood 2005; 106:1278-85; PMID:15878980; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Trends Immunol 2013; 34:482-6; PMID:23608151; http://dx.doi.org/10.1016/j.it.2013.03.00121.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Immunol 2008; 180:6836- 45; PMID:18453604; http://dx.doi.org/10.4049/ jimmunol.180.10.6836 22.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Con-trol Release 2010; 144:118-26; PMID:20156497; http://dx.doi.org/10.1016/j.jconrel.2010.02.013 23.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Eur J Immunol 2013; 43:2543-53; PMID:23784881; http://dx.doi.org/10.1002/eji.201343429 24.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Immunol 2003; 170:1635-9; PMID:12574325; http://dx.doi.org/ 10.4049/jimmunol.170.4.1635 25.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Mol Immunol 2013; 53:387-97; PMID:23103377; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Control Release 2012; 160:88-95; PMID:22366522; http://dx.doi.org/ 10.1016/j.jconrel.2012.02.007 27.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Int J Cancer 2008; 122:839-46; PMID:17957800;http://dx.doi.org/10.1002/ijc.23101 28.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Mol Immunol 2009; 47:164-74; PMID:19818504; http://dx.doi.org/ 10.1016/j.molimm.2009.09.026 29.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Nat Biotechnol 2008; 26:326-34; PMID:18297056; http://dx.doi.org/10.1038/nbt1390 30.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Cancer Res 2010; 70:7788-99; PMID:20924102; http://dx.doi.org/ 10.1158/0008-5472.CAN-10-1736 31.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Exp Med 2008; 205:2125-38; PMID:18725522;http://dx.doi.org/10.1084/jem.20080099 33.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Clin Invest 2005; 115:3623-33;PMID:16308572; http://dx.doi.org/10.1172/ JCI25947 35.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Blood 2008; 112:610-8; PMID:18519811; http://dx.doi.org/ 10.1182/blood-2008-01-135319 36.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Blood 2013; 122:2185-94; PMID:23958949; http://dx.doi.org/10.1182/ blood-2012-09-456988 37.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Exp Med 2007; 204:57-63; PMID:17200412; http://dx.doi.org/ 10.1084/jem.20061852 38.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Nature 2003; 421:852-6; PMID:12594515; http://dx.doi.org/10.1038/nature01441 39.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Cancer Res 2010; 70:8368-77; PMID:20940398; http://dx.doi.org/ 10.1158/0008-5472.CAN-10-1322 40.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Eur J Immunol 2010; 40:3325-35; PMID:21072887; http://dx.doi.org/ 10.1002/eji.201041093 41.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Nat Immunol 2007; 8:191-7;PMID:17136045; http://dx.doi.org/10.1038/ni1428 43.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Eur J Immunol 2014; 44:2990-3002 (epub ahead of print)PMID:25042334; http://dx.doi.org/10.1002/eji.201344315 44.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Clin Invest 2011; 121:3846- 59; PMID:21926464; http://dx.doi.org/10.1172/ JCI44952 45.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Cancer Res 2010; 70:7800-9;PMID:20924111; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1681 46.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Nature 1998; 393:480-3; PMID:9624005; http://dx.doi.org/ 10.1038/31002 47.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Exp Med 1998; 187:693-702; PMID:9480979; http://dx.doi.org/10.1084/jem.187.5.693 48.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Curr Opin Immunol 2013; 25:277-83; PMID:23619309;http://dx.doi.org/10.1016/j.coi.2013.03.007 49.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Exp Med 2009; 206:1717-25; PMID:19581407; http://dx.doi.org/10.1084/jem.20082492 50.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
NEngl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 51.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
J Immunol 2005; 174:5994- 6004; PMID:15879092; http://dx.doi.org/10.4049/ jimmunol.174.10.5994 52.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
Curr Opin Immunol 2012; 24:207-12; PMID:22236695; http://dx.doi.org/10.1016/j.coi.2011.12.009 53.,OADS,/arxiv_data1/oa_pdf/40/d5/koni-04-08-970462.PMC4570108.pdf
"Speciﬁcally, the Th2 dominance thatis present in metastatic melanoma may be present in theregional lymph nodes and could be contributing to lymphatic *Correspondence to: Svetomir N Markovic; Email: markovic.svetomir@mayo.edu Submitted: 01/29/2015; Revised: 02/24/2015; Accepted: 02/27/2015 http://dx.doi.org/10.1080/2162402X.2015.1026504 www.tandfonline.com e1026504-1 OncoImmunologyOncoImmunology 4:8, e1026504; August 2015; © 2015 Taylor & Francis Group, LLCORIGINAL RESEARCH",Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
J Surg Oncol 2011; 104(4):379-85;PMID:21858832; http://dx.doi.org/10.1002/ jso.21876 2.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Cancer ImmunolImmunother 1989; 30(5):277-82; PMID:2696592; http://dx.doi.org/10.1007/BF01744894 3.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Mod Pathol 2011; 4:487-94; PMID:21151098; http://dx.doi.org/10.1038/modpathol.2010.227 6.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Clin Cancer Res 2009; 15(6):1931- 9; PMID:19240164; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1980 7.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Curr Oncol Rep 2002; 4(3):250-5; PMID:11937016; http://dx.doi.org/10.1007/s11912-002-0023-1 8.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Cancer Immunol Res 2014; 2 (2):127-32; PMID:24778276; http://dx.doi.org/ 10.1158/2326-6066.CIR-13-0163 9.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Oncoimmunology 2013; 2(5): e24436; PMID:23762809; http://dx.doi.org/10.4161/onci.24436 10.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
J Immunol 2001;166(2):996-1002; PMID:11145678; http://dx.doi.org/ 10.4049/jimmunol.166.2.99612.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Cancer Res 2011; 71(16):5455- 66; PMID:21715565; http://dx.doi.org/10.1158/ 0008-5472.CAN-11-1687 13.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Infect Immun 2007; 75(5):2244-52; PMID:17307945; http://dx.doi.org/ 10.1128/IAI.00024-07 14.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
PLoS Med 2007; 4(5):e176; PMID:17488182;http://dx.doi.org/10.1371/journal.pmed.0040176 15.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Cancer 2010; 116 (7):1757-66; PMID:20143437; http://dx.doi.org/ 10.1002/cncr.24899 17.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
JImmunother 2012; 35(2):169-78; PMID:22306905; http://dx.doi.org/10.1097/CJI.0b013e318247a4e7 18.,OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Clin Cancer Res 2014; 20 (19):5064-74; PMID:24714771; http://dx.doi.org/10.1158/1078-0432.CCR-13-3271 19.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Blood 2009; 114(8):1537-44; PMID:19423728; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
N Engl J Med 2011;364(26):2517-26; PMID:21639810; http://dx.doi.org/ 10.1056/NEJMoa1104621 21.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Clin Cancer Res 2007; 13(11):3125-32; PMID:17545514; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2645 22.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
J Am Acad Dermatol 2003; 49(2):255-63; PMID:12894074; http://dx.doi.org/10.1067/S0190-9622(03)00921-6 23.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
J Immunol 2010; 185(9):5648-55; PMID:20921519; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Ann Surg Oncol 2007; 14(8):2367-76; PMID:17534686; http://dx.doi.org/ 10.1245/s10434-007-9389-5 26.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Ann Surg Oncol 2012; 19(2):620-6; PMID:21861214; http://dx.doi.org/10.1245/s10434-011-2027-2 27.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Ecancermedicalscience 2008; 2:108; PMID:22275984; http://dx.doi.org/ 10.3332/ecancer.2008.108 28.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Cancer Res 2010; 70(15):6171-80; PMID:20631075; http://dx.doi.org/10.1158/0008- 5472.CAN-10-0153 29.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Clin Cancer Res 2011; 17(7):1776-83; PMID:21349994; http://dx.doi.org/10.1158/1078-0432.CCR-10-2836 30.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Nat Rev Immunol 2006; 6 (9):659-70; PMID:16932751; http://dx.doi.org/ 10.1038/nri1919 31.,Non-OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
Surg Oncol Clin N Am 2007; 16(1):247-61; PMID:17336247; http://dx.doi.org/10.1016/j.soc.,OADS,/arxiv_data1/oa_pdf/e9/c7/koni-04-08-1026504.PMC4570120.pdf
"The majority of the tissue-associated gdT cells bear the V d1 TCR, whereas the V d2 T cells represent the largest group in the blood, reaching up to 95%.11gdT cells in© Heleen H Van Acker, S /C19ebastien Anguille, Viggo F Van Tendeloo, and Eva Lion *Correspondence to: Heleen H Van Acker; Email: Heleen.VanAcker@uantwerp.be Submitted: 12/22/2014; Revised: 02/13/2015; Accepted: 02/14/2015http://dx.doi.org/10.1080/2162402X.2015.1021538 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Nat Rev Immunol 2013; 13:88-100; PMID:23348415; http://dx.doi.org/10.1038/nri3384 2.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunity 2009; 31:184- 96; PMID:19699170; http://dx.doi.org/10.1016/j.immuni.2009.08.006 3.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cell Mol Immunol2013; 10:13-20; PMID:23085946; http://dx.doi.org/ 10.1038/cmi.2012.45 4.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Br J Haematol 2013; 160:123-32;PMID:23061882; http://dx.doi.org/10.1111/ bjh.12090 5.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Oncoimmunology 2014; 3:e27572; PMID:24734216; http://dx.doi.org/ 10.4161/onci.27572 6.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Lancet Oncol 2014; 15:e257-e67; PMID:24872109; http://dx.doi.org/10.1016/S1470-2045(13)70585-0 7.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Intl J Med Microbiol 2008; 298:11-20; PMID:17719274; http://dx.doi.org/10.1016/j.ijmm.2007.07.003 8.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
AIDS 2012; 26: F1-12; PMID:22156965; http://dx.doi.org/10.1097/QAD.0b013e32834f33e8 9.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol2013; 190:3328-37; PMID:23447683; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Blood 2009; 114:4422-31; PMID:19762486; http://dx.doi.org/10.1182/blood- 2009-06-227256 11.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Int Rev Immunol 2013; 32:223-48; PMID:23617235; http://dx.doi.org/10.3109/08830185.2013.783831 12.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunity 2013;39:184-95; PMID:23890071; http://dx.doi.org/ 10.1016/j.immuni.2013.06.015 13.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cell Immunol2010; 264:71-7; PMID:20483407; http://dx.doi.org/ 10.1016/j.cellimm.2010.04.01314.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cell Mol Immunol 2013; 10:50-7; PMID:23064104; http://dx.doi.org/10.1038/cmi.2012.43 15.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunol Rev 2007;215:59-76; PMID:17291279; http://dx.doi.org/ 10.1111/j.1600-065X.2006.00479.x 16.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cytometry B Clin Cytom 2006; 70:379-90; PMID:16977635; http://dx.doi.org/10.1002/cyto.b.20115 17.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cancer Immunol Immunother 2009; 58:493-502; PMID:18682944; http://dx.doi.org/ 10.1007/s00262-008-0571-9 18.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2009; 182:7287-96; PMID:19454726; http://dx.doi.org/10.4049/jimmunol.0804288 19.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Neuro Oncol 2009; 11:357-67; PMID:19211933;http://dx.doi.org/10.1215/15228517-2008-111 20.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Trends Mol Med 2009; 15:275-84; PMID:19487160; http://dx.doi.org/10.1016/j.molmed.2009.04.005 21.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Oncol Res 2010; 18:493-501;PMID:20681408; http://dx.doi.org/10.3727/ 096504010X12671222663638 24.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Bone Mar- row Transplan 2007; 39:751-7; PMID:17450185; http://dx.doi.org/10.1038/sj.bmt.170565025.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cell Mol Immunol 2013; 10:21-9; PMID:23085947; http://dx.doi.org/10.1038/cmi.2012.44 26.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
EurJ Immunol 2009; 39:1361-8; PMID:19404979; http://dx.doi.org/10.1002/eji.200838409 28.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunol Res 2007; 37:97-111; PMID:17695246; http://dx.doi.org/ 10.1007/BF02685893 29.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Science 2005; 309:264-8; PMID:15933162; http://dx.doi.org/10.1126/science.1110267 30.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cell Mol Life Sci 2011; 68:2443- 52; PMID:21573785; http://dx.doi.org/10.1007/ s00018-011-0706-6 31.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunol Lett 2009; 124:1-8; PMID:19465238; http://dx.doi.org/10.1016/j.imlet.2009.03.011 33.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2013; 190:2403-14;PMID:23355732; http://dx.doi.org/10.4049/ jimmunol.1202369 34.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cancer Res 2013; 73:6137-48; PMID:23959855; http://dx.doi.org/10.1158/0008- 5472.CAN-13-0348 35.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Hepatol 2013; 58:977-83; PMID:23262246; http://dx.doi.org/10.1016/j.jhep.2012.12.015 36.,OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cancer Immunol Immunother2010; 59:1109-20; PMID:20306041; http://dx.doi.org/ 10.1007/s00262-010-0839-8 39.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Curr Mol Med 2007; 7:658-73; PMID:18045144; http://dx.doi.org/10.2174/ 156652407782564345 40.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cell Mol Immunol 2008; 5:161-70; PMID:18582397; http://dx.doi.org/10.1038/cmi.2008.20 41.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Clin Invest 1995; 95:296-303; PMID:7814628; http://dx.doi.org/10.1172/ JCI117654 42.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cytotherapy 2002; 4:293-304;PMID:12194726; http://dx.doi.org/10.1080/ 146532402320219817 43.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2006; 176:1386-93; PMID:16424165; http://dx.doi.org/10.4049/jimmunol.176.3.1386 44.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Blood 2007; 110:921- 7; PMID:17403919; http://dx.doi.org/10.1182/blood- 2006-09-044321 45.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Exp Med 2003; 197:163-8; PMID:12538656; http://dx.doi.org/10.1084/jem.20021500 46.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2012; 189:5212-22; PMID:23105138;http://dx.doi.org/10.4049/jimmunol.1200093 48.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2007; 179:3057-64; PMID:17709520; http://dx.doi.org/10.4049/jimmunol.179.5.3057 49.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2010; 185:1770-6;PMID:20592281; http://dx.doi.org/10.4049/ jimmunol.1000966 50.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
"PloS One 2014; 9: e111095; PMID:25340508; http://dx.doi.org/ 10.1371/journal.pone.0111095 51. von Lilienfeld-Toal M, Sievers E, Bodemuller V, Mihailescu C, Marten A, Gorschluter M, Schmidt- Wolf IG.",OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunol Lett 2005; 99:103-8;PMID:15894118; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cytokine Growth Factor Rev 2014; 26 (1):15-24; PMID:25306466; http://dx.doi.org/ 10.1016/j.cytogfr.2014.09.001 53.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Eur J Immunol 2005; 35:1764-72; PMID:15915537; http://dx.doi.org/10.1002/eji.200525983 54.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Leukocyte Biol 2011; 90:727-34; PMID:21724805; http://dx.doi.org/10.1189/jlb.0311132 55.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Hum Vaccin Immunother 2013; 9:1956-61; PMID:23778748; http://dx.doi.org/ 10.4161/hv.25373 56.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Transl Med 2009; 7:109;PMID:20021667; http://dx.doi.org/10.1186/1479- 5876-7-109 57.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Eur J Immunol 2007; 37:1678-90; PMID:17492620; http://dx.doi.org/ 10.1002/eji.200636329 58.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Eur J Immunol 1997; 27:3135-42; PMID:9464798; http://dx.doi.org/ 10.1002/eji.1830271209 59.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Ann N Y Acad Sci 2005; 1062:79-94; PMID:16461791;http://dx.doi.org/10.1196/annals.1358.011 60.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
JImmunol 2009; 183:3625-33; PMID:19710464; http://dx.doi.org/10.4049/jimmunol.0901571 61.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunology 2004; 112:369-77; PMID:15196204; http://dx.doi.org/ 10.1111/j.1365-2567.2004.01908.x 62.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Exp Med 2011; 208:491-503; PMID:21383056; http://dx.doi.org/10.1084/jem.2010026963.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
EurJ Immunol 2010; 40:1927-37; PMID:20397212; http://dx.doi.org/10.1002/ eji.200940157 64.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunother 2012; 35:205-13; PMID:22306909; http://dx.doi.org/10.1097/ CJI.0b013e318245bb1e 65.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Exp Dermatol 2014; 24(1):35-41; PMID:25363560;http://dx.doi.org/10.1111/exd.12581 66.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Leukocyte Biol 2008; 83:742-54; PMID:18156189; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunother 2010; 33:40- 52; PMID:19952957; http://dx.doi.org/10.1097/ CJI.0b013e3181b51447 68.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2011; 187:1578-90; PMID:21753152; http://dx.doi.org/10.4049/jimmunol.1002514 70.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Bone Miner Res 2004; 19:278-88; PMID:14969398; http://dx.doi.org/10.1359/JBMR.0301230 71.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunol Cell Biol 2013; 91:461-8; PMID:23797069; http://dx.doi.org/10.1038/ icb.2013.30 72.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Cancer Immunol Immunother 2012; 61:535-47; PMID:22002242; http://dx.doi.org/ 10.1007/s00262-011-1121-4 73.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Immunobiology 2014; 219:503-11;PMID:24674241; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2005; 175:5656-65; PMID:16237055; http://dx.doi.org/ 10.4049/jimmunol.175.9.5656 75.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
J Immunol 2005; 174:252-60; PMID:15611247; http://dx.doi.org/10.4049/jimmunol.174.1.252 76.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Front Immunol 2014; 5:7; PMID:24550907; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Brit J Haematol 2011;153:796-9; PMID:21477159; http://dx.doi.org/ 10.1111/j.1365-2141.2010.08490.x78.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
Front Immunol 2014; 5:366; PMID:25132835; http://dx.doi.org/10.3389/ﬁmmu.2014.00366 79.,Non-OADS,/arxiv_data1/oa_pdf/6a/3d/koni-04-08-1021538.PMC4570126.pdf
"Based on our ﬁndings, wepropose a model in which stromalexpression of IP-10, induced by PCCs, © Serena Lunardi, Su Yin Lim, Ruth J Muschel, and Thomas B Brunner *Correspondence to: Serena Lunardi; Email: serena.lunardi@oncology.oxon.orgSubmitted: 03/03/2015; Accepted: 03/03/2015 http://dx.doi.org/10.1080/2162402X.2015.1027473 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
New Engl J Med 2011; 364:1817-25; PMID:21561347; http://dx.doi.org/ 10.1056/NEJMoa1011923 2 .,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
New EnglJ Med 2013; 369: 1691-703; PMID:24131140; http://dx.doi.org/ 10.1056/NEJMoa1304369 3.,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
Biochi m Biophys Acta 2013; 1836:287-95; PMID:23994549; http://dx.doi.org/ 10.1016/j.bbcan.2013.08.002 5.,OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
Cancer Res 2012; 72:4351-60; PMID:22798340; http://dx.doi.org/ 10.1158/0008-5472.CAN-12-0579 6.,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
Clin Cancer Res 2013;19:336-46; PMID:23213058; http://dx.doi.org/ 10.1158/1078-0432.CCR-11-3314 7.,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
Cancer Res2012; 72:3735-43; PMID:22593190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
Immunotherapy 2011; 3:517-37; PMID:21463193;http://dx.doi.org/10.2217/imt.11.10 9.,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
CancerCell 2014; 25:719-34; PMID:24856586; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9c/0a/koni-04-09-1027473.PMC4570127.pdf
See this link for the animation: http://youtu.be/ xHbwQuCTkRc.,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
"The previous results provide a basis to understand the antitumor immune *Correspondence to: Nicolle H Rekers; Email: nicolle.rekers@maastrichtuniversity.nl Submitted: 02/13/2015; Revised: 02/13/2015; Accepted: 02/14/2015 http://dx.doi.org/10.1080/2162402X.2015.1021541 www.tandfonline.com e1021541-1 OncoImmunologyOncoImmunology 4:8, e1021541; August 2015; © 2015 Taylor & Francis Group, LLCAUTHOR'S VIEW",Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
Front Oncol 2012; 2:153; PMID:23112958;http://dx.doi.org/10.3389/fonc.2012.00153 2.,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
Front Oncol 2012; 2:191;PMID:23251903; http://dx.doi.org/10.3389/fonc.,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
Nat Rev Cancer 2012;12:860-75; PMID:23151605; http://dx.doi.org/ 10.1038/nrc33804.,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
18:391-5; PMID:25179250; http://dx.doi.org/ 10.1016/j.canrad.2014.06.012 6.,OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
J Immunol 2014; 192:5451-8;PMID: 24907378; http://dx.doi.org/10.4049/ jimmunol.1490019 7.,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
Clin Pharmacol 2013; 5:29-45; PMID:23990735; http://dx.doi.org/10.2147/CPAA.S492318.,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
N Engl J Med 2012; 366:925-31; PMID:22397654; http://dx.doi.org/ 10.1056/NEJMoa1112824 10.,OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
Front Immu- nol 2012; 3:21; PMID:22566905; http://dx.doi.org/ 10.3389/ﬁmmu.2012.00021 www.tandfonline.com e1021541-3 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/1c/26/koni-04-08-1021541.PMC4570128.pdf
"(2)Reports documenting the use of ﬂuconazole in CS are scarce; one case report, Open AccessV Schwetz and others Fluconazole, acetazolamide in Cushing’s syndromeID: 15-0027; June 2015 DOI: 10.1530/EDM-15-0027 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/10/05/edmcr-2015-150027.PMC4570129.pdf
"Fluconazole was started with 200 mg daily, after 2 days was increased to 400 mg, then gradually up to 1200 mg. After 1 week, ﬂuconazole doses were tapered again to V Schwetz and others Fluconazole, acetazolamide in Cushing’s syndromeID: 15-0027; June 2015 DOI: 10.1530/EDM-15-0027 http://www.edmcasereports.com 2",Non-OADS,/arxiv_data1/oa_pdf/10/05/edmcr-2015-150027.PMC4570129.pdf
"Treatment changes:Day 15 acetazolamide 250 mg, day 17 acetazolamide 750 mg. V Schwetz and others Fluconazole, acetazolamide in Cushing’s syndromeID: 15-0027; June 2015 DOI: 10.1530/EDM-15-0027 http://www.edmcasereports.com 3",Non-OADS,/arxiv_data1/oa_pdf/10/05/edmcr-2015-150027.PMC4570129.pdf
"( doi:10.1097/00003246- 200103000-00039 ) V Schwetz and others Fluconazole, acetazolamide in Cushing’s syndromeID: 15-0027; June 2015 DOI: 10.1530/EDM-15-0027 http://www.edmcasereports.com 4",Non-OADS,/arxiv_data1/oa_pdf/10/05/edmcr-2015-150027.PMC4570129.pdf
"01.005 ) Received in ﬁnal form 15 May 2015 Accepted 21 May 2015 V Schwetz and others Fluconazole, acetazolamide in Cushing’s syndromeID: 15-0027; June 2015 DOI: 10.1530/EDM-15-0027 http://www.edmcasereports.com 5",Non-OADS,/arxiv_data1/oa_pdf/10/05/edmcr-2015-150027.PMC4570129.pdf
"We observed an increased rate ofinduced CAC tumor formation in TSSP-deﬁcient mice compared to TSSP-proﬁ-cient, thus conﬁrming their enhancedsusceptibility to cancer development.Induced colitis experiments showed that © Lydie Brisson and Alice Carrier *Correspondence to: Alice Carrier; Email: alice.carrier@inserm.frSubmitted: 02/27/2015; Accepted: 02/27/2015 http://dx.doi.org/10.1080/2162402X.2015.1026536 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
Nat Rev Cancer 2012; 12:298-306; PMIsD:22419253; http://dx.doi.org/10.1038/nrc3245 2.,Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
Cell Immunol 1999; 196:80-6; PMID:10527559; http://dx.doi.org/ 10.1006/cimm.1999.1543 3.,Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
Immunoge netics 1999; 50:255-70; PMID:10630289; http://dx.doi.org/10.1007/ s002510050601 4.,Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
Eur J Immunol 2009; 39:956-64; PMID:19283781; http://dx.doi.org/ 10.1002/eji.200839175 6.,Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
"Viret C, Leung-Theung-Long S, Serre L, Lamare C, Vignali DA, Malissen B, Carrier A, Guerder S. Thy- mus-speciﬁc serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice.J Clin Invest 2011; 121:1810-21; PMID:21505262; http://dx.doi.org/10.1172/JCI43314 8.",Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
Cell Rep 2015; 10:39-46; PMID:25543139; http://dx.doi.org/ 10.1016/j.celrep.2014.12.009 www.tandfonline.com e1026536-3 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/38/28/koni-04-09-1026536.PMC4570136.pdf
"12Inhibitory © Camille Laurent, Konstantina Charmpi, Pauline Gravelle, Marie Tosolini, Camille Franchet, Lo €ıc Ysebaert, Pierre Brousset, Alexandre Bidaut, Bernard Ycart, and Jean-Jacques Fourni /C19e *Correspondence to: Camille Laurent; Email: laurent.c@chu-toulouse.frSubmitted: 02/03/2015; Revised: 02/27/2015; Accepted: 02/27/2015 http://dx.doi.org/10.1080/2162402X.2015.1026530 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
59 Statistical analysis KS tests for IEGS distribution analysis This analysis of transcriptomes from human FL and DLBCL biopsies as well as B cell controls was based on relevant datasetsdownloaded from NCBI GEO (http://www.ncbi.nlm.nih.gov/ gds).,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Nat Rev Cancer 2012; 12:252- 64; PMID:22437870; http://dx.doi.org/10.1038/ nrc3239 3.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Science 1996; 271:1734-6; PMID:8596936; http://dx.doi.org/ 10.1126/science.271.5256.1734 5.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Proc Natl Acad Sci USA 2003; 100:4712-7; PMID:12682289; http://dx.doi.org/ 10.1073/pnas.0830997100 7.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992; http://dx.doi.org/10.1056/NEJMoa1003466 8.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Ann Hematol 2011;90:409-16; PMID:20938662; http://dx.doi.org/ 10.1007/s00277-010-1093-z 9.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Clin Invest 2007; 117:1147-54; PMID:17476344; http://dx.doi.org/ 10.1172/JCI31178 11.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Immunity 1999; 11:141-51; PMID:10485649; http://dx.doi.org/10.1016/S1074-7613(00)80089-8 16.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Nat Med 2002; 8:793-800; PMID:12091876; http://dx.doi.org/10.1038/nm0902-1039c 18.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Exp Med 2006; 203:883-95; PMID:16606670; http://dx.doi.org/ 10.1084/jem.20051776 19.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Nature2011; 471:377-81; PMID:21368758; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Blood 2010; 116:3268-77; PMID:20628145; http://dx.doi.org/10.1182/blood- 2010-05-282780 21.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Clin Cancer Res 2012; 18:1611-8; PMID:22271878; http://dx.doi.org/ 10.1158/1078-0432.CCR-11-1942 22.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Exp Med 2014; 211:781-90; PMID:24778419; http://dx.doi.org/10.1084/jem.20131916 23.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
N Engl J Med 2002;346:1937-47; PMID:12075054; http://dx.doi.org/ 10.1056/NEJMoa012914 24.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Leukemia 2014; 28:1784-92; PMID:24691076; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Curr Opin Oncol 2014; 26:204-14; PMID:24424272; http://dx.doi.org/10.1097/CCO.0000000000000054 26.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
PMID: 25482239; http://dx.doi.org/ 10.1056/NEJM oa1411087 27.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Immunity 2004; 21:503-13; PMID:15485628; http://dx.doi.org/10.1016/j.immuni.2004.08.010 28.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Cancer Res 2012; 72:917-27; PMID:22186141; http://dx.doi.org/ 10.1158/0008-5472.CAN-11-1620 29.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Nature 2009; 459:717-21; PMID:19412164;http://dx.doi.org/10.1038/nature07968 30.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Exp Med2008; 205:2251-68; PMID:18794340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
In: http://www.ncbi.nlm.nih.gov/geo/query/acc.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Leuke- mia 2007; 21:541-9; PMID:17252022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Blood 2004; 103:275-82; PMID:14504078; http://dx.doi.org/10.1182/blood-2003-05-1545 36.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Clin Cancer Res 2011; 17:4232-44; PMID:21540239; http://dx.doi.org/10.1158/1078-0432.CCR-10-2660 37.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Cell 2015; 160:48-61; PMID:25594174; http://dx.doi.org/ 10.1016/j.cell.2014.12.033 38.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Cancer Immunol Res 2013; 1:112-22; PMID:24409449; http://dx.doi.org/10.1158/2326-6066.CIR-13-0028 39.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Lab Invest 2014; 94:107-16; PMID:24217091; http://dx.doi.org/ 10.1038/labinvest.2013.130 40.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Clin Oncol 2013; 31:4311-8; PMID:24145345; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Clin Cancer Res 2013; 19:3462-73;PMID:23674495; http://dx.doi.org/10.1158/1078- 0432.CCR-13-0855 42.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Clin Neuropathol 2014; 33:42-9; PMID:24359606; http://dx.doi.org/10.5414/NP300698 43.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Nature 2000; 403:503-11; PMID:10676951; http://dx.doi.org/ 10.1038/35000501 44.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Exp Med 2001; 194:1861-74; PMID:11748286; http://dx.doi.org/10.1084/jem.194.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Cancer Immunol Res 2013; 1:85-91; PMID:24777499; http://dx.doi.org/10.1158/2326- 6066.CIR-13-0078 46.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Immunol 2003; 170:1257-66; PMID:12538684; http://dx.doi.org/10.4049/jimmunol.170.3.1257 48.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Clin Cancer Res 2010; 16:637-50; PMID:20068089; http://dx.doi.org/ 10.1158/1078-0432.CCR-09-2487 49.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Leukemia 2012; 26:1053-63; PMID:22015774; http://dx.doi.org/10.1038/leu.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Blood 2013; 121:1367-76; PMID:23297127; http://dx.doi.org/10.1182/blood-2012-04-421826 51.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Clin Oncol 2009; 27:1470-6; PMID:19224853; http://dx.doi.org/ 10.1200/JCO.2008.18.0513 52.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Blood 2010; 115:289-95; PMID:19901260;http://dx.doi.org/10.1182/blood-2009-07-23559853.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Lancet Oncol 2014; 15:69-77; PMID:24332512; http://dx.doi.org/ 10.1016/S1470-2045(13)70551-5 54.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
J Clin Oncol2014; 32:1020-30; PMID:24590637; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Nature 2001; 410:1107-11; PMID:11323675; http://dx.doi.org/10.1038/ 35074122 59.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
Biometrics 1977; 33:159-74; PMID:843571; http://dx.doi.org/10.2307/2529310 60.,Non-OADS,/arxiv_data1/oa_pdf/d7/40/koni-04-08-1026530.PMC4570141.pdf
"Within © Kalijn F Bol, Carl G Figdor, Erik HJG Aarntzen, Marieke EB Welzen, Michelle M van Rossum, Willeke AM Blokx, Mandy WMM van de Rakt, Nicole M Scharenborg, Annemiek J de Boer, Jeanette M Pots, Michel AM olde Nordkamp, Tom GM van Oorschot, Roel DM Mus, Sandra AJ Croockewit, Joannes FM Jacobs, Gerold Schu- ler, Bart Neyns, Jonathan M Austyn, Cornelis JA Punt, Gerty Schreibelt, and I Jolanda M de Vries*Correspondence to: I Jolanda M de Vries; Email: Jolanda.deVries@radboudumc.nlSubmitted: 01/14/2015; Revised: 02/09/2015; Accepted: 02/09/2015 http://dx.doi.org/10.1080/2162402X.2015.1019197 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Nature 2007; 449:419-26; PMID:17898760; http://dx.doi.org/10.1038/nature061752.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Nat Med 2004; 10:475-80; PMID:15122249; http://dx.doi.org/10.1038/nm10393.,OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
387:713-7; PMID:9192897; http://dx.doi.org/ 10.1038/42716 4.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588 5.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Nat Med 1999; 5:405-11;PMID:10202929; http://dx.doi.org/10.1038/7403 6.,OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
"Crit RevOncol Hematol 2008; 66:118-34; PMID:18262431; http://dx.doi.org/10.1016/j.critrevonc.2007.12.007 7. de Vries IJ, Bernsen MR, Lesterhuis WJ, Scharenborg NM, Strijk SP, Gerritsen MJ, Ruiter DJ, Figdor CG, Punt CJ, Adema GJ.",OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Clin Oncol 2005; 23:5779-87;PMID:16110035; http://dx.doi.org/10.1200/JCO.,OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Cancer Res 2012:72:6102-10; PMID:23010076; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Immunol 2004;172:1304-10; PMID:14707109; http://dx.doi.org/ 10.4049/jimmunol.172.2.1304 10.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
"J Immunother 2011; 34:448-56; PMID:21577140;http://dx.doi.org/10.1097/CJI.0b013e31821dcb31 11. de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ et al.",OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Int J Cancer 2001; 93:243-51; PMID:11410873; http://dx.doi.org/10.1002/ijc.1323 13.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Mol Ther 2008; 16:1170-80; PMID:18431362; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Clin Cancer Res 2009; 15:3366-75; PMID:19417017; http://dx.doi.org/ 10.1158/1078-0432.CCR-08-2982 17.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Mol Ther 2012; 20:1063-74; PMID:22371843; http://dx.doi.org/10.1038/mt.2012.11 21.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Ann Oncol 2013; 24:2686-93; PMID:23904461; http://dx.doi.org/ 10.1093/annonc/mdt245 22.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Nucl Med Biol 2006; 33:453-8; PMID:16720236; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Clin Invest 2000; 106:1065-9; PMID:11067858; http://dx.doi.org/ 10.1172/JCI11405 24.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Exp Med 1996; 183:527-34; PMID:8627164; http://dx.doi.org/ 10.1084/jem.183.2.527 25.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Exp Med 2000; 192:1755-62; PMID:11120772; http://dx.doi.org/10.1084/jem.192.12.1755 26.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Cancer Res 2013; 73: 19-29; PMID:23087058; http://dx.doi.org/10.1158/ 0008-5472.CAN-12-1127 27.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
"Van Nuffel AM, Wilgenhof S, Thielemans K, Bonehill A. Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapy.Oncoimmunology 2012; 1:1392-s4; PMID:23243604; http://dx.doi.org/10.4161/onci.20926 28.",Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Can- cer Res 2009; 69:2927-34; PMID:19318559; http://dx.doi.org/10.1158/0008-5472.CAN-08-3920 29.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Blood 2001; 98:49-56;PMID:11418462; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Cancer Immunol Immunother 2009;58:1109-15; PMID:19018531; http://dx.doi.org/ 10.1007/s00262-008-0626-y 31.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Immunol 2006;176:5153-9; PMID:16621978; http://dx.doi.org/ 10.4049/jimmunol.176.9.5153 32.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657; http://dx.doi.org/10.1158/1078-0432.CCR-11-3368 33.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Cancer Immunol Immunother 2011; 60:249-60; PMID:21069321; http://dx.doi.org/10.1007/s00262-010-0942-x 36.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Clin Cancer Res 2011; 17:5725-35; PMID:21771874; http://dx.doi.org/10.1158/1078-0432.CCR-11-1261 37.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
J Immunol 2003; 171:6275-82; PMID:14634145; http://dx.doi.org/ 10.4049/jimmunol.171.11.6275 38.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Nat Med 2015; 21:81-5; PMID:25531942; http://dx.doi.org/10.1038/nm.3773 39.,OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Cancer Res 2013; 73:1063-75; PMID:23345163; http://dx.doi.org/10.1158/0008- 5472.CAN-12-2583 40.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Oncoimmunology 2013; 2:e23431; PMID:23802086; http://dx.doi.org/10.4161/onci.23431 41.,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
Cancer Immunol Immunother 2012; 61:2003-11; PMID:22527252;http://dx.doi.org/10.1007/s00262-012-1263-z www.tandfonline.com e1019197-11 OncoImmunology,Non-OADS,/arxiv_data1/oa_pdf/2b/2c/koni-04-08-1019197.PMC4570143.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/dc/bbu045.PMC4570199.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/4b/bbv001.PMC4570204.pdf
BOLD: The barcode of life data system (http://www.barcodinglife.org).,Non-OADS,/arxiv_data1/oa_pdf/db/4b/bbv001.PMC4570204.pdf
"For sequence analysis, adapters were removed,and the 12- to 50-nt fragments were aligned to the mouse tRNAgenomic database (mm10, http://gtrnadb.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/e2/01/embj0034-2350.PMC4570521.pdf
"Data access Gene expression, tRNA fragment sequencing, and ribosome profil- ing sequencing data are available in the NCBI GEO database: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE65758 Proteomic data are available at: https://www.proteomicsdb.org/ #projects/4218?accessCode=b76cde20c76128282b5f4806dad0a92461182315a5285b074ee356df210d52ad Expanded View for this article is available online: http://emboj.embopress.org Acknowledgements We thank Matthias Schaefer for valuable advice and helpful comments onthe manuscript.",OADS,/arxiv_data1/oa_pdf/e2/01/embj0034-2350.PMC4570521.pdf
Figures 1–4 are prepared with the program PyMOL (http://www.PyMOL.org).,Non-OADS,/arxiv_data1/oa_pdf/2d/1a/pro0024-1389.PMC4570534.pdf
"To create the figures,default settings from the Weblogo website (http://weblogo.berkeley.edu/) were used except for the smallsample correction, which decreases the height of all ofthe letters in small samples; given the small samplesizes, it was important for all letters to be visible forthe analysis.",Non-OADS,/arxiv_data1/oa_pdf/7d/14/pro0024-1423.PMC4570537.pdf
"duPont Hospital for Children, Wilming- ton, DE 19803, USA;9Dipartimento di Biologia Cellulare e Neuroscienze, Istituto Superiore di Sanita `, Rome, 00161 Italy;10Mendel Laboratory, IRCCS Casa Sollievo della Sofferenza, Rome, 00198 Italy;11Dipartimento di Psicologia, Sezione di Neuroscienze, Universita `‘‘La Sapienza,’’ Rome, 00161 Italy;12Sezione di Istologia e Embriologia Medica, Dipartimento di Scienze Anatomiche, Istologiche, Medico-legali e dell’Apparato Locomotore, Universita `‘‘La Sapienza,’’ Rome, 00161 Italy;13De´partement de Ge ´ne´tique Me ´dicale, Ho ˆpital d’Enfants de la Timone, Marseille, 13385 France;14Division of Medical Genetics, Ochsner Health System, New Orleans, LA 70121, USA;15Department of Pediatrics, Center for Genetic Medicine, University of Yamanashi, Chuo, Yamana- shi, 409-3898 Japan;16Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute/NIH, Bethesda, MD 20892, USA; 17Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, MO 63104, USA;18Institut fu ¨r Humangenetik, Universita ¨tz uL u ¨beck, Lu¨beck, 23538 Germany;19Department of Pediatrics, Sainte-Justine Hospital, University of Montreal, Montreal, H3T 1C5 Canada;20Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA;21Institut Curie Centre de Recherche, CNRS UMR 3347, INSERM U1021, Paris Sud University, Orsay, 91405 France 22These authors contributed equally to this work 23These authors contributed equally to this work *Correspondence: marco.tartaglia@iss.it http://dx.doi.org/10.1016/j.ajhg.2015.03.001 ./C2112015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/69/29/main.PMC4570552.pdf
Supplemental Data Supplemental data include six ﬁgures and eight tables and can be found with this article online at http://dx.doi.org/10.1016/j.ajhg.,OADS,/arxiv_data1/oa_pdf/69/29/main.PMC4570552.pdf
"Received: January 22, 2015 Accepted: March 2, 2015 Published: April 9, 2015 Web Resources The URLs for data presented herein are as follows: ArrayExpress, http://www.ebi.ac.uk/arrayexpress/ Combined Annotation Dependent Depletion (CADD), http:// cadd.gs.washington.edu/ dbNSFP v.2.0, https://sites.google.com/site/jpopgen/dbNSFP GeneDistiller, http://www.genedistiller.org/ NCBI Gene, http://www.ncbi.nlm.nih.gov/gene OMIM, http://www.omim.org/ RCSB Protein Data Bank, http://www.rcsb.org/pdb/home/home.do References 1.",OADS,/arxiv_data1/oa_pdf/69/29/main.PMC4570552.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/36/main.PMC4570591.pdf
"On electron microscopy, we observed severe podocytejournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/7a/36/main.PMC4570591.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7a/36/main.PMC4570591.pdf
http://dx.doi.org/10.1016/j.krcp.2014.09.003 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/7a/36/main.PMC4570591.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/e2/main.PMC4570593.pdf
"Signi ﬁcantly low serum magnesium levels have been associated with bradycardia, hypotension, seizures,tetany, and death [1,2].journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/c7/e2/main.PMC4570593.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c7/e2/main.PMC4570593.pdf
http://dx.doi.org/10.1016/j.krcp.2015.03.001 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/c7/e2/main.PMC4570593.pdf
Epub 2014 Jan 10. http://dx.doi.org/10.1136/ bcr-2012-006342 .,Non-OADS,/arxiv_data1/oa_pdf/c7/e2/main.PMC4570593.pdf
"Manypotential mediators of this increased risk have been proposed,including an increased prevalence of traditional risk factors, such as hypertension, diabetes, and dyslipidemia, as well as other factors that may relate more directly to reduced kidneyfunction, such as endothelial dysfunction, increased sympatheticjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/df/02/main.PMC4570594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/df/02/main.PMC4570594.pdf
http://dx.doi.org/10.1016/j.krcp.2015.02.003 Kidney Res Clin Pract 34 (2015) 1 –3,Non-OADS,/arxiv_data1/oa_pdf/df/02/main.PMC4570594.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
"Diabetes, hypertension,and glomerular renal disease are documented as commonjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
http://dx.doi.org/10.1016/j.krcp.2015.05.002 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
"Gene SNPs were identi ﬁed using the National Centerfor Biotechnology Information dbSNP database, version 131 (National Center for Biotechnology Information, Bethesda, MD,USA; http://www.ncbi.nlm.nih.gov/SNP ) and the International HapMap Project database ( http://www.Hapmap.org/index.html ).",OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
Statistical analysis Compliance with the Hardy –Weinberg equilibrium was eval- uated using the SNPstats software ( http://bioinfo.iconcologia.net / index.php module ¼SNPStats) for all the SNPs.,OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
We also used the online program AliBaba2.1 (Labmom.com; http://www.gene-regulation.,OADS,/arxiv_data1/oa_pdf/51/6c/main.PMC4570595.pdf
Letter and Reply Toll-like receptor 4 antagonist and obesity associated kidney disease: Where should we go from here?journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect To the Editor: The toll-like receptor (TLR) family plays an important regula- tory role in the innate immune system.,Non-OADS,/arxiv_data1/oa_pdf/5e/8d/main.PMC4570596.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/8d/main.PMC4570596.pdf
http://dx.doi.org/10.1016/j.krcp.2014.10.007 Kidney Res Clin Pract 34 (2015) 64 –65,Non-OADS,/arxiv_data1/oa_pdf/5e/8d/main.PMC4570596.pdf
"Available at: http://www.labanimal.co.kr/product/ pdf/RD%20High%20Fat01.pdf [2]Chin SH, Item F, Wueest S, Zhou Z, Wiedemann MS, Gai Z, Schoenle EJ, Kullak-Ublick GA, Al-Hasani H, Konrad D: Opposing effects of reduced kidney mass on liver and skeletal muscle insulin sensitiv- ity in obese mice.",Non-OADS,/arxiv_data1/oa_pdf/5e/8d/main.PMC4570596.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/c5/main.PMC4570600.pdf
"Since the discovery of mutation of NPHS1 gene, which codes for nephrin (an SD-associated protein), in patients with Finnish-type congenital NS, mutations of several podocyte- associated genes including CD2AP ,T R P C 6 [17],NPHS2 ,a n d NEPH1 were found to be associated with NS [3,4].P o d o c y t e sa n djournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/main.PMC4570600.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/c5/main.PMC4570600.pdf
http://dx.doi.org/10.1016/j.krcp.2015.03.003 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/5e/c5/main.PMC4570600.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/d7/62/main.PMC4570601.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/62/main.PMC4570601.pdf
http://dx.doi.org/10.1016/j.krcp.2015.02.004 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/d7/62/main.PMC4570601.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/87/main.PMC4570602.pdf
When classi ﬁed by the recommended range according to the Kidney Disease Outcome Quality Initiativejournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/59/87/main.PMC4570602.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/87/main.PMC4570602.pdf
http://dx.doi.org/10.1016/j.krcp.2015.02.002 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/59/87/main.PMC4570602.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/2a/main.PMC4570603.pdf
There is a possibility that thejournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/08/2a/main.PMC4570603.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/2a/main.PMC4570603.pdf
"http://dx.doi.org/10.1016/j.krcp.2014.11.002 nCorresponding author: Department of Internal Medicine, Korea University A n a mH o s p i t a l ,5 K a ,A n a m - D o n g ,S e o n g b u k - G u ,S e o u l ,1 3 6 - 7 0 5 ,K o r e a .E-mail address: sang-kyung@korea.ac.kr (S-K Jo).Kidney Res Clin Pract 34 (2015) 13 –19",Non-OADS,/arxiv_data1/oa_pdf/08/2a/main.PMC4570603.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/57/main.PMC4570604.pdf
"Laboratory values on admission to the hospital were as follows: white blood cell count, 8,400/mm 3with 81.1% ofjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/f8/57/main.PMC4570604.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/57/main.PMC4570604.pdf
http://dx.doi.org/10.1016/j.krcp.2014.09.006 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/f8/57/main.PMC4570604.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/01/main.PMC4570605.pdf
"Different modi ﬁcations of testing end- othelium-dependent vasorelaxation have become the standard for diagnosing ECD, together with other surrogate biomarkers such as markers of oxidative stress [8-iso-prostaglandin F2-alphaand oxidized low-density lipoprotein (LDL)], proin ﬂammatory markers (high-sensitivity C-reactive protein, lipoprotein- associated phospholipase A2, soluble intercellular adhesionjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/c2/01/main.PMC4570605.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/01/main.PMC4570605.pdf
http://dx.doi.org/10.1016/j.krcp.2015.05.003 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/c2/01/main.PMC4570605.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/16/main.PMC4570630.pdf
"Case report A 49 year old, 53 kg woman on continuous ambulatory peritoneal dialysis since August 2011 developed her ﬁrstjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/16/main.PMC4570630.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/16/main.PMC4570630.pdf
http://dx.doi.org/10.1016/j.krcp.2014.09.005 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/ae/16/main.PMC4570630.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/c4/main.PMC4570631.pdf
"Many studies have shown the bene ﬁcial effects of anemia treatment such as improved quality of life; protection against cardiovascular disease [4];a n dr e d u c e dm o r - tality, morbidity, and hospitalization rates [5]in patients withjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/25/c4/main.PMC4570631.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/c4/main.PMC4570631.pdf
http://dx.doi.org/10.1016/j.krcp.2014.11.003 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/25/c4/main.PMC4570631.pdf
Available at: http://www.nhis.or.kr/portal/site/main/MENU_WBDDC04 [Date accessed: 21 Nov 2013].,Non-OADS,/arxiv_data1/oa_pdf/25/c4/main.PMC4570631.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ ucm259639.htm [Date accessed: 15 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/25/c4/main.PMC4570631.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/3d/main.PMC4570632.pdf
"Bradley and Bradley [1], more than 60 years ago, found that intra- abdominal hypertension (IAH) induced by abdominaljournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/5f/3d/main.PMC4570632.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/3d/main.PMC4570632.pdf
http://dx.doi.org/10.1016/j.krcp.2015.03.004 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/5f/3d/main.PMC4570632.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/b1/main.PMC4570633.pdf
"The possible causes of PHT in dialysis patients are classi ﬁed into three categories: (1) increased cardiac output caused by an arteriovenous ﬁstula, anemia, or hypervole- mia; (2) increased pulmonary vascular resistance caused by uremic endothelial dysfunction, pulmonary embolism, pulmonary artery calci ﬁcations, or other comorbid diseases including chronic obstructive pulmonary disease or connective tissue disease; and(3) elevated pulmonary capillary wedge pressure caused byjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/16/b1/main.PMC4570633.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/b1/main.PMC4570633.pdf
http://dx.doi.org/10.1016/j.krcp.2015.01.003 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/16/b1/main.PMC4570633.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/c5/main.PMC4570644.pdf
A 24-hour urine collection revealedjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/c8/c5/main.PMC4570644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/c5/main.PMC4570644.pdf
http://dx.doi.org/10.1016/j.krcp.2014.10.008 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/c8/c5/main.PMC4570644.pdf
Given itsjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/5f/da/main.PMC4570645.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/da/main.PMC4570645.pdf
http://dx.doi.org/10.1016/j.krcp.2015.05.001 Kidney Res Clin Pract 34 (2015) 67 –68,Non-OADS,/arxiv_data1/oa_pdf/5f/da/main.PMC4570645.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/77/main.PMC4570646.pdf
"Aquaporin-11 (AQP11) is one of the newly described members, and its function is still not clearlyunderstood.journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/05/77/main.PMC4570646.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/77/main.PMC4570646.pdf
http://dx.doi.org/10.1016/j.krcp.2015.01.002 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/05/77/main.PMC4570646.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/44/main.PMC4570647.pdf
CT indicated the presence of multiple renal stones and dilatedjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/e4/44/main.PMC4570647.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e4/44/main.PMC4570647.pdf
http://dx.doi.org/10.1016/j.krcp.2014.09.004 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/e4/44/main.PMC4570647.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4570648.pdf
"On further questioning, she confessed to having taken large amounts of three types of nonprescription laxatives (up to 50 tablets daily) for at least 10 years after thejournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4570648.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4570648.pdf
http://dx.doi.org/10.1016/j.krcp.2014.10.009 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/bf/fc/main.PMC4570648.pdf
And the unit of urine volume was not mL/d but μL/d.journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/main.PMC4570650.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/f6/main.PMC4570650.pdf
http://dx.doi.org/10.1016/j.krcp.2015.03.002DOI of original article: http://dx.doi.org/10.1016/j.krcp.2013.11.002 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/b5/f6/main.PMC4570650.pdf
"Available at: http://www.theisn.org/topics/interventional-nephrology38 [2] Roy-Chaudhury P, Yevzlin A, Bonventre JV, Agarwal A, Almehmi A, Besarab A, Dwyer A, Hentschel DM, Kraus M,Maya I, P ﬂederer T, Schon D, Wu S, Work J: Academic interventional nephrology: a model for training, research, and patient care.",Non-OADS,/arxiv_data1/oa_pdf/a5/1c/main.PMC4570651.pdf
"J Korean Radiol Soc 51:45 –53, 2004journal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.",Non-OADS,/arxiv_data1/oa_pdf/a5/1c/main.PMC4570651.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a5/1c/main.PMC4570651.pdf
http://dx.doi.org/10.1016/j.krcp.2015.04.001 Kidney Res Clin Pract 34 (2015) 120 –121,Non-OADS,/arxiv_data1/oa_pdf/a5/1c/main.PMC4570651.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/d2/main.PMC4570652.pdf
Introduction Long-term peritoneal dialysis (PD) results in peritoneal damage that is characterized by a decreased ultra ﬁltrationjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/13/d2/main.PMC4570652.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/d2/main.PMC4570652.pdf
http://dx.doi.org/10.1016/j.krcp.2015.03.005 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/13/d2/main.PMC4570652.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/02/main.PMC4570653.pdf
The importance of AVF placement is that once the suitability forjournal homepage: http://www.krcp-ksn.comKidney Research and Clinical Practice Contents lists available at ScienceDirect 2211-9132/$ - see front matter Copyright &2015.,Non-OADS,/arxiv_data1/oa_pdf/1c/02/main.PMC4570653.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/02/main.PMC4570653.pdf
http://dx.doi.org/10.1016/j.krcp.2015.02.001 nCorresponding author.,OADS,/arxiv_data1/oa_pdf/1c/02/main.PMC4570653.pdf
"To compare the distribution of age groups across the quartiles for the SD of SBP, we used the Cochran–Mantel– Haenszel statistics, which revealed that very elderly group accounted for a significantly larger distribution of the higher quartiles than elderly group ( P<0.001) (Supplementary Figure 1 http://links.lww.com/HJH/A499).",OADS,/arxiv_data1/oa_pdf/03/38/jhype-33-2165.PMC4570687.pdf
"The Cochran–Man- tel–Haenszel statistics revealed that there were significantly fewer very elderly patients from the olmesartan along with CCB group than the olmesartan along with diuretic group inthe higher quartiles for the SD of SBP ( P¼0.017) (Supple- mentary Figure 2b http://links.lww.com/HJH/A499), whereas there was no significant difference for elderly group ( P¼0.11) (Supplementary Figure 2a http://links.",Non-OADS,/arxiv_data1/oa_pdf/03/38/jhype-33-2165.PMC4570687.pdf
"Other metrics of VVV of SBP such as SDIM, peak size, and ARV of SBP showed almost same results with SD of SBP; larger in the very elderly group than in the elderly group, smaller in the olmesartan along with CCB group than in the olmesartan along with diuretic group among very elderly patients, and association of larger VVV of SBP with higher incidence of cardiovascular events with regard- less of age or treatment except peak size in both age groups and ARV in very elderly treated with olmesartan along with diuretic (Supplemental Table 1 http://links.lww.com/HJH/ A499 and Supplemental Figure 1 http://links.lww.com/ HJH/A499).",Non-OADS,/arxiv_data1/oa_pdf/03/38/jhype-33-2165.PMC4570687.pdf
Clinical Trial Registration-URL: http://www.clinical- trials.gov.,Non-OADS,/arxiv_data1/oa_pdf/03/38/jhype-33-2165.PMC4570687.pdf
"http://www.gpo.gov/fdsys/ pkg/FR-1997-09-30/pdf/97-25823.pdf (accessed July, 2015).",Non-OADS,/arxiv_data1/oa_pdf/fb/73/bkv081.PMC4570939.pdf
"Keywords:  Knee, Patellar dislocation, Medial patellofemoral ligament, ReconstructionReview Article Knee Surg Relat Res 2015;27(3):133-140 http://dx.doi.org/10.5792/ksrr.2015.27.3.133 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 15, 2014; Revised February 4, 2015;   Accepted February 25, 2015 Correspondence to: Hee-Soo Kyung, MD Department of Orthopedic Surgery, Kyungpook National University  Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea Tel: +82-53-420-5636, Fax: +82-53-422-6605 E-mail: hskyung@knu.ac.kr 133This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ef/ksrr-27-133.PMC4570947.pdf
http://dx.doi.org/10.1007/s12306-014-0335-y.,Non-OADS,/arxiv_data1/oa_pdf/b3/ef/ksrr-27-133.PMC4570947.pdf
"Keywords:  Knee, Unicompartmental arthroplasty, Postoperative complications, Prosthesis failureReview Article Knee Surg Relat Res 2015;27(3):141-148 http://dx.doi.org/10.5792/ksrr.2015.27.3.141 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 20, 2015; Revised (1st) May 13, 2015;  (2nd) May 29, 2015; Accepted June 8, 2015 Correspondence to: Kwang-Jun Oh, MD Department of Orthopaedic Surgery, Konkuk University Medical  Center, 120 Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea Tel: +82-2-2030-7615, Fax: +82-2-2030-7749 E-mail: damioh@gmail.com 141This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/b0/ksrr-27-141.PMC4570948.pdf
http://dx.doi.org/10.1007/ s00167-014-3131-1.,Non-OADS,/arxiv_data1/oa_pdf/b0/b0/ksrr-27-141.PMC4570948.pdf
Available from: https://aoanjrr.dmac.adelaide.edu.au/ annual-reports-2008.,Non-OADS,/arxiv_data1/oa_pdf/b0/b0/ksrr-27-141.PMC4570948.pdf
"Keywords:  Knee, Arthroplasty, Bibliometric analysis, AsiaOriginal Article Knee Surg Relat Res 2015;27(3):149-155 http://dx.doi.org/10.5792/ksrr.2015.27.3.149 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 29, 2014; Revised February 15, 2015; Accepted February 19, 2015 Correspondence to: Tae Kyun Kim, MD Department of Orthopedic Surgery, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620,  Korea  Tel: +82-31-787-7196, Fax: +82-31-787-4056 E-mail: osktk@snubh.org 149This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/2a/ksrr-27-149.PMC4570949.pdf
Available from: http://data.worldbank.org/ data-catalog/world-development-indicators.,OADS,/arxiv_data1/oa_pdf/63/2a/ksrr-27-149.PMC4570949.pdf
Available from: http://wokinfo.com/essays/ impact-factor/#ref.6.,Non-OADS,/arxiv_data1/oa_pdf/63/2a/ksrr-27-149.PMC4570949.pdf
"Keywords:  Knee, Arthroplasty, Prosthesis design, Survival analylsisOriginal Article Knee Surg Relat Res 2015;27(3):156-162 http://dx.doi.org/10.5792/ksrr.2015.27.3.156 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received February 10, 2015; Revised April 19, 2015;   Accepted June 2, 2015 Correspondence to: Jeung Tak Suh, MD Department of Orthopaedic Surgery, Pusan National University  Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea Tel: +82-51-240-7248, Fax: +82-51-247-8395 E-mail: jtsuh@pusan.ac.kr 156This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/e5/ksrr-27-156.PMC4570950.pdf
"Keywords:  Knee, Arthroplasty, Component roation, Patellar trackingOriginal Article Knee Surg Relat Res 2015;27(3):163-167 http://dx.doi.org/10.5792/ksrr.2015.27.3.163 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 21, 2014; Revised (1st) December 27, 2014;  (2nd) May 25, 2015; Accepted June 16, 2015 Correspondence to: Jong Heon Kim, MD Department of Orthopedic Surgery, Guri Hospital, Hanyang University  College of Medicine, 153 Gyeongchun-ro, Guri 11923, Korea Tel: +82-31-560-2313, Fax: +82-31-557-8781 E-mail: jhkim111@hanyang.ac.kr 163This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9f/7a/ksrr-27-163.PMC4570951.pdf
"Keywords:  Knee, Degenerative arthritis, Arthroplasty, Autologous transfusionOriginal Article Knee Surg Relat Res 2015;27(3):168-172 http://dx.doi.org/10.5792/ksrr.2015.27.3.168 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 8, 2014; Revised (1st) November 21, 2014; (2nd) April 4,  2015; (3rd) June 22, 2015; (4th) June 23, 2015; Accepted June 24, 2015 Correspondence to: Hee-Gon Park, MD Department of Orthopaedic Surgery, Dankook University College of  Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea Tel: +82-41-550-6579, Fax: +82-41-565-6167 E-mail: osdku@dankook.ac.kr 168This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/cc/ksrr-27-168.PMC4570952.pdf
"Keywords:  Knee, Osteoarthritis, Arthroplasty, Tibia vara, Malalignment, IndianOriginal Article Knee Surg Relat Res 2015;27(3):173-180 http://dx.doi.org/10.5792/ksrr.2015.27.3.173 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 18, 2014; Revised (1st) March 13, 2015;  (2nd) May 7, 2015; (3th) June 4, 2015; (4th) July 10, 2015;   Accepted July 23, 2015 Correspondence to: Mandeep S. Dhillon, MS Department of Orthopaedics, Post Graduate Institute of Medical  Education and Research, Sector 12, Near Punjab University, Chandigarh  160012, India Tel: +91-172-2694774, Fax: +91-981-595-1090 E-mail: drdhillon@gmail.com 173This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/95/ksrr-27-173.PMC4570953.pdf
"Keywords:  Knee, High tibial osteotomy, Opening wedge, Fixation plate, Biomechanical studyOriginal Article Knee Surg Relat Res 2015;27(3):181-186 http://dx.doi.org/10.5792/ksrr.2015.27.3.181 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 10, 2014; Revised (1st) January 2, 2015;   Accepted January 29, 2015 Correspondence to: Jong Hwan Seol, MD Department of Orthopedic Surgery, Chonnam National University  Hwasun Hospital, 322 Seoyang-ro, Hwasun 58128, Korea Tel: +82-61-379-7676, Fax: +82-61-379-7681 E-mail: kssul5@naver.com 181This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/18/ksrr-27-181.PMC4570954.pdf
"Keywords:  Anterior cruciate ligament, Anterior cruciate ligament insufficiency, Lachman test, Biplane fluoroscopy, Three-dimensional  kinematics Original Article Knee Surg Relat Res 2015;27(3):187-193 http://dx.doi.org/10.5792/ksrr.2015.27.3.187 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 15, 2014; Revised (1st) March 6, 2015;  (2nd) June 8, 2015; Accepted June 21, 2015 Correspondence to: Joon Ho Wang, MD Department of Orthopaedic Surgery, Samsung Medical Center, 81  Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: +82-2-3410-3507, Fax: +82-2-3410-0035 E-mail: mdwang88@gmail.com *The first two authors contributed equally to this study.",Non-OADS,/arxiv_data1/oa_pdf/13/66/ksrr-27-187.PMC4570955.pdf
"187This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/66/ksrr-27-187.PMC4570955.pdf
"Keywords:  Knee, Arthritis, Pseudogout, Anterior cruciate ligament, ReconstructionCase Report Knee Surg Relat Res 2015;27(3):194-196 http://dx.doi.org/10.5792/ksrr.2015.27.3.194 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received August 7, 2013; Revised (1st) March 24, 2014;  (2nd) November 10, 2014; (3rd) February 21, 2015; Accepted June 1, 2015 Correspondence to: Simon Peter Mills, MBChB Department of Orthopaedic, Blackpool Victoria Hospital, 38 Whinney  Heys Road, Blackpool, Lancashire FY3 8NR, UK Tel: +44-01253-655983, Fax: +44-01253-303530 E-mail: bcharalambos@hotmail.com 194This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/e1/ksrr-27-194.PMC4570956.pdf
"Errata to ""Coronal Alignment of the Lower Limb and  the Incidence of Constitutional Varus Knee in Korean  Females"" Moo-Ho Song, MD1, Seong-Ho Y oo, MD1, Suk-Woong Kang, MD1, Y eong-Joon Kim, MD1, Gyu-Taek Park,  MD1, and Y ong-Seon Pyeun, MD2 Departments of 1Orthopaedic Surgery and 2Radiology, Daedong General Hospital, Busan, Korea http://dx.doi.org/10.5792/ksrr.2015.27.1.49 Knee Surg Relat Res 2015;27(1):49-55 Errata are published when significant errors related to patient care, scientific data or record-keeping, or authorship are discovered  after printing.",Non-OADS,/arxiv_data1/oa_pdf/f5/5d/ksrr-27-197.PMC4570957.pdf
"On page 53, line 37, Bellemann et al.6) should be corrected to Bellemans et al.6).Errata Knee Surg Relat Res 2015;27(3):197 http://dx.doi.org/10.5792/ksrr.2015.27.3.197 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Correspondence to: Seong-Ho Y oo, MD Department of Orthopaedic Surgery, Daedong General Hospital, 187  Chungnyeol-daero, Dongnae-gu 607-711, Busan, Korea Tel: +82-451-554-8996, Fax: +82-451-553-7575 E-mail: mhsong21@hanmail.net 197This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/5d/ksrr-27-197.PMC4570957.pdf
"Retrieved from http://www.nature.com/ncomms/2014/   140729/ncomms5567/full/ncomms5567.htmlFalk, E. B., Berkman, E. T., Whalen, D., & Lieberman, M. D.  (2011).",OADS,/arxiv_data1/oa_pdf/34/0d/10.1177_0956797615588467.PMC4570982.pdf
"However, there are conflicting  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/d3/bjv040.PMC4570991.pdf
"Avail - able from: http://www.ams.usda.gov/AMSv1.0/getfile?dDocName=STEL DEV3011889 Voigt N, Stein J, Galindo MM, Dunkel A, Raguse JD, Meyerhof W, Hofmann  T, Behrens M. 2014.",Non-OADS,/arxiv_data1/oa_pdf/9c/d3/bjv040.PMC4570991.pdf
/C2112015 by the Biophysical Society 0006-3495/15/08/0630/9 http://dx.doi.org/10.1016/j.bpj.2015.06.035 630 Biophysical Journal Volume 109 August 2015 630–638,Non-OADS,/arxiv_data1/oa_pdf/ab/5f/main.PMC4571001.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/35/20/cardiovascmed-04-02-25414.PMC4571058.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/16/64/2385.PMC4571295.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a9/cc/2402.PMC4571296.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/28/1f/2418.PMC4571297.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b9/c9/2426.PMC4571298.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/50/44/2439.PMC4571299.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c8/99/2456.PMC4571300.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/26/b2/2466.PMC4571301.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/   licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d2/60/2475.PMC4571302.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/22/76/2491.PMC4571303.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/6d/08/2505.PMC4571304.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/0a/2519.PMC4571305.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/49/4e/2535.PMC4571306.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/61/d7/2550.PMC4571307.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8d/4c/2561.PMC4571308.pdf
"11 www.chinaphar.com Tan ME et al Acta Pharmacologica Sinicanpg Database World Wide Web Server at the Lady Davis Institute  for Medical Research, available at http://androgendb.mcgill.",OADS,/arxiv_data1/oa_pdf/70/52/aps201418a.PMC4571323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/70/52/aps201418a.PMC4571323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ compose a family of functionally related transcription factors.",Non-OADS,/arxiv_data1/oa_pdf/40/d3/aps201486a.PMC4571324.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0 Un - ported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8e/78/2873.PMC4571326.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a3/26/2885.PMC4571327.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/77/b8/2895.PMC4571328.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/93/c4/2913.PMC4571329.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4d/81/2927.PMC4571330.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/00/1c/2939.PMC4571331.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d0/9a/2727.PMC4571333.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e4/7d/2733.PMC4571334.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/03/bf/2742.PMC4571335.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/91/8c/2755.PMC4571336.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/84/de/2769.PMC4571337.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by   -nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/c6/4e/2788.PMC4571338.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0b/d0/2801.PMC4571339.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/1e/2810.PMC4571340.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/36/73/2823.PMC4571341.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/31/9d/2833.PMC4571342.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unport - ed Creative Commons License (http://creativecommons.org/licenses/by-nc   -sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4b/0c/2845.PMC4571343.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/15/b5/2858.PMC4571344.pdf
"The survey consisted of 11 questions pertaining to demographic information, perceptions regarding the causes of childhood cancer, history-taking behaviors and training, patient experiences, and home practices; with multiple andopen-ended responses allowed (see Supplemental AppendixI, Supplemental Digital Content 1, http://links.lww.com/ JPHO/A102 for the full-text survey).",Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://www.cancer.gov/aboutnci/serving- people/cancer-statistics/snapshots.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at:http://seer.cancer.gov/csr/1975_2008/.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://www.cancer.gov/cancertopics/factsheet/ Sites-Types/childhood.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://deainfo.nci.nih.gov/advisory/pcp/annualReports/pcp08-09rpt/ PCP_Report_08-09_508.pdf.,OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://www.oehha.org/ air/environmental_tobacco/pdf/app3partb2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://www.neefusa.org/ pdf/PositionStatement.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at:https://www.surveymo nkey.com/s/Pediatr ic_Oncology_and_ Environment_Survey.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://hdl.handle.net/10419/40684.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
Available at: http://fundedre-search.cancer.gov/nciportfolio/.,Non-OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
2013.Available at: http://report.nih.gov/categorical_spending.aspx.,OADS,/arxiv_data1/oa_pdf/f5/64/mph-37-491.PMC4571458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/4f/kev194.PMC4571489.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/da/78/main.PMC4571538.pdf
"To test this, we exposed HaCaT human keratinocytes to microgravity in the Random Positioning http://dx.doi.org/10.1016/j.fob.2015.08.012 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/da/78/main.PMC4571538.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: FAK, focal adhesion kinases; GPCR, G-protein-coupled receptors; hg, hypergravity; mAbs, monoclonal antibodies; RPM, Random Positioning Machine ⇑Corresponding authors at: Dip.",Non-OADS,/arxiv_data1/oa_pdf/da/78/main.PMC4571538.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/67/fb/main.PMC4571539.pdf
Human euthanasia of rats was http://dx.doi.org/10.1016/j.fob.2015.09.001 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/67/fb/main.PMC4571539.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: HSP, heat shock protein; MHP, mild heat preconditioning; HI, heat injury; siRNA-HSP72, pSUPER plasmid expressing HSP72 small interfering RNA ⇑Corresponding authors at: Department of Medical Research, Chi Mei Medical Center, No.",Non-OADS,/arxiv_data1/oa_pdf/67/fb/main.PMC4571539.pdf
ABLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ) search of the human genome database was done to ensure that the sequence did not target other gene transcripts.,OADS,/arxiv_data1/oa_pdf/67/fb/main.PMC4571539.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/08/45/main.PMC4571540.pdf
"BDNF levels in the hypothala- mus correlated with MeCP2 levels, with lower levels in http://dx.doi.org/10.1016/j.fob.2015.08.010 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/08/45/main.PMC4571540.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ATF3, activating transcription factor 3; BDNF, brain derived neurotrophic factor; CFA, complete Freund’s adjuvant; DRG, dorsal root ganglia;L4/L5, 4th or 5th lumbar vertebra; MeCP2, methyl-CpG-binding protein 2; MeCP2T158A/Y, male MeCP2 T158A knock in mouse; RTT, Rett syndrome; SNI, sparednerve injury; T158A, threonine 158 conversion to alanine; TrkB, tropomyosinreceptor kinase B; 3 0UTR, three prime untranslated region; /C0/Y, male Mecp2 -null mouse; +/Y, male wild-type littermate control for either MeCP2 T158A knock in mouse or Mecp2 -null mouse ⇑Corresponding author at: Pharmacology & Physiology, Drexel University College of Medicine, 245 North 15th Street, Mail Stop 488, Philadelphia, PA 19102, USA.Tel.",Non-OADS,/arxiv_data1/oa_pdf/08/45/main.PMC4571540.pdf
"82.2.782.8654E-mail: ahyun@catholic.ac.kr This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permitsunrestricted non-commercial use, distribution, and reproduction inany medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/8d/ni-10-51.PMC4571554.pdf
Key Words : Acute ischemic stroke; Thrombolysis; Endovascular therapyNeurointervention 2015;10:51-59 http://dx.doi.org/10.5469/neuroint.2015.10.2.51ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/5d/8d/ni-10-51.PMC4571554.pdf
"852.2818.4350    E-mail: acotsang@hku.hkThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/f1/ni-10-60.PMC4571555.pdf
Our experience suggested that flow diverting stents alone may not be the ideal treat-Neurointervention 2015;10:60-66 http://dx.doi.org/10.5469/neuroint.2015.10.2.60ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/9b/f1/ni-10-60.PMC4571555.pdf
"82.2.476.0090    E-mail: dhlee@amc.seoul.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/37/ni-10-67.PMC4571556.pdf
Neurointervention 2015;10:67-73 http://dx.doi.org/10.5469/neuroint.2015.10.2.67ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/38/37/ni-10-67.PMC4571556.pdf
"human brain activity and developed by the Medical College of Wisconsin and the National Institutes ofHealth (AFNI, MCW and NIH, http://afni.nimh.nih.gov) and ImageJ, a public domain, Java-based, imageprocessing program developed at the National Institutesof Health (NIH, Bethesda, MD, USA; http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/38/37/ni-10-67.PMC4571556.pdf
"82.2.476.0090    E-mail: dhlee@amc.seoul.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/51/ni-10-74.PMC4571557.pdf
Key Words : Therapeutic/methods; Endovascular technique; Transradial approach; Transbrachial approach; Transfemoral approachNeurointervention 2015;10:74-81 http://dx.doi.org/10.5469/neuroint.2015.10.2.74ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/ce/51/ni-10-74.PMC4571557.pdf
"82.2.476.0090    E-mail: dhlee@amc.seoul.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/aa/ni-10-82.PMC4571558.pdf
"Conclusion: PAs harboring a wide-necked aneurysm requiring stent assistance for coiling showed signifi- cant enlargement of the lumen, especially at the distal transition segment of the aneurysm ostiumand the PA. Key Words : Cerebral aneurysms; Parent artery; Cerebral angiography; Intracranial stenting; Vascular morphologyNeurointervention 2015;10:82-88 http://dx.doi.org/10.5469/neuroint.2015.10.2.82ISSN (Print): 2093-9043 ISSN (Online): 2233-6273",Non-OADS,/arxiv_data1/oa_pdf/f8/aa/ni-10-82.PMC4571558.pdf
"82.2.476.0090    E-mail: dcsuh@amc.seoul.krThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction i n any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/e8/ni-10-89.PMC4571559.pdf
Key Words : Stent; Intracranial aneurysm; HemodynamicsNeurointervention 2015;10:89-93 http://dx.doi.org/10.5469/neuroint.2015.10.2.89ISSN (Print): 2093-9043 ISSN (Online): 2233-6273,Non-OADS,/arxiv_data1/oa_pdf/34/e8/ni-10-89.PMC4571559.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Few reports exist regarding thrombosed aneurysms where the  initial work up was concerning for a neoplasm.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/SNI-6-146.PMC4571614.pdf
"Surg Neurol Int 2015;6:146. http://surgicalneurologyint.com/A-completely-thrombosed,-nongiant-middle- cerebral-artery-aneurysm-mimicking-an-intra-axial-neoplasm/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/SNI-6-146.PMC4571614.pdf
"Surgical Neurology International 2015, 6:146  http://www.surgicalneurologyint.com/content/6/1/146Thrombosis is commonly associated with giant cerebral  aneurysms while the phenomenon is rarely reported in  nongiant cerebral aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/SNI-6-146.PMC4571614.pdf
"Surgical Neurology International 2015, 6:146  http://www.surgicalneurologyint.com/content/6/1/146feeders that came off the aneurysm remained pink and  pulsatile and seemed to have adequate retrograde flow  at this point.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/SNI-6-146.PMC4571614.pdf
"Surgical Neurology International 2015, 6:146  http://www.surgicalneurologyint.com/content/6/1/146REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/SNI-6-146.PMC4571614.pdf
"Surgical Neurology International 2015, 6:146  http://www.surgicalneurologyint.com/content/6/1/146Disappearance and reappearance of a cerebral aneurysm: A case report.",Non-OADS,/arxiv_data1/oa_pdf/9c/01/SNI-6-146.PMC4571614.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d4/8f/cardiovascmed-04-02-26949.PMC4571620.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–6 doi:10.1093/ijnp/pyv019 Brief report 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/95/pyv019.PMC4571622.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–12 doi:10.1093/ijnp/pyv005 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/af/pyv005.PMC4571624.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–8 doi:10.1093/ijnp/pyv006 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/76/pyv006.PMC4571628.pdf
http://www.who.int/mental_health/management/depression/en/.,Non-OADS,/arxiv_data1/oa_pdf/43/76/pyv006.PMC4571628.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–10 doi:10.1093/ijnp/pyv023 Review 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/pyv023.PMC4571632.pdf
"Supplementary Material For supplementary material accompanying this paper, visit http://dx.doi.org/10.1017/S00000000000000 Acknowledgments None.",Non-OADS,/arxiv_data1/oa_pdf/98/ca/pyv023.PMC4571632.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/b6/pyv048.PMC4571635.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–9 doi:10.1093/ijnp/pyv037 Advance Access Publication Date: March 14, 2014Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/f1/pyv037.PMC4571636.pdf
"Cortical reconstruction and volumetric segmentation was  performed with the FreeSurfer image analysis suite (version 4.5, http://surfer.nmr.mgh.harvard.edu) to derive measures of cortical thickness (Fischl and Dale, 2000), subcortical volume (Fischl et al., 2002), and total intracranial volume (Buckner et al.,  2004).",OADS,/arxiv_data1/oa_pdf/e3/f1/pyv037.PMC4571636.pdf
"Published by Oxford University Press on behalf of CINP.International Journal of Neuropsychopharmacology, 2015, 1–10 doi:10.1093/ijnp/pyv025 Research Article 1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction   in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/e0/pyv025.PMC4571637.pdf
"Bioinformatic Sequence Analysis Prediction of miRNA binding to the DRD2 (NM_000795, NM_016574) 3’ untranslated region (3’-UTR) was performed by algorithms obtained from TargetScan (http://www.targetscan.org), PicTar (http://pictar.mdc-berlin.de), miRanda (http://www.",OADS,/arxiv_data1/oa_pdf/6f/e0/pyv025.PMC4571637.pdf
"microrna.org), and miRWalk (http://www.umm.uniheidel-berg.de/apps/zmf/mirwalk).",OADS,/arxiv_data1/oa_pdf/6f/e0/pyv025.PMC4571637.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com © 2015 Surgical Neurology International | Published by Wolters Kluwer - MedknowCase Report Astounding recovery after resection of an intradural nerve sheath  tumor in an adult male from Vietnam Paul King, Saleen Khan1, Ovais Inamullah1 Department of Neurosurgery, Atlanta Medical Center, Atlanta, GA, USA, 1Ross University School of Medicine, Banana Trail, Portsmouth, Dominica  E‑mail:  Paul King ‑ pkingmd440@gmail.com; Saleen Khan ‑ saleen.khan@students.rossu.edu; *Ovais Inamullah ‑ ovais.inamullah@students.rossu.edu   *Corresponding author Received: 03 March 15  Accepted: 08 July 15  Published: 07 September 15 Abstract Background:  Spinal cord tumors can be classified as intramedullary, intradural  extramedullary, or extradural.",Non-OADS,/arxiv_data1/oa_pdf/98/b0/SNI-6-145.PMC4571639.pdf
"Surg  Neurol Int 2015;6:145. http://surgicalneurologyint.com/Astounding-recovery-after-resection-of-an- intradural-nerve-sheath-tumor-in-an-adult-male-from-Vietnam/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/98/b0/SNI-6-145.PMC4571639.pdf
"Surgical Neurology International 2015, 6:145  http://www.surgicalneurologyint.com/content/6/1/145or extradural.",Non-OADS,/arxiv_data1/oa_pdf/98/b0/SNI-6-145.PMC4571639.pdf
"Surgical Neurology International 2015, 6:145  http://www.surgicalneurologyint.com/content/6/1/145removed, and hemostasis achieved by placing a padded  gelfoam.",Non-OADS,/arxiv_data1/oa_pdf/98/b0/SNI-6-145.PMC4571639.pdf
"Surgical Neurology International 2015, 6:145  http://www.surgicalneurologyint.com/content/6/1/145from meningiomas and other CNS tumors based on MRI  imaging,[7] but an accurate diagnosis requires evaluation  of the tissue in a pathology lab.",Non-OADS,/arxiv_data1/oa_pdf/98/b0/SNI-6-145.PMC4571639.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/90/rjv116.PMC4571654.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/1e/43/mtm201535.PMC4571730.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/4.0/  Supplementary Information accompanies this paper on the Molecular Therapy—Methods & Clinical Development website (http://www.nature.com/mtm)",Non-OADS,/arxiv_data1/oa_pdf/06/35/mtm201530.PMC4571731.pdf
This case report is an illustration of an invited review available inRespirology : http://dx.doi.org/10.1111/resp.12568.,Non-OADS,/arxiv_data1/oa_pdf/57/5e/rcr20003-0085.PMC4571734.pdf
Retrieved from http://www.jschild.or.jp/book/ pdf/2010_kenchousa.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/1b/3a/jrm-10-020.PMC4571746.pdf
"In fact, it was reported that only Table 4 Final form of living will The original version is written in Japanese, and can be downloaded from the homepage of JA Toride Medi-cal Center (http://www.toride-medical.or.jp/).",Non-OADS,/arxiv_data1/oa_pdf/06/f9/jrm-10-029.PMC4571747.pdf
Available from: https://uwaterloo.ca/murray-alzheimer-research-and-education-program/sites/ca.murray-alzheimer-research-and-education-program/files/ uploads/files/InTheirOwnV oices-LiteratureReview.pdf [ac- cessed 14 February 2013].,Non-OADS,/arxiv_data1/oa_pdf/3a/8f/jrm-10-034.PMC4571748.pdf
Available  from: http://www8.ocn.ne.jp/~halfboil/criteria/tab-x5.html  [accessed 16 September 2014].,Non-OADS,/arxiv_data1/oa_pdf/3a/8f/jrm-10-034.PMC4571748.pdf
ProQuest Disserta-tions and Theses 2013; Retrieved from http://search.proquest.com/docview/1355174663?accountid=14500.,Non-OADS,/arxiv_data1/oa_pdf/3a/8f/jrm-10-034.PMC4571748.pdf
"Sawala et al., 2015, Cell Reports 12, 1584–1593 September 8, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.celrep.2015.08.012",OADS,/arxiv_data1/oa_pdf/92/c8/main.PMC4571823.pdf
"Cell Reports Report Peak BMP Responses in the Drosophila Embryo Are Dependent on the Activation of Integrin Signaling Annick Sawala,1,2Margherita Scarcia,1Catherine Sutcliffe,1Scott G. Wilcockson,1and Hilary L. Ashe1,* 1Faculty of Life Sciences, University of Manchester, Manchester M13 9PT, UK 2Present address: The Francis Crick Institute, Mill Hill Laboratory, The Ridgeway, London NW7 1AA, UK *Correspondence: hilary.ashe@manchester.ac.uk http://dx.doi.org/10.1016/j.celrep.2015.08.012 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/92/c8/main.PMC4571823.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and ﬁve ﬁgures and can be found with this article online at http://dx.doi.org/ 10.1016/j.celrep.2015.08.012 .,Non-OADS,/arxiv_data1/oa_pdf/92/c8/main.PMC4571823.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/25/cvv205.PMC4571836.pdf
The main goals of the study are to evaluate safety and efﬁcacy (http://clinicaltrials.gov/show/NCT01002430).,Non-OADS,/arxiv_data1/oa_pdf/ce/25/cvv205.PMC4571836.pdf
"However, recently it was announced that this Phase 2b CUPID2 trialdid not meet its primary and secondary endpoints (http://ir.celladon.",Non-OADS,/arxiv_data1/oa_pdf/ce/25/cvv205.PMC4571836.pdf
"Front Physiol 2013; 4. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764331/ (30 April 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/ce/25/cvv205.PMC4571836.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/18/cvv209.PMC4571837.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/29/ott-8-2469.PMC4571928.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2469–2478OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2469Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9060 2Thyroid transcription factor-1 expression is  significantly associated with mutations in exon 21  of the epidermal growth factor receptor gene in  chinese patients with lung adenocarcinoma Qingchun Zhao1,* song Xu1,2,* Jinghao liu1 Ying li2 Yaguang Fan2 Tao shi3 sen Wei1 shou-ching Tang4,5 hongyu liu2 Jun chen1,2 1Department of lung cancer  surgery, 2Tianjin Key laboratory of  lung cancer Metastasis and Tumor  Microenvironment, Tianjin lung  cancer institute, 3Department of  Pathology, Tianjin Medical University  general hospital, Tianjin, People’s  republic of china; 4Division of  hematology and Oncology, georgia  regents University cancer center,   augusta, ga, Usa; 5Department of  surgery, Tianjin Tumor hospital and  research institute, Tianjin Medical  University cancer institute and  hospital, Tianjin, People’s republic of  china *These authors contributed equally  to this workObjective:  The aim of this retrospective study was to investigate the relationship between  thyroid transcription factor-1 (TTF-1) expression and epidermal growth factor receptor ( EGFR )  gene mutations in lung adenocarcinomas of Chinese patients.",Non-OADS,/arxiv_data1/oa_pdf/d5/29/ott-8-2469.PMC4571928.pdf
"With the identification of epidermal growth fac - tor receptor ( EGFR ) gene mutations in NSCLCs and the development of the EGFR  correspondence: Jun chen; hongyu liu Tianjin Key laboratory of lung cancer  Metastasis and Tumor Microenvironment,  Tianjin lung cancer institute, Tianjin  Medical University general hospital,  154 anshan road, heping District, Tianjin  300052, People’s republic of china email huntercj2004@yahoo.co m;  liuhongyu123@hotmail.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhao et al Running head recto: TTF-1 and EGFR  in Chinese adenocarcinoma patients DOI: http://dx.doi.org/10.2147/OTT.S90602",Non-OADS,/arxiv_data1/oa_pdf/d5/29/ott-8-2469.PMC4571928.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d5/29/ott-8-2469.PMC4571928.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/29/ott-8-2469.PMC4571928.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/35/dddt-9-5213.PMC4571929.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d2/35/dddt-9-5213.PMC4571929.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres sDrug Design, Development and Therapy Drug Design, Development and Therapy 2015:9 5213Dove press submit your manuscript | www.dovepress.co m Dove press  5213CorrigenDumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9561 2Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease  [Corrigendum] Bennett LL, Turcotte K. Drug Des Devel Ther .",Non-OADS,/arxiv_data1/oa_pdf/d2/35/dddt-9-5213.PMC4571929.pdf
"On page 4643, Table 2, the drug name Cardelga® should  have been Cerdelga®.Journal name: Drug Design, Development and Therapy Article Designation: Corrigendum Y ear: 2015 Volume: 9 Running head verso: Bennett and Turcotte Running head recto: Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease DOI: http://dx.doi.org/10.2147/DDDT.S95612",Non-OADS,/arxiv_data1/oa_pdf/d2/35/dddt-9-5213.PMC4571929.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/5d/ijn-10-5671.PMC4571930.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5671–5685International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5671OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8879 8T etracycline-grafted Plga nanoparticles as   bone-targeting drug delivery system hua Wang1  Jun liu2  shan Tao2  guihong chai2  Jianwei Wang3 Fu-Qiang hu2 hong Yuan2 1center of analysis and Measurement,   2college of Pharmaceutical sciences,   Zhejiang University, hangzhou, 3The  second affiliated hospital of Zhejiang  University school of Medicine,   hangzhou, People’s republic of chinaPurpose:  Nanoparticles (NPs) that target bone tissue were developed using poly(lactic-co-glycolic  acid) (PLGA) copolymers and tetracycline (TC)-based bone-targeting moieties.",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/ijn-10-5671.PMC4571930.pdf
"It is known that more than 95% of gastrointestinally  absorbed statins will be decomposed in the liver, resulting in a much lower concentra - tion in the bone;2 this decomposition may be the reason why most clinical studies using  routine dosage of statins result in inconsistent effects on the bone.3,4 Positive results correspondence: hong Yuan   college of Pharmaceutical sciences,  Zhejiang University, 866 Yuhangtang  road, hangzhou 310058, People’s   republic of china  Tel +86 571 8820 8439  Fax +86 571 8820 8439  email yuanhong70@zju.edu.c n  Jianwei Wang The Second Affiliated Hospital  of Zhejiang University school of  Medicine, 88 Jiefang road, hangzhou  310009, People’s republic of china Tel +86 159 5818 5118  email w angjianwei_i@sina.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Tetracycline-grafted PLGA NPs as bone-targeting drug delivery system DOI: http://dx.doi.org/10.2147/IJN.S88798",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/ijn-10-5671.PMC4571930.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b5/5d/ijn-10-5671.PMC4571930.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/5d/ijn-10-5671.PMC4571930.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/6e/copd-10-1853.PMC4571931.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1853–1855International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1853Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S6445 5Roflumilast in COPD: a Brazilian perspective roberto Stirbulov1 José r Jardim2 1Department of respiratory Diseases,   Santa Casa School of Medical  Sciences in São Paulo, 2Department  of respiratory Diseases, escola  Paulista de Medicina, Federal  University of São Paulo, Hospital  São Paulo, São Paulo, BrazilDear editor We would like to discuss the use of roflumilast in Brazil and its perspectives, based on  the data currently available.",Non-OADS,/arxiv_data1/oa_pdf/99/6e/copd-10-1853.PMC4571931.pdf
"This may contribute to a decrease Correspondence: roberto Stirbulov Department of respiratory Diseases,  Santa Casa School of Medical Sciences in  São Paulo, Rua Dr José Ferraz de Oliveira  100, São Paulo 04645-010, Brazil email stirbulov@uol.com.b rJournal name: International Journal of COPD Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: Stirbulov and Jardim Running head recto: Roflumilast use in Brazil DOI: http://dx.doi.org/10.2147/COPD.S64455",Non-OADS,/arxiv_data1/oa_pdf/99/6e/copd-10-1853.PMC4571931.pdf
Availaible from: http://www2.datasus.gov.br/DATASUS/index.php .,OADS,/arxiv_data1/oa_pdf/99/6e/copd-10-1853.PMC4571931.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/99/6e/copd-10-1853.PMC4571931.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/6e/copd-10-1853.PMC4571931.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/69/ppa-9-1271.PMC4571932.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1271–1278Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1271OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8706 6Predictive factors for obtaining a correct  therapeutic range using antivitamin K  anticoagulants: a tertiary center experience of  patient adherence to anticoagulant therapy Ruxandra Jurcuţ1 sebastian Militaru1 Oliviana geavlete1 Nic Drăgotoiu1 Sergiu Sipoş1 Răzvan Roşulescu2 Carmen Ginghină1 Ciprian Jurcuţ2 1Prof Dr cc iliescu emergency  institute for cardiovascular Diseases,   University of Medicine and Pharmacy,   2Dr carol Davila central University  emergency Military hospital,   Bucharest, romaniaBackground:  Patient adherence is an essential factor in obtaining efficient oral anticoagulation  using vitamin K antagonists (VKAs), a situation with a narrow therapeutic window.",Non-OADS,/arxiv_data1/oa_pdf/55/69/ppa-9-1271.PMC4571932.pdf
"It is prescribed for  various indications, the most common being atrial fibrillation (AF) (with a prevalence  estimated at 1%–2% of the general population1), followed by prosthetic heart valves  and venous thromboembolic disease.correspondence:  Ruxandra Jurcuţ cardiology Department, Prof Dr  cc iliescu emergency institute for  cardiovascular Diseases, sos Fundeni  258, sector 2 022328 Bucuresti, romania Tel +40 724 506 434 email rjurcut@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Jurcu ţ et al Running head recto: Factors predicting a correct therapeutic range using VKAs DOI: http://dx.doi.org/10.2147/PPA.S87066",Non-OADS,/arxiv_data1/oa_pdf/55/69/ppa-9-1271.PMC4571932.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/55/69/ppa-9-1271.PMC4571932.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/dddt-9-5195.PMC4571933.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5195–5201Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8966 9Pentoxifylline and electromagnetic field improved  bone fracture healing in rats Yusuf atalay1 nedim gunes2 Mehmet Dervis guner3 Veysi akpolat4 Mustafa salih celik4 rezzan guner2 1Department of Oral and Maxillofacial  surgery, Faculty of Dentistry, afyon  Kocatepe University, afyonkarahisar,   2Department of Oral and Maxillofacial  surgery, Faculty of Dentistry, Dicle  University, Diyarbakır, 3Department  of Orthopedics, Medicana hospitals,   ankara, 4Department of Biophysics,   Faculty of Medicine, Dicle University,   Diyarbakır, T urkeyBackground:  The aim of this study was to evaluate the effects of a phosphodiesterase inhibitor  pentoxifylline (PTX), electromagnetic fields (EMFs), and a mixture of both materials on bone  fracture healing in a rat model.",Non-OADS,/arxiv_data1/oa_pdf/f8/c7/dddt-9-5195.PMC4571933.pdf
"Despite progressions in maxillofacial surgery, bone fractures  do not always heal successfully.2 Therefore, studies in recent years have researched  different factors such as growth factors, the applied force values, drug injections, or  electrical stimulation, which could be considered to be of benefit in more successful  rapid bone remodeling.3 Pentoxifylline (PTX) is a competitive non-selective phosphodiesterase inhibitor  (PDEI),4 which reduces inflammation, and enhances microcirculation, blood flow,  and tissue oxygenation.5 In addition, PTX improves red blood cell deformability and  decreases the potential for platelet aggregation and thrombus formation.6 In a previous  study, daily injections of PTX have been shown to stimulate bone formation and to  increase systemic bone mass in mice.7 In another study, Labib and Farid suggested that  PTX could be regarded as a valid approach in the management of osseointegration.8  In addition, many studies have demonstrated the positive effects of PTX in healing of  mandibular.9,10 The efficacy of PTX in treatment is essentially due to its potential to  increase blood flow and tissue oxygenation with its hemorheologic effects.11 Since a  vascular response is a prerequisite for successful bone healing physiology,12,13 it was correspondence: Yusuf atalay Department of Oral and Maxillofacial  surgery, Faculty of Dentistry,  afyon Kocatepe University, 03030  afyonkarahisar, Turkey Tel +90 272 216 7900 ext 1025-1038 email dt_atalay@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Atalay et al Running head recto: Healing bone fractures with pentoxifylline and electromagnetic fields DOI: http://dx.doi.org/10.2147/DDDT.S89669",Non-OADS,/arxiv_data1/oa_pdf/f8/c7/dddt-9-5195.PMC4571933.pdf
Available  from: http://www.totbid.org.tr/files/ONLIB/6_1-2/5.pd f. Turkish.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/dddt-9-5195.PMC4571933.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f8/c7/dddt-9-5195.PMC4571933.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/c7/dddt-9-5195.PMC4571933.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)PRDM1 hypermethylation in Burkitt lymphoma T Zhang et al 9 © 2014 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/de/87/bcj201475a.PMC4571983.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Table 4b.",Non-OADS,/arxiv_data1/oa_pdf/5d/41/bcj201476a.PMC4571984.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/ott-8-2443.PMC4571986.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2443–2451OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2443Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8966 1a common genetic variation in CEBPE  and acute  lymphoblastic leukemia: a meta-analysis of the  available evidence Xiao-Xia Zhang1,* Yue-Feng Du2,* Ya-Jing Zhai1 Fan gao3 Yu-Juan Yang4 Xian-cang Ma3 Jun lu3 Jie Zheng3 1Department of Pharmacy, The First  affiliated hospital, Xi’an Jiaotong  University, Xi’an, shaanxi, People’s  republic of china; 2Department  of Urology, The First affiliated  hospital, Xi’an Jiaotong University,   Xi’an, shaanxi, People’s republic of  china; 3clinical research center,   The First affiliated hospital, Xi’an  Jiaotong University, Xi’an, shaanxi,   People’s republic of china; 4The Third  Department of cardiology, shaanxi  Provincial People’s hospital, Xi’an,   shaanxi, People’s republic of china *These authors contributed equally  to this workAbstract:  Acute lymphoblastic leukemia (ALL) has been studied intensively for decades, but  the details of its etiology and underlying mechanisms have yet to be fully elucidated.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/ott-8-2443.PMC4571986.pdf
"The populations studied  in the aforementioned genome-wide association studies were limited, and the many correspondence: Jie Zheng clinical research center, The First  Affiliated Hospital, Xi’an Jiaotong  University, Xi’an, shaanxi 710061,  People’s republic of china Tel +86 29 8532 3614 Fax +86 29 8532 3473 email jiezheng_xjtu@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: rs2239633 and the risk of ALL DOI: http://dx.doi.org/10.2147/OTT.S8966 1",Non-OADS,/arxiv_data1/oa_pdf/42/b3/ott-8-2443.PMC4571986.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/42/b3/ott-8-2443.PMC4571986.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/b3/ott-8-2443.PMC4571986.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/15/ddv263.PMC4572003.pdf
"This network as well as a rich set of additional information (in-cluding mapped eQTLs, GWAS hits to clinical phenotypes, and drug-target information) is available at http://gwas.eu/si .",OADS,/arxiv_data1/oa_pdf/02/15/ddv263.PMC4572003.pdf
"The functional annotations include regula-tory elements, eQTLs, associations to clinical traits and alsoassociations to metabolic traits as provided by the NHGRI-EBI GWAS catalog ( http://www.ebi.ac.uk/gwas ).",OADS,/arxiv_data1/oa_pdf/02/15/ddv263.PMC4572003.pdf
"http://e-jbm.org/   107Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:107-112 http://dx.doi.org/10.11005/jbm.2015.22.3.107 pISSN 2287-6375 eISSN 2287-7029 Discrepancy between Vitamin D Total  Immunoassays due to Various Cross-reactivities Jun Hyung Lee, Jee-Hye Choi, Oh Joo Kweon, Ae Ja Park Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea Background:  The purpose of this study was to find out the cause of discrepancy between  various automated immunoassays for 25-hydroxy-vitamin D (25-[OH]D).",Non-OADS,/arxiv_data1/oa_pdf/42/1e/jbm-22-107.PMC4572031.pdf
"108  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.107the metabolic syndrome, as well as cardiovascular disease  events including stroke and congestive heart failure.",Non-OADS,/arxiv_data1/oa_pdf/42/1e/jbm-22-107.PMC4572031.pdf
Discrepancy between Vitamin D Total Immunoassays http://dx.doi.org/10.11005/jbm.2015.22.3.107  http://e-jbm.org/   109Table 2.,Non-OADS,/arxiv_data1/oa_pdf/42/1e/jbm-22-107.PMC4572031.pdf
110  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.107Fig.,Non-OADS,/arxiv_data1/oa_pdf/42/1e/jbm-22-107.PMC4572031.pdf
"Discrepancy between Vitamin D Total Immunoassays http://dx.doi.org/10.11005/jbm.2015.22.3.107  http://e-jbm.org/   111Second, the possible alternative is to use relatively cheap  standard reference material.",Non-OADS,/arxiv_data1/oa_pdf/42/1e/jbm-22-107.PMC4572031.pdf
112  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.10718.,Non-OADS,/arxiv_data1/oa_pdf/42/1e/jbm-22-107.PMC4572031.pdf
"http://e-jbm.org/   113Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:113-118 http://dx.doi.org/10.11005/jbm.2015.22.3.113 pISSN 2287-6375 eISSN 2287-7029 A FRAX Experience in Korea: Fracture Risk  Probabilities with a Country-specific Versus a  Surrogate Model  Yong-Ki Min1*, Dong-Yun Lee2*, Youn-Soo Park3, Young-Wan Moon3, Seung-Jae Lim3, Young-Kyun Lee4,   DooSeok Choi2, Byung-Koo Yoon2 1Division of Endocrinology and Metabolism, Department of Medicine, 2Department of Obstetrics and Gynecology, and 3Department of  Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul;   4Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea Background:  Recently, a Korean fracture-risk assessment tool (FRAX) model has become  available, but large prospective cohort studies, which are needed to validate the model,  are still lacking, and there has been little effort to evaluate its usefulness.",Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
"114  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.113in women sustaining fracture,[3] and hip fractures occur in  36% of women without osteoporosis, as determined by  femoral neck BMD.",Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
"[8] Recently, a Kore - an FRAX model has become available (http://www.shef.",Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
FRAX Experience in Korea  http://dx.doi.org/10.11005/jbm.2015.22.3.113  http://e-jbm.org/   115significantly lower than those calculated by the Japanese  model in both sexes.,Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
116  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.113the two models for MOF (Fig.,Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
FRAX Experience in Korea  http://dx.doi.org/10.11005/jbm.2015.22.3.113  http://e-jbm.org/   117DISCUSSION This study evaluated the usefulness of the Korean FRAX  model in a high risk group of patients with an established  hip fracture.,Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
118  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.113when applied to patients with hip fracture.,Non-OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
Available from: http://kosis.kr/statH - tml/statHtml.do?orgId =101&tblId =DT_1B80A17&conn_ path=I2 18.,OADS,/arxiv_data1/oa_pdf/db/9a/jbm-22-113.PMC4572032.pdf
"http://e-jbm.org/   119Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:119-126 http://dx.doi.org/10.11005/jbm.2015.22.3.119 pISSN 2287-6375 eISSN 2287-7029 Comparison of Calcium Intake Status by Region and  Socioeconomic Status in Korea: The 2011-2013 Korea  National Health and Nutrition Examination Survey Hee-Sook Lim1,2, Yoon-Hyung Park1, Hae-Hyeog Lee4, Tae-Hee Kim4*, Soon-Kyung Kim3* 1Department of Preventive Medicine, Soonchunhyang University College of Medicine, Cheonan;   2Department of Nutrition, Soonchunhyang University Bucheon Hospital, Bucheon;   3Department of Food Sciences & Nutrition, Soonchunhyang University, Asan;   4Department of Obstetrics and Gynecology, Soonchunhyang University College of Medicine, Bucheon, Korea Background:  Calcium is an essential element nutrient in our body, and insufficient calci - um intake is very common in Korean.",Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
"120  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.119the calcium intake of adults in Korea was found to reach  only 70% of the recommended calcium intake for adults,  and only 17.8% of the population was found to consume  calcium at adequate levels.",Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
Calcium Intake by Region and Socioeconomic Status in Korea http://dx.doi.org/10.11005/jbm.2015.22.3.119  http://e-jbm.org/   121less than 0.05 was considered statistically significant.,OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
"All  statistical analyses were performed using R 3.1.3 version  freely available on the web (http://cran.r-project.org/) and  SPSS (version 18.0; SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
122  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.119Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
Calcium Intake by Region and Socioeconomic Status in Korea http://dx.doi.org/10.11005/jbm.2015.22.3.119  http://e-jbm.org/   123Table 3.,Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
"124  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.119to 29, and ≥65 years.",Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
"Calcium Intake by Region and Socioeconomic Status in Korea http://dx.doi.org/10.11005/jbm.2015.22.3.119  http://e-jbm.org/   125creased, the quality of nutrition may also increase.",Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
"126  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.119vin, and periodontitis in Korean adults: using the 2007- 2010 Korea National Health and Nutrition Examination  Surveys.",Non-OADS,/arxiv_data1/oa_pdf/ad/90/jbm-22-119.PMC4572033.pdf
"http://e-jbm.org/   127Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:127-133 http://dx.doi.org/10.11005/jbm.2015.22.3.127 pISSN 2287-6375 eISSN 2287-7029 Effects of Serum 25-hydroxy-vitamin D and Fetal  Bone Growth during Pregnancy Dong Hyun Lee1, Hyun Mee Ryu2, You Jung Han2, Si Won Lee2, So Young Park1, Chang Hoon Yim1,   Sung Hoon Kim1, Hyun Koo Yoon1 1Division of Endocrinoloy, 2Department of Obstetrics & Gynecology,  Cheil General Hospital & Women’s Healthcare Center, Dankook  University College of Medicine, Seoul, Korea Background:  This study was conducted to observe the prevalence of vitamin D deficien - cy during pregnancy and the effects of maternal 25-hydroxy-vitamin D (25-[OH]D) levels  on fetal bone growth.",Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
"128  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.127ble consequences, the desired optimal level for pregnant  women, the amount of vitamin D intake required to main - tain adequate levels and the role of vitamin D during preg - nancy are poorly do cumented.",Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
Serum 25-(OH)D and Fetal Growth in Pregnant Women http://dx.doi.org/10.11005/jbm.2015.22.3.127  http://e-jbm.org/   129Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
130  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.12720 to 22 weeks and growth velocity of fetal biparietal di - ameter between 20 to 22 and 32 to 34 weeks of pregnancy  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
"Serum 25-(OH)D and Fetal Growth in Pregnant Women http://dx.doi.org/10.11005/jbm.2015.22.3.127  http://e-jbm.org/   131women was also common, and the prevalence was 88.9%  at 12 to 14 weeks of pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
"132  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.127ence, and femur and humerus length were not associated  with the changes of 25-(OH)D levels.",Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
Serum 25-(OH)D and Fetal Growth in Pregnant Women http://dx.doi.org/10.11005/jbm.2015.22.3.127  http://e-jbm.org/   133112:1081-7.,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/jbm-22-127.PMC4572034.pdf
"http://e-jbm.org/   135Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:135-141 http://dx.doi.org/10.11005/jbm.2015.22.3.135 pISSN 2287-6375    eISSN 2287-7029 Change of Bone Mineral Density and Biochemical  Markers of Bone Turnover in Patients on  Suppressive Levothyroxine Therapy for  Differentiated Thyroid Carcinoma Chei Won Kim1, Seokbo Hong1, Se Hwan Oh1, Jung Jin Lee1,2, Joo Young Han1, Seongbin Hong1, So Hun Kim1,  Moonsuk Nam1, Yong Seong Kim1 1Department of Endocrinology, Inha University School of Medicine, Incheon;   2Department of Internal Medicine, Hallym General Hospital, Incheon, Korea Untreated hyperthyroidism and high-dose thyroid hormone are associated with osteo - porosis, and increased bone mineral density (BMD) has been demonstrated in post - menopausal females with hypoparathyroidism.",Non-OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
"136  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.135roidism accelerates bone turnover and shortens the normal  bone remodeling cycle, it was expected that suppressive  levothyroxine (LT4) therapy might decrease the bone min - eral density (BMD).",Non-OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
Bone Mineral Density in Patients on LT4 Therapy  http://dx.doi.org/10.11005/jbm.2015.22.3.135  http://e-jbm.org/   137tests for categorical measures.,Non-OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
"138  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.135thyroidism, there were no significant differences between  levels at baseline and follow-up period on all three sites,  except femur neck in postmenopausal women without hy - poparathyroidism ( P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
"Bone Mineral Density in Patients on LT4 Therapy  http://dx.doi.org/10.11005/jbm.2015.22.3.135  http://e-jbm.org/   139low up level of serum calcium and phosphorus ( P=0.001,  P=0.001, respectively), not only the level of PTH in relation  to hypoparathyroidism.",Non-OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
140  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.135LT4 on BMD and bone turnover marker according to meno - pausal and parathyroid status.,OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
Bone Mineral Density in Patients on LT4 Therapy  http://dx.doi.org/10.11005/jbm.2015.22.3.135  http://e-jbm.org/   141tes Obes 2012;19:435-42.,Non-OADS,/arxiv_data1/oa_pdf/4e/9f/jbm-22-135.PMC4572035.pdf
"http://e-jbm.org/   87Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:87-91 http://dx.doi.org/10.11005/jbm.2015.22.3.87 pISSN 2287-6375    eISSN 2287-7029 Atypical Femoral Fracture: 2015 Position Statement  of the Korean Society for Bone and Mineral  Research Kyu Hyun Yang1, Byung Woo Min2, Yong-Chan Ha3 1Department of Orthopedic Surgery, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul;   2Department of Orthopaedic Surgery, School of Medicine, Keimyung University, Daegu;   3Department of Orthopedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea  Bisphosphonate (BP) is a useful anti-resorptive agent which decreases the risk of osteo - porotic fracture by about 50%.",Non-OADS,/arxiv_data1/oa_pdf/9b/4b/jbm-22-87.PMC4572036.pdf
88  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.87lus at the lateral femoral cortex.,Non-OADS,/arxiv_data1/oa_pdf/9b/4b/jbm-22-87.PMC4572036.pdf
Atypical Femoral Fracture : Position Statement http://dx.doi.org/10.11005/jbm.2015.22.3.87  http://e-jbm.org/   89due to its low occurrence in BP users.,Non-OADS,/arxiv_data1/oa_pdf/9b/4b/jbm-22-87.PMC4572036.pdf
90  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.87 Fig.,Non-OADS,/arxiv_data1/oa_pdf/9b/4b/jbm-22-87.PMC4572036.pdf
Atypical Femoral Fracture : Position Statement http://dx.doi.org/10.11005/jbm.2015.22.3.87  http://e-jbm.org/   912012;27:672-8.,Non-OADS,/arxiv_data1/oa_pdf/9b/4b/jbm-22-87.PMC4572036.pdf
"http://e-jbm.org/   93Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:93-97 http://dx.doi.org/10.11005/jbm.2015.22.3.93 pISSN 2287-6375 eISSN 2287-7029 Comparison of the Chemical Composition of  Subchondral Trabecular Bone of Medial Femoral  Condyle between with Advanced Osteoarthritis and  without Osteoarthritis Kwang Kyoun Kim1, Yougun Won1,3, Tae-Gyun Kim1, Myong-Hyun Baek2, Jaewon Choi4 1Department of Orthopedic Surgery, Konyang University College of Medicine, Daejeon;   2Medical Device Development Center, Medical Innovation Foundation, Osong;   3Department of Orthopaedics, Graduate School of Medicine, Yonsei University, Seoul;   4Medicine Major,  Konyang University  College of  Medicine, Daejeon, Korea Background:  The purpose of this study is to investigate differences of chemical compo - sition between subchondral bone in advanced osteoarthritic (OA) and non-OA distal fe - mur.",Non-OADS,/arxiv_data1/oa_pdf/e9/c4/jbm-22-93.PMC4572037.pdf
94  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.93but also chemical changes has been reported.,OADS,/arxiv_data1/oa_pdf/e9/c4/jbm-22-93.PMC4572037.pdf
" Chemical Composition of Subchondral Bone in Osteoarthritis http://dx.doi.org/10.11005/jbm.2015.22.3.93  http://e-jbm.org/   95RESULTS The wavenumber showed a similar trend in the OA and  non-OA knees, but Raman intensity showed substantial  difference (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e9/c4/jbm-22-93.PMC4572037.pdf
96  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.93ies have reported the changes in mechanical properties and  micro-structures of the subchondral bones in early OA.,OADS,/arxiv_data1/oa_pdf/e9/c4/jbm-22-93.PMC4572037.pdf
 Chemical Composition of Subchondral Bone in Osteoarthritis http://dx.doi.org/10.11005/jbm.2015.22.3.93  http://e-jbm.org/   975.,Non-OADS,/arxiv_data1/oa_pdf/e9/c4/jbm-22-93.PMC4572037.pdf
"http://e-jbm.org/   99Copyright © 2015 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li - cense (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribu - tion, and reproduction in any medium, provided the original  work is properly cited.J Bone Metab 2015;22:99-106 http://dx.doi.org/10.11005/jbm.2015.22.3.99 pISSN 2287-6375 eISSN 2287-7029 Relationship between Low Muscle Mass and  Metabolic Syndrome in Elderly People with Normal  Body Mass Index Ji Hyun Moon1,2, Se Ryung Choo3, Jong Seung Kim4 1Department of Family Medicine, Jeju National University School of Medicine, Jeju;    2Graduate School of Medicine, Jeju National University, Jeju;   3Department of Family Medicine, Seoul National University Hospital, Seoul;   4Department of Family Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea Background:  Metabolically obese normal weight (Wt) occurs in people who have high  prevalence of cardiovascular disease even with normal body mass index (BMI).",Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
100  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.99er morbidity to metabolic diseases are defined as metaboli - cally obese normal-Wt (MONW).,Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
Normal Weight Obesity and Metabolic Syndrome http://dx.doi.org/10.11005/jbm.2015.22.3.99  http://e-jbm.org/   10121.35% as references.,Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
102  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.99HDL cholesterolemia were presented with statistically sig - nificant increases ( P<0.05).,Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
"Normal Weight Obesity and Metabolic Syndrome http://dx.doi.org/10.11005/jbm.2015.22.3.99  http://e-jbm.org/   103those adjusted for age and BMI ( P=0.002, P=0.123) (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
"104  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.99aged subjects ≥65 years old whose BMI was ≥23.0 kg/m2  as collected from the data of the KNHANES conducted in  the same period to this study, the men with low muscle  mass class 1 was 39.5% and class 2 was 19.5% out of 883  male subjects.",Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
Normal Weight Obesity and Metabolic Syndrome http://dx.doi.org/10.11005/jbm.2015.22.3.99  http://e-jbm.org/   105to reduction in skeletal muscle mass as the conditions for  defining sarcopenia.,Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
106  http://e-jbm.org/  http://dx.doi.org/10.11005/jbm.2015.22.3.9911.,Non-OADS,/arxiv_data1/oa_pdf/1d/e7/jbm-22-99.PMC4572038.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1016/j.nicl.2015.08.011 2213-1582/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1148/ radiol.248107030018566173 .,OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1161/01.CIR.97.5.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1088/0031-9155/55/16/00820671353 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1161/STROKEAHA.110.58105820431077 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1227/01.NEU.0000371730.11404.3620644437 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1159/00031902520948197 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"Psychiatry 17 (11), 976– 985. http://dx.doi.org/10.1097/JGP.",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1212/01.wnl.0000314697.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1088/0031-9155/57/ 22/732923079725 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1161/01.STR.30.12.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1016/j.ultrasmedbio.,OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"322 (1 –2), 20 –24.http://dx.doi.org/10.1016/j.jns.2012.05.02022658531 .",OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"Cerebrovasc Dis 6 (Suppl 2), 1. http://dx.doi.org/10.1159/000108071 .",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
JRSM Cardiovasc Dis 3. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"Imaging 29 (1), 15 –30.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"34 (10), 1666– 1677. http://dx.doi.org/10.1016/j.ultrasmedbio.2008.02.",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1088/0031-9155/53/ 22/00818941278.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"http://dx.doi.org/10.1088/0031-9155/ 52/2/00617202622 .Shim, Y.S., et al., 2015.",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1161/ STROKEAHA.114.00680025256179 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"41 (1), 64 –71.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1177/01617346010230040212051276 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1016/j.cult.2009.10.00920798841 .,OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1109/58.58521218244114 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1016/j.neuint.,OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"40 (1), 78 –89.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
5627 –5630 http://dx.doi.org/10.1109/EMBC.2014.694490325571271 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
http://dx.doi.org/10.1002/hbm.2058618465744 .,Non-OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"1496,1–9.http://dx.doi.org/10.1016/j.brainres.2012.12.00823246924 .",OADS,/arxiv_data1/oa_pdf/62/66/main.PMC4572385.pdf
"The accumulation ofContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.07.014 2213-2317/Published by Elsevier B.V. nCorresponding author at: The Sam and Ann Barshop Institute for Longevity and Aging Studies, The University of Texas Health Science Center at San Antonio, 15355Lambda Drive, San Antonio 78245-3207, TX, USA.",OADS,/arxiv_data1/oa_pdf/51/68/main.PMC4572386.pdf
Although gap junction communication has been shown to play an important role in the induction of bystander effects inContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.08.018 2213-2317/ &2015 Elsevier B.V..,OADS,/arxiv_data1/oa_pdf/d0/05/main.PMC4572387.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/00/6d/main.PMC4572398.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Drugs and Drug Resistance journal homepage: www.elsevier.com /locate/ijppaw http://dx.doi.org/10.1016/j.ijpddr.2015.07.003 2211-3207/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/00/6d/main.PMC4572398.pdf
"Statistical analysis Calculation of closantel ef ﬁcacy based on FEC was determined by two different methods: 1) FEC reduction was expressed as the difference in arithmetic means between pre-treatment and post- treatment levels with 95% con ﬁdence limit, as recommended by the World Association for the Advancement of Veterinary Parasi- tology ( Coles et al., 1992 ); 2) the percentage FEC reduction was determined using Bayesian hierarchical models in the platform ‘eggCounts ’ (http://www.math.uzh.ch/as/index.php?id ¼254) (Torgerson et al., 2014 ).",OADS,/arxiv_data1/oa_pdf/00/6d/main.PMC4572398.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4c/b6/main.PMC4572399.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.08.002 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/b6/main.PMC4572399.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/8e/awv071.PMC4572482.pdf
http://dx.doi.org/10.1016/j.ajhg.2015.05.015 ./C2112015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/d8/main.PMC4572492.pdf
Supplemental Data Supplemental Data include ﬁve ﬁgures and eight tables and can be found with this article online at http://dx.doi.org/10.1016/j.ajhg.,OADS,/arxiv_data1/oa_pdf/44/d8/main.PMC4572492.pdf
"Received: February 28, 2015 Accepted: May 26, 2015 Published: July 2, 2015 Web Resources The URLs for data presented herein are as follows: GWAS data for the type 1 diabetes study, DCCT/EDIC, available through dbGaP, http://www.ncbi.nlm.nih.gov/projects/gap/ cgi-bin/study.cgi?study_id ¼phs000086.v3.p1 JLS analysis tool, http://www.utstat.toronto.edu/sun/ OMIM, http://www.omim.org/ References 1.Cordell, H.J.",Non-OADS,/arxiv_data1/oa_pdf/44/d8/main.PMC4572492.pdf
Supplemental material for this article may be found at http://dx.doi.org/10.1128 /JCM.00715-15 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
"The sequences obtained were then edited (BioEdit version 7.0.9),and compared to homologous sequences ( /H1102299% similarity) in GenBank using BLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cgi ), to determine the Giardia assemblage.",OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http: //webarchive.nationalarchives.gov.uk/20120528152708/ http://www.hpa .org.uk/Topics/InfectiousDiseases/InfectionsAZ/Giardia/EpidemiologicalData/gairDataEwAgeRates/ .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1136/gut.2011 .238386 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId /H1100518977 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1017/S0950268800051505 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1016/j.ijpara.2013.06.001 .,OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
BMC Infect Dis 14:78. http://dx.doi.org /10.1186/1471-2334-14-78 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10 .2307/3284315 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10 .1017/S0031182009990436 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1017/S0950268810000208 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1016/j.meegid.2014.01.007 .,OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1371/journal.pntd.0001262 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
J Clin Microbiol 40:446 – 452. http://dx.doi.org/10.1128/JCM.40.2.446-452 .2002 .,OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1016/S1201-9712(02)90110-4 .,OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.1080/09603120600869265 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
BMC Public Health 10:41.http://dx.doi.org/10.1186/1471-2458-10-41 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi .org/10.1017/S0950268806006406 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
Am J Public Health 74:155– 156. http://dx.doi.org/10.2105/AJPH.74.2.155 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org /10.1016/S0140-6736(00)04251-3 .,OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org /10.1016/j.ijpara.2006.09.009 .,OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
http://dx.doi.org/10.3201/eid1007.030582 .,Non-OADS,/arxiv_data1/oa_pdf/0f/e0/zjm3133.PMC4572545.pdf
Editor: H. Wiley/C2112015 The Authors 0006-3495/15/08/0639/8 http://dx.doi.org/10.1016/j.bpj.2015.06.034 Biophysical Journal Volume 109 August 2015 639–646 639,Non-OADS,/arxiv_data1/oa_pdf/87/36/main.PMC4572570.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/1b/rru069.PMC4572582.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/f9/rru076.PMC4572583.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/e7/rru087.PMC4572585.pdf
"Moscow: Nauka, 1964. http://handle.dtic.mil/100.2/ AD683060 (28 July 2008, date last accessed).",OADS,/arxiv_data1/oa_pdf/bd/e7/rru087.PMC4572585.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/23/rru086.PMC4572588.pdf
"Available from: http://www.rtog.org/ClinicalTrials/Protocol Table.aspx (1 June 2014, data last accessed).",OADS,/arxiv_data1/oa_pdf/ab/23/rru086.PMC4572588.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/84/rru079.PMC4572592.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f4/d7/rru077.PMC4572594.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/41/rru070.PMC4572596.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/db/rru094.PMC4572601.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/80/1e/rru078.PMC4572603.pdf
"Proceedings of the 14th Prefectural Oversight Committee Meeting for FukushimaHealth Management Survey .http://www.fmu.ac.jp/radiation health/results/ (3 September 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/80/1e/rru078.PMC4572603.pdf
"Human Metabolome Database 3.6.http://www.hmdb.ca (3 September 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/80/1e/rru078.PMC4572603.pdf
"http://www.massbank.jp (3 September 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/80/1e/rru078.PMC4572603.pdf
"Key Words Balance; Posture; Parkinson’s disease; Falls;  Management.http://dx.doi.org/10.14802/jmd.15018  /  J Mov Disord  2015 ;8(3):109-114 pISSN 2005-940X / eISSN 2093-4939 REVIEW ARTICLE cc This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which per - mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided  the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/6f/jmd-8-3-109.PMC4572660.pdf
"Key Words Parkinson disease; Deep brain stimulation;   Movement disorder.http://dx.doi.org/10.14802/jmd.15043  /  J Mov Disord  2015 ;8(3):115-121 pISSN 2005-940X / eISSN 2093-4939 REVIEW ARTICLE cc This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which per - mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided  the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/ae/jmd-8-3-115.PMC4572661.pdf
Available from: http://kostat.go.kr/portal/korea/kor_ nw/2/2/6/index.board?bmode=read&bSeq=207&aSeq=25 2623&pageNo=1&rowNum=10&navCount=10&currPg= &sTarget=title&sTxt=.,OADS,/arxiv_data1/oa_pdf/f8/ae/jmd-8-3-115.PMC4572661.pdf
Available from:  http://www.hira.or.kr/rd/dissdic/infoMdfeeList.,OADS,/arxiv_data1/oa_pdf/f8/ae/jmd-8-3-115.PMC4572661.pdf
"Key Words Progressive supranuclear palsy; Genetics; MAPT ;  Microtubule-associated protein tau;   Familial progressive supranuclear palsy.http://dx.doi.org/10.14802/jmd.15033  /  J Mov Disord  2015 ;8(3):122-129 pISSN 2005-940X / eISSN 2093-4939 REVIEW ARTICLE cc This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which per - mits unrestricted non-commercial use, distribution, and reproduction in any medium, provided  the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/34/jmd-8-3-122.PMC4572662.pdf
"Key Words aaParkinson’s disease; Gender; Dopamine transporter activity; PET; Striatum.ORIGINAL ARTICLEhttp://dx.doi.org/10.14802/jmd.15031  /  J Mov Disord  2015 ;8(3):130-135 pISSN 2005-940X / eISSN 2093-4939 Received:  August 6, 2015    Revised:  August 13, 2015    Accepted:  August 18, 2015 Corresponding author:  Young H. Sohn, MD, PhD, Department of Neurology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 03722, Korea / Tel: +82-2-2228-1601 / Fax: +82-2-393-0705 / E-mail:  yhsohn62@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JMD Gender differences are a well-known clinical characteristic  of Parkinson’s disease (PD).1 PD occurs more often in men than  in women: a meta-analysis showed an increased relative risk of  1.5 in men.2 Age at PD onset is later in women than in men,3,4  and partly correlates with fertile life span in women.3 Clinically,  women with PD exhibit less severe PD motor features, and show  greater levodopa responses with more severe levodopa-induced  dyskinesia.5,6 Female sex hormones (i.e., estrogen) are thought  to play an important role in the gender differences observed in  PD.7 These gender differences suggest a beneficial influence of  estrogens against the development and progression of PD.",Non-OADS,/arxiv_data1/oa_pdf/e4/3e/jmd-8-3-130.PMC4572663.pdf
Supplementary Materials The online-only Data Supplement is available with this arti - cle at http://dx.doi.org/10.14802/jmd.15031.,Non-OADS,/arxiv_data1/oa_pdf/e4/3e/jmd-8-3-130.PMC4572663.pdf
"Key Words aaCreutzfeldt-Jakob Disease; Prions; Parkinsonism; Myoclonus; Dementia; Thailand.CASE REPORT Received:  April 16, 2015    Revised:  May 11, 2015    Accepted:  June 30, 2015 Corresponding author:  Praween Lolekha, MD, MSc, Neurology Division, Department of Internal Medicine, Faculty of Medicine, Thammasat University, 95  Moo 8 Paholyotin Road, Amphur Klongluang, Pathumthani 12120, Thailand / Tel: +66-2-9269794 / Fax: +66-2-9269793 / E-mail:  pwlolekha@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Creutzfeldt-Jakob Disease (CJD) is a rare, incurable, and in - evitably fatal neurodegenerative disorder.",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/jmd-8-3-136.PMC4572664.pdf
Electroencephalography (EEG) revealed generalized and syn - chronous periodic sharp wave complexes occurring at intervals http://dx.doi.org/10.14802/jmd.15014  /  J Mov Disord  2015 ;8(3):136-140 pISSN 2005-940X / eISSN 2093-4939JMD,OADS,/arxiv_data1/oa_pdf/8f/ec/jmd-8-3-136.PMC4572664.pdf
"Copyright © 2015 The Korean Movement Disorder Society   141LETTER TO THE EDITORhttp://dx.doi.org/10.14802/jmd.15021  /  J Mov Disord  2015 ;8(3):141-143 pISSN 2005-940X / eISSN 2093-4939 Received:  June 1, 2015    Revised:  July 1, 2015    Accepted:  July 29, 2015 Corresponding author:  Jee-Young Lee , MD, PhD, Department of Neurology, Seoul National University-Seoul Metropolitan Government Boramae Medi - cal Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea / Tel: +82-2-870-2476 / Fax: +82-2- 831-2826 / E-mail:  wieber04@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.JMD Dear Sir, Although the association between reversible parkinsonism  with dementia and dural arteriovenous fistula (dAVF) is well  documented, its pathophysiological mechanism has not been  fully described.",Non-OADS,/arxiv_data1/oa_pdf/b0/ff/jmd-8-3-141.PMC4572665.pdf
"144  Copyright © 2015 The Korean Movement Disorder SocietyLETTER TO THE EDITORhttp://dx.doi.org/10.14802/jmd.15017  /  J Mov Disord  2015 ;8(3):144-146 pISSN 2005-940X / eISSN 2093-4939JMD Dear Sir, Cefepime is a commonly prescribed antibiotic, but the fre - quency and incidence of its neurotoxicity are unknown.1 Com - mon symptoms of neurotoxicity include lethargy, confusion,  agitation, global aphasia, seizures, coma, and myoclonus.2 Early  discontinuation after the development of neurotoxicity is cru - cial to recovery and to reducing morbidity and mortality.3 The  pathophysiology of cefepime-induced myoclonus is unknown.",Non-OADS,/arxiv_data1/oa_pdf/92/22/jmd-8-3-144.PMC4572666.pdf
"George’s University School of Medicine, Grenada 3Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, USA Received:  May 3, 2015    Revised:  August 21, 2015    Accepted:  August 21, 2015 Corresponding author:  Harini Sarva , MD, Division of Neurology, Maimonides Medical Center, 883 65th Street Brooklyn, NY 11220, USA / Tel:  +17182837470 / Fax: +17186356082 / E-mail:  hsarva@maimonidesmed.org cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/22/jmd-8-3-144.PMC4572666.pdf
We deeply regret this mistake and apologize for any inconvenience to authors and readers of Journal of Movement Dis - orders .RETRACTIONhttp://dx.doi.org/10.14802/jmd.11008.r  /  J Mov Disord  2015 ;8(3):147-147 pISSN 2005-940X / eISSN 2093-4939JMD,Non-OADS,/arxiv_data1/oa_pdf/26/7d/jmd-8-3-147.PMC4572667.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5701–5713International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5701RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S8364 2Biomimetics: forecasting the future of science,  engineering, and medicine Jangsun Hwang1 Y oon Jeong1,2 Jeong Min Park3 Kwan Hong Lee1,2,4 Jong wook Hong1,2 Jonghoon Choi1,2 1Department of Bionano T echnology,   Graduate School, Hanyang University,   Seoul, 2Department of Bionano  engineering, Hanyang University  eRICA, Ansan, Korea; 3Department  of Biomedical engineering, Boston  University, 4Open view venture  Partners, Boston, MA, USAAbstract:  Biomimetics is the study of nature and natural phenomena to understand the principles  of underlying mechanisms, to obtain ideas from nature, and to apply concepts that may benefit  science, engineering, and medicine.",Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
"More specifi - cally, biomimetics is a creative form of technology that uses or imitates nature to  improve human lives.Correspondence: Jonghoon Choi 55 Hanyangdae-hak ro, Ansan, 426-791,  South Korea Tel +82 31 400 5203 Fax +82 31 436 8146 email jonghchoi@hanyang.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Hwang et al Running head recto: Potential of biomimetics in science, engineering, and medicine DOI: http://dx.doi.org/10.2147/IJN.S83642",Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
"Note:  Reproduced with permission of Annual Review of Materials Research, Vol 41, © by Annual Reviews, http://www.annualreviews.org, from Lee BP, Messersmith PB,  Israelachvili JN, waite JH.",Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
http://www.swissinfo.ch/eng/search/Result.htm l  16.,Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/d8/ijn-10-5701.PMC4572716.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, providea link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/73/73/12325_2015_Article_232.PMC4572721.pdf
2013. http://www.who.int/ mediacentre/factsheets/fs204/en/ .,Non-OADS,/arxiv_data1/oa_pdf/73/73/12325_2015_Article_232.PMC4572721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/43/ott-8-2479.PMC4572722.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2479–2484OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2479Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8921 2GSTM1  null genotype may be associated with an  increased nasopharyngeal cancer risk in south  china: an updated meta-analysis and review Yanni li1,2,* Wuhanhui Wan1,2,* Ting li1,2 Jing cao1,2 ge Xu1,2 1Department of Otolaryngology, PU ai  hospital, 2T ongji Medical college,   huazhong University of science and  T echnology, Wuhan, hubei Province,   People’s republic of china *These authors contributed equally  to this workAbstract:  Although many epidemiologic studies investigated the GSTM1  gene polymorphism  and its association with nasopharyngeal carcinoma (NPC) in Chinese, definite conclusions cannot  be drawn.",Non-OADS,/arxiv_data1/oa_pdf/a0/43/ott-8-2479.PMC4572722.pdf
"The most common genotype of GSTM1  gene is  homozygous deletion (null genotype), which has been suggested to be associated with  the loss of enzyme activity, increased vulnerability to cytogenetic damage, and results correspondence: ge Xu  Department of Otolaryngology, PUai  hospital, Tongji Medical college,  huazhong University of science and  Technology, 473 hanzheng street,  Wuhan, hubei Province 430030,  People’s republic of china email gexu2596@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Li et al Running head recto: GSTM1  polymorphism and NPC DOI: http://dx.doi.org/10.2147/OTT.S89212",Non-OADS,/arxiv_data1/oa_pdf/a0/43/ott-8-2479.PMC4572722.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a0/43/ott-8-2479.PMC4572722.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/43/ott-8-2479.PMC4572722.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/32/copd-10-1857.PMC4572723.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1857–1862International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1857OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8771 4The relationship between anthropometric  indicators and walking distance in patients with  chronic obstructive pulmonary disease shu-Chuan ho1,* Min-Fang hsu2,3,* han-Pin Kuo4 Jiun-Yi Wang2 li-Fei Chen4 Kang-Yun lee5,6 hsiao-Chi Chuang1 1school of respiratory Therapy,   College of Medicine, Taipei Medical  University, Taipei, 2Department  of healthcare administration,   asia University, Wufeng, Taichung,   3Department of nursing, Kang- ning  Junior College of Medical Care and  Management, Taipei, 4Department  of Thoracic Medicine, Chang gung  Memorial hospital, Chang gung  University College of Medicine, Taipei,   5Division of Pulmonary Medicine,   Department of Internal Medicine,   shuang ho hospital, 6Department of  Internal Medicine, school of Medicine,   College of Medicine, Taipei Medical  University, Taipei, Taiwan *These authors contributed equally  to this workBackground:  Exercise intolerance is a major issue affecting many people with COPD.",Non-OADS,/arxiv_data1/oa_pdf/a6/32/copd-10-1857.PMC4572723.pdf
"To reduce Correspondence: shu-Chuan ho school of respiratory Therapy, College  of Medicine, Taipei Medical University,  number 250, Wuxing st, Taipei, 11031,  Taiwan Tel +886 2 2736 1661 ext 3512 Fax +886 2 2739 1143 email shu-chuan@tmu.edu.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ho et al Running head recto: The relationship between anthropometry and 6MWD in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S87714",Non-OADS,/arxiv_data1/oa_pdf/a6/32/copd-10-1857.PMC4572723.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a6/32/copd-10-1857.PMC4572723.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/32/copd-10-1857.PMC4572723.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/29/copd-10-1837.PMC4572725.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1837–1846International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1837OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8805 8Does eosinophilic COPD exacerbation have a  better patient outcome than non-eosinophilic in  the intensive care unit?,Non-OADS,/arxiv_data1/oa_pdf/3a/29/copd-10-1837.PMC4572725.pdf
The majority of COPD exacerbations have an infectious origin.6 Some stud - ies have investigated the decision to use steroids or antibiotics based on the COPD  exacerbation.7–11 Sputum and peripheral eosinophilia (2%–3% eosinophils) have been Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Saltürk et al Running head recto: Eosinophilic COPD exacerbation in ICU DOI: http://dx.doi.org/10.2147/COPD.S88058,Non-OADS,/arxiv_data1/oa_pdf/3a/29/copd-10-1837.PMC4572725.pdf
Available from:   http://www.goldcopd.or g 4.,Non-OADS,/arxiv_data1/oa_pdf/3a/29/copd-10-1837.PMC4572725.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3a/29/copd-10-1837.PMC4572725.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/29/copd-10-1837.PMC4572725.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/40/ijn-10-5687.PMC4572731.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 5687–5700International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5687OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8717 4Imaging of hsp70-positive tumors with cm hsp70.1  antibody-conjugated gold nanoparticles Mathias K gehrmann1 Melanie a Kimm2 stefan stangl1 Thomas e schmid1 Peter B Noël2 ernst J rummeny2 gabriele Multhoff1 1Department of radiation Oncology,   2Department of Diagnostic and  Interventional radiology, Klinikum  rechts der Isar, T echnische Universität  München, Munich, germanyAbstract:  Real-time imaging of small tumors is still one of the challenges in cancer diagnosis,  prognosis, and monitoring of clinical outcome.",Non-OADS,/arxiv_data1/oa_pdf/5f/40/ijn-10-5687.PMC4572731.pdf
"Tumor imaging with nanoparticles can be improved by coupling them correspondence: gabriele Multhoff Department of radiation Oncology,  Klinikum rechts der Isar, Technische  Universität München, Ismaninger  straße 22, D-81675 Munich, germany Tel +49 89 4140 4514 Fax +49 89 4140 4299 email gabriele.multhoff@tum.d eJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Gehrmann et al Running head recto: Imaging of Hsp70-positive tumors DOI: http://dx.doi.org/10.2147/IJN.S87174",Non-OADS,/arxiv_data1/oa_pdf/5f/40/ijn-10-5687.PMC4572731.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5f/40/ijn-10-5687.PMC4572731.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/40/ijn-10-5687.PMC4572731.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/dc/dddt-9-5169.PMC4572734.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5169–5183Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8157 8regulation of bone formation by baicalein via the  mTOrc1 pathway sheng-fa li1,2,* Jia-jun Tang1,2,* Jian chen1–3,* Pei Zhang4,* Ting Wang5 Tian-yu chen1,2 Bo Yan1,2 Bin huang1,2 liang Wang1,2 Min-jun huang1,2 Zhong-min Zhang1,2 Da-di Jin1,2 1academy of Orthopedics of  guangdong Province, guangzhou,   People's republic of china;   2Department of Orthopedics, The  Third affiliated hospital, southern  Medical University, guangzhou,   guangdong, People’s republic of  china; 3Three gorges central  hospital of chongqing, chongqing,   People’s republic of china; 4school  of Traditional chinese Medicine,   southern Medical University,   guangzhou, guangdong, People’s  republic of china; 5Department of  cell Biology, school of Basic Medical  science, southern Medical University,   guangzhou, guangdong, People’s  republic of china *These authors contributed equally  to this workAbstract:  Osteoporosis is a systemic skeletal disease that is characterized by low bone density  and microarchitectural deterioration of bone tissue.",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/dddt-9-5169.PMC4572734.pdf
"Therefore, correspondence: Zhong-min Zhang;  Da-di Jin Department of Orthopedics, The  Third Affiliated Hospital of Southern  Medical University, 183 West Zhongshan   avenue, guangzhou 510665,  People’s republic of china  Tel +86 020 6278 4602;   +86 020 3825 2295 email 13002006619@163.co m;  jinda_di@yahoo.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Li et al Running head recto: Regulation of bone formation by baicalein via mTORC1 DOI: http://dx.doi.org/10.2147/DDDT.S81578",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/dddt-9-5169.PMC4572734.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3c/dc/dddt-9-5169.PMC4572734.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/dc/dddt-9-5169.PMC4572734.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cc/0f/copd-10-1847.PMC4572735.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1847–1852International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1847OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8981 4Balance impairment and systemic inflammation in  chronic obstructive pulmonary disease emanuela T udorache1 Cristian Oancea1 Claudiu avram2 Ovidiu Fira-Mladinescu1 lucian Petrescu3 Bogdan Timar4 1Department of Pulmonology,   University of Medicine and Pharmacy  “Victor Babes”, 2Physical education  and sport Faculty, West University of  Timisoara, 3Department of Cardiology,   University of Medicine and Pharmacy  “Victor Babes”, 4Department of  Biostatistics and Medical Informatics,   University of Medicine and Pharmacy  “Victor Babes”, Timisoara, romaniaBackground/purpose:  Chronic obstructive pulmonary disease (COPD), especially in severe  forms, is commonly associated with systemic inflammation and balance impairment.",Non-OADS,/arxiv_data1/oa_pdf/cc/0f/copd-10-1847.PMC4572735.pdf
"Although reduction in muscle performance, functional  mobility, and exercise capacity has been demonstrated, more evidence suggests that  individuals with COPD also present an important risk of falls.2 Multiple medications, impaired mobility, muscle weakness, and the presence of  chronic diseases are often mentioned as risk factors that can lead to falls in older adults.3  Just a small percentage of falls are the result of a single cause; therefore, the etiology  is considered to be multifactorial, involving patient-related factors (intrinsic) and envi - ronmental circumstances (extrinsic) as well as variables related with the activity.4Correspondence: Cristian Oancea Department of Pulmonology, University  of Medicine and Pharmacy “Victor  Babes”, eftimie Murgu square, number 2,  Timisoara, romania Tel +40 769 221 057 Fax +40 256 207 673 email oancea@umft.r o Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Tudorache et al Running head recto: Balance impairment and inflammation in COPD DOI: http://dx.doi.org/10.2147/COPD.S89814",Non-OADS,/arxiv_data1/oa_pdf/cc/0f/copd-10-1847.PMC4572735.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/cc/0f/copd-10-1847.PMC4572735.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cc/0f/copd-10-1847.PMC4572735.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/2d/dddt-9-5203.PMC4572747.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5203–5211Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5203Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8696 9Dabigatran etexilate retards the initiation and  progression of atherosclerotic lesions and inhibits  the expression of oncostatin M in apolipoprotein  E-deficient mice Michael r Preusch1,2 nicholas ieronimakis1 errol s Wijelath3 sara cabbage1 Jerry ricks1 Florian Bea2 Morayma reyes1 Joanne van ryn4 Michael e rosenfeld1,5 1Department of Pathology, University  of Washington, seattle, W a, Usa;   2Department of internal Medicine,   University of heidelberg, heidelberg,   germany; 3Department of surgery,   University of Washington, seattle, W a,   Usa; 4Department of cardioMetabolic  Disease research, Boehringer  ingelheim Pharma gmbh & co K g,   Biberach, germany; 5Department  of environmental and Occupational  health sciences, University of  Washington, seattle, W a, UsaObjective:  Thrombin has multiple proatherogenic effects including platelet activation and the  induction of inflammatory processes.",Non-OADS,/arxiv_data1/oa_pdf/f1/2d/dddt-9-5203.PMC4572747.pdf
"For example, it has been shown that thrombin mediates vasoconstriction due to an  inhibition of the activation of endothelial nitric oxide synthase (eNOS).5–7 There are  additional reports of thrombin-triggered oxidative stress due to increased synthesis of correspondence: Michael r Preusch University of heidelberg, internal  Medicine iii, Department of cardiology,  angiology, Pneumology, im neuenheimer  Feld 410, 69120 heidelberg, germany Tel +49 6221 56 8611 Fax +49 6221 56 7638 email michael.preusch@med.uni- heidelberg.d e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Preusch et al Running head recto: Dabigatran etexilate retards atherosclerosis and OSM expression DOI: http://dx.doi.org/10.2147/DDDT.S86969",Non-OADS,/arxiv_data1/oa_pdf/f1/2d/dddt-9-5203.PMC4572747.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/f1/2d/dddt-9-5203.PMC4572747.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/2d/dddt-9-5203.PMC4572747.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/85/msv048.PMC4572785.pdf
"Sequence Data Processing and Trancriptome De Novo Assembly After trimming off the adaptor sequences, the raw reads were ﬁltered based on both quality and length using the FASTX-Toolkit ( http://hannonlab.cshl.edu/fastx_toolkit/ ,l a s t accessed March 12, 2015; Version 0.0.13).",OADS,/arxiv_data1/oa_pdf/2c/85/msv048.PMC4572785.pdf
"Phylogenetic Analyses Homologous genes searches were performed with BLASTPusing translated ORFs from our P. rapae de novo transcrip- tome assembly as queries against protein databases of thefollowing species: six Lepidoptera: P. rapae translated ORFs (our data), B. mori (http://silkworm.genomics.org.cn/ ,l a s t accessed March 12, 2015; Bombyx_m ori.Bmor1.21.pep.all.fa), D. plexippus (http://monarchbase.umassmed.edu/ ,l a s t accessed March 12, 2015; Dp_geneset_OGS1_pep.fasta), H. melpomene (http://www.butterﬂygenome.org/ , last accessed March 12, 2015; heliconius_melpomene_v1.1_primary Scaffs_Protein.faa), Manduca sexta (http://agripestbase.org/manduca/ , last accessed March 12, 2015; Manduca_sexta_OGS2_20140407_proteins.fa), Plutella xylostella (http://iae.",OADS,/arxiv_data1/oa_pdf/2c/85/msv048.PMC4572785.pdf
"fafu.edu.cn/DBM/ , last accessed March 12, 2015; P.xylostella.pep.fasta); two Diptera: Drosophila melanogaster (http://ﬂybase.org/ , last accessed March 12, 2015; dmel-all- translation-r5.57.fasta) and Aedes aegypti (Liverpool strain, https://www.vectorbase.org/ , last accessed March 12, 2015; Aedes-aegypti-Liverpool_PEPTIDES_AaegL3.1.fa); and two ad- ditional insects, Apis mellifera (www.beebase.org/ ,l a s t accessed March 12, 2015; amel _OGSv3.2_pep.fa) and Tribolium castaneum (http://beetlebase.org/ ,l a s ta c c e s s e d March 12, 2015; Tcas20051011-glean_ peptide).",Non-OADS,/arxiv_data1/oa_pdf/2c/85/msv048.PMC4572785.pdf
"Animal procedures were performed in accordance with the guidelines of the University of Montreal and the Canadian Council onAnimal Care for the use of experimental animals (http://www.ccac.ca).All surgeries were carried out in adult B6.Cg.Tg[Thy1-YFPH]2Jrs/J mice (Jackson Laboratory, Bar Harbor, ME, USA) or wild-type litter mate controls maintained in our animal facility.",Non-OADS,/arxiv_data1/oa_pdf/16/c9/cdd2014149a.PMC4572858.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/REDD2-induced mTOR loss leads to dendrite pathology B Morquette et al 625 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/16/c9/cdd2014149a.PMC4572858.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Glucocorticoids promote foetal cardiomyocyte maturation EA Rog-Zielinska et al 1116 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/ac/5f/cdd2014181a.PMC4572859.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Human acinar-to- β-cell reprogramming M Lemper et al 1130 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/0a/c7/cdd2014193a.PMC4572860.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/c-FLIP Lin ER morphology and tethering ES Marini et al 1143 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/ae/d5/cdd2014197a.PMC4572861.pdf
In In Stem Cell Information [http://stemcells.nih.gov/info/basics/ pages/basics3.aspx].,OADS,/arxiv_data1/oa_pdf/a2/44/cdd2014205a.PMC4572863.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Suppression of EMT and apoptotic pathways in maintaining self-renewal of ESCs W-T Guo et al 1169 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/a2/44/cdd2014205a.PMC4572863.pdf
"4Statistical data analysis was performed at the Bioinformatics Core Facility (http://bioinformatics.tigem.it) ofTIGEM, Italy.",OADS,/arxiv_data1/oa_pdf/cb/c7/cdd201524a.PMC4572871.pdf
Genes were classified based on Gene Ontology terms (DAVID Bioinformatics Resources; http://david.abcc.ncifcrf.gov).,OADS,/arxiv_data1/oa_pdf/cb/c7/cdd201524a.PMC4572871.pdf
The ImageJ software (open source; http://imagej.nih.gov/ij) was used for densitometric quantification.,OADS,/arxiv_data1/oa_pdf/cb/c7/cdd201524a.PMC4572871.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)L-Proline ↔AAR axis controls ESC identity CD ’Aniello et al 1105 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/cb/c7/cdd201524a.PMC4572871.pdf
"Key Words: electroencephalography ◼ heart arrest ◼ hypothermia, induced ◼ prognostication Circulation is available at http://circ.ahajournals.org DOI: 10.1161/CIRCULATIONAHA.115.015754Received January 28, 2015; accepted July 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/81/85/cir-132-1094.PMC4572885.pdf
The online-only Data Supplement is available with this article at http://circ.ahajournals.org/lookup/suppl/doi:10.1161/CIRCULATIONAHA.,Non-OADS,/arxiv_data1/oa_pdf/81/85/cir-132-1094.PMC4572885.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2485–2492OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2485Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8531 3comparison of the utility and applicability of the  sokal, hasford, and eUTOs scores in a population  of chinese patients with chronic-phase chronic  myeloid leukemia undergoing imatinib therapy leiming Xia1,2,* Wei Qian3,* Mingzhen Yang3,4 Qingsheng li4 Fei liu5 Yanyan Xie4 1Department of hematology, The  Third affiliated hospital of anhui  Medical University, hefei, People’s  republic of china; 2Department of  hematology, hefei Binhu hospital,   hefei, People’s republic of china;   3Department of hematology, The  Fourth affiliated hospital of anhui  Medical University, hefei, People’s  republic of china; 4Department  of hematology, The First affiliated  hospital of anhui Medical University,   hefei, People’s republic of china;   5Department of hematology, The  second People’s hospital of Wuhu,   Wuhu, People`s republic of china *These authors contributed equally  to this workBackground:  Tyrosine kinase inhibitors are increasingly used to treat chronic myeloid leukemia  (CML), but loss of complete cytogenetic response (CCyR) indicates treatment failure.",Non-OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
"Keywords:  chronic-phase chronic myeloid leukemia, prognosis, Sokal, EUTOS, Hasford,  complete cytogenic response Introduction The etiology of chronic myeloid leukemia (CML) is unknown, but has been attributed to  tyrosine kinase activity and genetic translocation of the Philadelphia (Ph) chromosome  that carries a fusion gene responsible for the disease.1–6 CML may present in chronic-phase  (CP-CML), accelerated-phase, or blast-phase; however, .90% of patients are diagnosed  in CP-CML.1 Over half of all CP-CML cases are asymptomatic;1 however, if untreated,  these patients will inevitably progress to blast-phase CML within 3–5 years.2 Tyrosine kinase inhibitors (TKIs) have greatly improved the prognosis of CML,  and projected survival of imatinib-responsive CML is close to 100% after 6–7 years.5  The IRIS trial achieved 94.9% 12-month event-free survival (EFS) with imatinib, in  comparison to 75.3% EFS in the control arm.6 In approximately 75% of patients, the  Ph chromosome cannot be detected after 2 years of therapy, a state termed complete correspondence: Mingzhen Yang Department of hematology, The First  Affiliated Hospital of Anhui Medical  University, hefei 230022, anhui,   People’s republic of china Tel +86 551 62922041 Fax +86 551 62923655 email yangmz89@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xia et al Running head recto: CCyR analysis of patients with CP-CML undergoing TKI DOI: http://dx.doi.org/10.2147/OTT.S85313",Non-OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
Prognosis Sokal and Hasford scores were calculated using an online  tool ( http://www.leukemia-net.org/content/leukemias/ cml/cml_score/index_eng.htm l).,OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
OncoTargets and Therapy 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press 2487ccyr analysis of patients with cP-cMl undergoing TKi calculated using an online tool ( http://www.leukemia-net.org/ content/leukemias/cml/eutos_score/index_eng.htm l).,Non-OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/00/ott-8-2485.PMC4573067.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/f1/dddt-9-5185.PMC4573071.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5185–5194Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5185Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8543 5exposure–response model for sibutramine and  placebo: suggestion for application to long-term  weight-control drug development seunghoon han1,2 sangil Jeon1,2 Taegon hong1,2 Jongtae lee1,2 soo hyeon Bae1,2 Wan-su Park1,2 gab-jin Park1,2 sunil Y oun1,2 Doo Yeon Jang1,2 Kyung-soo Kim3 Dong-seok Yim1,2 1Department of Pharmacology,   college of Medicine, The  catholic University of Korea,   2Pharmacometrics institute for  Practical education and Training,   3Department of Family Medicine,   seoul st Mary’s hospital, seochogu,   seoul, republic of KoreaAbstract:  No wholly successful weight-control drugs have been developed to date, despite the  tremendous demand.",Non-OADS,/arxiv_data1/oa_pdf/85/f1/dddt-9-5185.PMC4573071.pdf
"By 2012, more than ten candidates  were under clinical development with targeted approval as either monotherapy or  combination drugs.6 However, judging from the failures in the past, we argue that the correspondence: Dong-seok Yim Department of Pharmacology, college  of Medicine, The catholic University  of Korea, 222 Banpo-Daero, seochogu,  seoul 137-701, republic of Korea Tel +82 2 2258 7327 Fax +82 2 2258 7876 email yimds@catholic.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Han et al Running head recto: Exposure–response model for weight-control drug DOI: http://dx.doi.org/10.2147/DDDT.S85435",Non-OADS,/arxiv_data1/oa_pdf/85/f1/dddt-9-5185.PMC4573071.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/85/f1/dddt-9-5185.PMC4573071.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/f1/dddt-9-5185.PMC4573071.pdf
Available from http://www.fda.gov/ downloads/Drugs/.../Guidances/ucm071612.pdf.,Non-OADS,/arxiv_data1/oa_pdf/85/f1/dddt-9-5185.PMC4573071.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/00/c1/ott-8-2461.PMC4573072.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2461–2467OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2461Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8664 2Three-dimensional conformal radiotherapy by  delineations on cT -based simulation in different  respiratory phases for the treatment of senile  patients with non-small cell lung cancer Weifeng Wang1,2 Feng Yuan2 guoping Wang2 Zhiren lin2 Yanling Pan2 longhua chen1 1Department of radiation Oncology,   nanfang hospital, southern Medical  University, guangzhou, guangdong  Province, People’s republic of china;   2Department of radiation Oncology,   haikou municipal hospital, haikou,   hainan Province, People’s republic of  chinaAim:  This study aimed to evaluate the application of three-dimensional conformal radiotherapy  (3D-CRT) for elderly patients with non-small cell lung cancer (NSCLC) based on computed  tomography (CT) simulations in different respiratory phases.",Non-OADS,/arxiv_data1/oa_pdf/00/c1/ott-8-2461.PMC4573072.pdf
"Three-dimensional conformal radiotherapy (3D-CRT) is a new modality of radio - therapy that has been designed for patients with inoperable disease or who refused  surgery.3 A meta-analysis has shown that 3D-CRT improved local control rates com - pared with conventional radiotherapy.3 However, 3D-CRT is associated with some correspondence: longhua chen Department of radiation Oncology,  nanfang hospital, southern Medical  University, guangzhou 510515,  guangdong Province, People’s republic  of china Tel +86 152 0366 8867 Fax +86 21 6408 5875 email chenlonghuasci@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: CT-based 3D conformal radiotherapy in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S86642",Non-OADS,/arxiv_data1/oa_pdf/00/c1/ott-8-2461.PMC4573072.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/00/c1/ott-8-2461.PMC4573072.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/00/c1/ott-8-2461.PMC4573072.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5215–5223Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5215ExpEr T OpiniO nopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8756 1Companion diagnostics and molecular imaging- enhanced approaches for oncology clinical trials ronald L Van Heertum robert Scarimbolo robert Ford Eli Berdougo Michael O’n eal BioClinica inc, princeton,    pA, USA Abstract:  In the era of personalized medicine, diagnostic approaches are helping pharmaceutical  and biotechnology sponsors streamline the clinical trial process.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
"Companion diagnostic assays (also referred to in the literature as pharmacodiag - nostics or theranostics) provide a test that can identify the presence or absence of a Correspondence: ronald L Van Heertum  BioClinic inc., 100 Overlook Center,  princeton, nJ 08540, USA  Tel +1 609 936 2868 Fax +1 609 514 4964 Email ronald.vanheertum@bioclinica.co m Journal name: Drug Design, Development and Therapy Article Designation: Expert Opinion Y ear: 2015 Volume: 9 Running head verso: Van Heertum et al Running head recto: Diagnostic approaches for oncology clinical trials DOI: http://dx.doi.org/10.2147/DDDT.S87561",Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
"Available  from: http://www.transparencymarketresearch.com/cancer-diagnostics- market.htm l. Accessed July 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
"Available from: http://www.fda.gov/downloads/ MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ UCM262327.pd f. Accessed July 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
"Available from: http://www.fda.gov/ downloads / Drugs/.../Guidances/ucm071600.pd f. Accessed July 20, 2015.",Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
Available from: http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm071603.,Non-OADS,/arxiv_data1/oa_pdf/4e/35/dddt-9-5215.PMC4573073.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/82/6f/cmar-7-291.PMC4573074.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 291–299Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  291Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3485 9Targeting autophagy in cancer management –  strategies and developments Bulent Ozpolat1 Doris M Benbrook2 1Department of experimental  Therapeutics, The University of   T exas – Houston, MD Anderson  Cancer Center, Houston, TX,   2Department of Obstetrics and  Gynecology, University of Oklahoma  HSC, Oklahoma City, OK, USA Correspondence: Bulent Ozpolat   Department of experimental  Therapeutics, The University of Texas,  MD Anderson Cancer Center,   1901 east Road, 3SCR3.3421,   Houston, TX 77054, USA   email b ozpolat@mdanderson.or gAbstract:  Autophagy is a highly regulated catabolic process involving lysosomal degradation  of intracellular components, damaged organelles, misfolded proteins, and toxic aggregates,  reducing oxidative stress and protecting cells from damage.",Non-OADS,/arxiv_data1/oa_pdf/82/6f/cmar-7-291.PMC4573074.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/82/6f/cmar-7-291.PMC4573074.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/6f/cmar-7-291.PMC4573074.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e2/a1/copd-10-1899.PMC4573075.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1899–1906International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1899OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8860 9respiratory muscle training with normocapnic  hyperpnea improves ventilatory pattern and  thoracoabdominal coordination, and reduces  oxygen desaturation during endurance exercise  testing in COPD patients eva Bernardi1 luca Pomidori1 Faisy Bassal1 Marco Contoli2 annalisa Cogo1 1Biomedical sport studies Center,   University of Ferrara, Ferrara,   2respiratory section, Department  of Medical sciences, University of  Ferrara, Cona (Fe), ItalyBackground:  Few data are available about the effects of respiratory muscle training with normo - capnic hyperpnea (NH) in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e2/a1/copd-10-1899.PMC4573075.pdf
"Keywords:  COPD, exercise, inspiratory muscle, pulmonary rehabilitation Introduction Dyspnea is the primary symptom that limits exercise in many patients with COPD.1,2  In COPD, exercise limitation is clearly multifactorial; one of the main contributors1  is ventilatory limitation due to increased airway resistance and pulmonary hyperin - flation, both increasing the work of breathing.3–5 In addition, COPD patients exhibit Correspondence: eva Bernardi Biomedical sport studies Center,  University of Ferrara, via gramicia 35,  44100 Ferrara, Italy email bernardi.eva@gmail.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Bernardi et al Running head recto: NH improves ventilatory pattern and oxygen saturation in COPD DOI: http://dx.doi.org/10.2147/COPD.S88609",Non-OADS,/arxiv_data1/oa_pdf/e2/a1/copd-10-1899.PMC4573075.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/e2/a1/copd-10-1899.PMC4573075.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e2/a1/copd-10-1899.PMC4573075.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/87/imcrj-8-185.PMC4573076.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 185–187International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  185Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S9200 7spontaneous resolution of massive expulsive  suprachoroidal hemorrhage with good   long-term visual outcome: a case report seung-Jun Lee* Jang Hun Lee* sang Wook park Moosang Kim sang Beom Han Department of ophthalmology,   Kangwon National University  Hospital, Kangwon National  University Graduate school of  Medicine, Chuncheon, Korea *these authors contributed equally   to this work Correspondence: sang Beom Han   Department of ophthalmology, Kangwon  National University Hospital, Kangwon  National University Graduate school  of Medicine,  156 Baengnyeong-ro,  Chuncheon, Gangwon  200-722, Korea   tel +82 33 258 9210  Fax +82 33 258 2296  email m.sangbeom.han@gmail.co mIntroduction:  Massive suprachoroidal hemorrhage (SCH) that completely fills the vitreous  cavity rarely resolves spontaneously.",Non-OADS,/arxiv_data1/oa_pdf/93/87/imcrj-8-185.PMC4573076.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/93/87/imcrj-8-185.PMC4573076.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/87/imcrj-8-185.PMC4573076.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/copd-10-1891.PMC4573078.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1891–1897International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1891OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9094 3Physical inactivity and arterial stiffness in COPD noriane a sievi1 Daniel Franzen1 Malcolm Kohler1,2 Christian F Clarenbach1 1Division of Pulmonology, University  hospital of Zurich, 2Zurich Center  for Integrative human Physiology,   University of Zurich, Zurich,   switzerlandBackground:  Arterial stiffness is an important predictor of cardiovascular risk besides classic  cardiovascular risk factors.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/copd-10-1891.PMC4573078.pdf
"Most patients with COPD present with remark - ably low levels of PA compared to subjects without COPD, even in mild to moderate  stages of the disease.14 In longitudinal cohort studies, regular PA has been shown to Correspondence: Christian F Clarenbach Division of Pulmonology, University  hospital of Zurich, raemistrasse 100,  8091 Zurich, switzerland Tel +41 44 255 3828 Fax +41 44 255 4451 email c hristian.clarenbach@usz.c h Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sievi et al Running head recto: Inactivity and arterial stiffness in COPD DOI: http://dx.doi.org/10.2147/COPD.S90943",Non-OADS,/arxiv_data1/oa_pdf/15/0d/copd-10-1891.PMC4573078.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/15/0d/copd-10-1891.PMC4573078.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/0d/copd-10-1891.PMC4573078.pdf
Comparison of the nucleotide sequences (568 bp) with the GenBank database revealed 99.3% similarity with Fonse- caea nubica type strain CBS 269.64 (accession number EU938592).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.08.001 2211-7539/ &2015 International Society for Human and Animal Mycology.,OADS,/arxiv_data1/oa_pdf/70/7a/main.PMC4573089.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.008 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"The face stimuli were created with FaceGen ( http://www.facegen.com ), a program used to create re- alistic human faces.",OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
Study 1: task-based fMRI analysis Functional data were sampled onto the cortical surface and projected onto an average spherical representation using the FreeSurfer analysis stream ( http://surfer.nmr.mgh.harvard.edu ).,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.cub.2009.04.02819427210 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
Psychiatry http://dx.doi.org/10.1111/eip.1212824576057 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"4 (1), 68 –83.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"J. Neurosci.32 (42), 14729– 14741. http://dx.doi.org/10.1523/JNEUROSCI.1599-12.201223077058 .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1172-11.201121677185 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5062-08.200919211893 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"Gen. Psychiatry 65 (1), 28 –37.http://dx.doi.org/10.1001/archgenpsychiatry.2007.",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/ 10.1093/schbul/sbl02916916889 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"11 (2), 93 –97.http://dx.doi.org/10.1037/h00270405778351 .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1037/h00351414583882 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1093/schbul/sbt15324191160 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"http://dx.doi.org/10.1159/00035325823867974 .Gessaroli, E., Santelli, E., di Pellegrino, G., Frassinetti, F., 2013.",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.2011.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1001/archgenpsychiatry.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1093/schbul/sbt13124072811 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1093/schbul/sbn04518495642 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"94 (2), 293 –33  5. http://dx.doi.org/10.1037/0033-2909.94.2.293 .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1176/ajp.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1523/JNEUROSCI.0686-13.201424647934 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1093/schbul/sbp06719605517 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"112 (1), 41 –50.http://dx.doi.org/10.1016/ S0165-1781(02)00177-412379449 .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1001/archpsyc.1964.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/ 10.1146/annurev.clinpsy.032408.15350219327031 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.2307/3033517 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.pscychresns.2008.06.00319243925 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1037/ 0021-843X.107.4.5589830243 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.cognition.2011.02.,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.schres.,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1852-08.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1177/0020764003049300214626359 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/S0028-3932(03)00177-514527539 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.psychres.,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1159/00008844216179812 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"2), 14–19.http://dx.doi.org/10.4088/JCP.13065su1.0424919166 .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/S0006-3223(02)01784- 512814861 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1017/S003329171000105420482936 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.jpsychires.2008.10.01219056093 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1126/ science.121002722053054 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1038/ nn177716998482 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"http://dx.doi.org/10.1016/0010- 440X(90)90015-K2311379 .Strau ss, G.P., Gold, J.M., 2012.",OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"J. Psychiatry 169 (4), 364– 373. http://dx.doi.org/10.1176/appi.ajp.2011.",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.jns.2013.12.02524398346 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1371/ journal.pone.002708922073126 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/ 10.1176/appi.ajp.2013.1304049824626638 .,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"J. Psychiatry 161 (2), 315– 321. http://dx.doi.org/10.1176/appi.ajp.161.2.31514754781 .",Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
"Cortex 3 (2), 79 –94.http://dx.doi.org/10.1093/cercor/3.2.798490322 .",OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.org/10.1016/j.pscychresns.2008.01.00518938066 .,OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/main.PMC4573090.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.nicl.2015.07.0182213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1017/neu.2013.225287727 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1097/WCO.0b013e32832d93dd19494774 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.dcn.2011.02.00221743819 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"1124, 1 –38.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"10 (3), 186– 198. http://dx.doi.org/10.1038/ nrn257519190637 .",Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1007/s00401-006-0085- 516819561 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1038/ nrn89612154363 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1136/ jnnp.2010.23911121693631 .230 B.E.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1089/cap.2014.011225919578 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1038/491S20a23136657 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1002/ana.2439125707715 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"5 (1), 49 –66.http://dx.doi.org/10.1002/ aur.23522139976 .",Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.mri.2006.04.01816997067 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1111/j.1467-7687.2010.01020.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1007/ s10803-008-0674-319082876 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"Neuroimage 82, 208– 225. http://dx.doi.org/ 10.1016/j.neuroimage.2013.05.116 .",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"221 (1), 63 –68.http://dx.doi.org/10.1016/j.pscychresns.2013.08.",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"Neuroimage 50 (2), 589– 599. http://dx.doi.org/10.1016/j.neuroimage.2009.12.04720026220 .",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"Autism 5, 35. http://dx.doi.org/10.1186/2040-2392-5-3524955232 .",Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1093/scan/nss106 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2007.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1093/brain/ awm33418234695 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"Neuroimage 12 (1), 20 –27.http://dx.doi.org/10.1006/ nimg.2000.059310875899 .",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1093/brain/awp30620008375 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1038/npp.2011.921346736 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuropsychologia.2007.07.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.05.05121640839 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.04.06919409498 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1093/cercor/bhq29621378114 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1002/hbm.2245624452854 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.brainres.2010.09.02120858465 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.media.2010.07.002 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"7, 85. http://dx.doi.org/10.3389/fncel.2013.0008523761734 .",Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.10.01822019881 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuron.2011.09.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.08.04823994314 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"Psychiatry 6, 56. http://dx.doi.org/10.1186/1471-244X-6- 5617166273 .",Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1034/j.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"2, 79 –94.http://dx.doi.org/10.1016/j.nicl.2012.11.",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1093/cercor/bhr17121784971 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1038/ npp.2009.19219956088 .231 B.E.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"NeuroImage 83, 45 –57.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
Cortex 36. http://dx.doi.org/10.1093/cercor/bhu03624646613 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1523/JNEUROSCI.5587- 06.200717329432 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1111/j.1469-7610.2010.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.07.05115501092 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.celrep.2013.10.00124210821 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2010.04.00920385244 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/ 10.1016/j.biopsych.2011.07.01421890111 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
Cortex 161. http://dx.doi.org/10.1093/cercor/bhu16125073720 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1089/brain.2012.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1152/jn.00783.,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1093/scan/ nss05322563003 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.02.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.brainres.2009.,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1016/j.brainres.2010.10.10221047495 .,OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1002/hbm.2145922102400 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1002/ hbm.2076719384887 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
http://dx.doi.org/10.1038/ nature1036021796121 .,Non-OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
"6 (1), 15–28.http://dx.doi.org/10.1038/nrneurol.2009.19820057496 .232 B.E.",OADS,/arxiv_data1/oa_pdf/bf/79/main.PMC4573091.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/7f/cia-10-1457.PMC4573195.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1457–1466Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1457RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8746 6Potential drug–drug interactions in Alzheimer  patients with behavioral symptoms Giuseppe Pasqualetti Sara T ognini valeria Calsolaro Antonio Polini Fabio Monzani Geriatrics Unit, Department of  Clinical and experimental Medicine,   University of Pisa, Pisa, ItalyAbstract:  The use of multi drug regimens among the elderly population has increased  tremendously over the last decade although the benefits of medications are always accompanied  by potential harm, even when prescribed at recommended doses.",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/cia-10-1457.PMC4573195.pdf
"Indeed, an ADR may be much more easily ascribed to “frailty” itself, an already existing Correspondence: Fabio Monzani Geriatrics Unit, Department of Clinical  and experimental Medicine, University of  Pisa, via Savi 10, 56126 Pisa, Italy  Tel +39 050 99 7363 Fax +39 050 99 7352  email fabio.monzani@med.unipi.i t Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Pasqualetti et al Running head recto: Drug–drug interactions in Alzheimer patients with behavioral symptoms DOI: http://dx.doi.org/10.2147/CIA.S87466",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/cia-10-1457.PMC4573195.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/cia-10-1457.PMC4573195.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fc/7f/cia-10-1457.PMC4573195.pdf
"Available from: http://www.cchrint.org/pdfs/ US_Food_and_Drug_Administration_Warnings_on_Antipsychotic_ Drugs.pd f. Accessed August 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fc/7f/cia-10-1457.PMC4573195.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/65/copd-10-1883.PMC4573196.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1883–1889International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1883OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8803 5Cognitive function and living situation in COPD:  is there a relationship with self-management and  quality of life?,Non-OADS,/arxiv_data1/oa_pdf/03/65/copd-10-1883.PMC4573196.pdf
"Keywords:  COPD, cognitive impairment, self-management ability Introduction Cognitive impairment is increasingly being found to be a common comorbidity in  chronic obstructive pulmonary disease (COPD).1–3 The Mayo Clinic Study of Aging  has demonstrated that patients with COPD have an increased risk of mild cognitive  impairment.3 The Cardiovascular Health Study found that patients with coexisting  COPD and cognitive impairment have increased respiratory-related and all-cause  hospitalization compared to those with COPD or cognitive impairment alone.4 A  more recent study found that patients with a recent exacerbation of the disease had  worse cognitive function compared to stable COPD or controls.5 In fact, 57% of those Correspondence: roberto P Benzo Division of Pulmonary and Critical Care  Medicine, Mindful Breathing laboratory,  Mayo Clinic, 200 First street sW  rochester, Mn 55905, Usa Tel +1 50 7774 0561 Fax +1 50 7266 4372 email benzo.roberto@mayo.ed u Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dulohery et al Running head recto: Cognitive function in COPD DOI: http://dx.doi.org/10.2147/COPD.S88035",Non-OADS,/arxiv_data1/oa_pdf/03/65/copd-10-1883.PMC4573196.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/03/65/copd-10-1883.PMC4573196.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/65/copd-10-1883.PMC4573196.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/41/imcrj-8-181.PMC4573197.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 181–183International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  181Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8751 8Bilateral isolated concurrent superior ophthalmic  vein thrombosis in systemic lupus erythematosus Kumar sambhav omar shakir Kakarla V Chalam Department of ophthalmology,   College of Medicine – Jacksonville,   University of Florida, Jacksonville, FL,   Usa Correspondence: Kakarla V Chalam   Department of ophthalmology, College  of Medicine – Jacksonville, University of  Florida, 580 West 8th street, Jacksonville,   FL 32209, Usa   tel +1 904 244 9361   Fax +1 904 244 9391   email kchalam@jax.ufl.ed uAbstract:  We describe a case of bilateral consecutive superior ophthalmic vein thrombosis as  a presenting feature in a patient previously not known to have systemic lupus erythematosus  (SLE).",Non-OADS,/arxiv_data1/oa_pdf/97/41/imcrj-8-181.PMC4573197.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/97/41/imcrj-8-181.PMC4573197.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/41/imcrj-8-181.PMC4573197.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/38/idr-8-321.PMC4573198.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 321–331Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  321RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S6559 2Prevention of invasive fungal infections in  immunocompromised patients: the role of  delayed-release posaconazole Ahmet Soysal Division of Pediatric Infectious  Diseases, Department of Pediatrics,   Faculty of Medicine, Marmara  University, Istanbul, T urkey Correspondence: Ahmet Soysal   TC Sağlık Bakanlı ğı-Marmara Üniversitesi  Pendik eğitim ve Araştırma Hastanesi,  Çocuk Enfeksiyon Hastalıkları Bilim Dalı,  Fevzi Çakmak Mah, Mimar Sinan Caddesi,  Üstkaynarca, Pendik, Istanbul, Turkey   Tel +90 216 625 4526   email asoysal@marmara.edu.t rAbstract:  Posaconazole is a triazole antifungal agent that has broad-spectrum activity against  many yeasts and filamentous fungi, including Candida  species, Cryptococcus neoformans ,  Aspergillus  species, and Zygomycetes.",Non-OADS,/arxiv_data1/oa_pdf/3e/38/idr-8-321.PMC4573198.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs / label/2009/022003s007lbl.pd f. Accessed March 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3e/38/idr-8-321.PMC4573198.pdf
"Available  from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/0220 03s008,022027s001lbl.pd f. Accessed March 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3e/38/idr-8-321.PMC4573198.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/3e/38/idr-8-321.PMC4573198.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/38/idr-8-321.PMC4573198.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1863–1881International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1863OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8708 2Comparative efficacy of combination  bronchodilator therapies in COPD:   a network meta-analysis eline l huisman1 Sarah M Cockle2 afisi s Ismaila3,4 Andreas Karabis1 Y ogesh Suresh Punekar2 1Mapi Group, Real World Strategy  and Analytics and Strategic Market  Access, Houten, the Netherlands;   2Value evidence and Outcomes,   GlaxoSmithKline, Uxbridge, UK;   3Value evidence and Outcomes,   GlaxoSmithKline R&D, Research  Triangle Park, NC, USA; 4Clinical  Epidemiology and Biostatistics,   McMaster University, Hamilton,   On, CanadaBackground:  Several new fixed-dose combination bronchodilators have been recently launched,  and assessing their efficacy relative to each other, and with open dual combinations is desir - able.",Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
"Keywords:  LABA/LAMA, UMEC/VI, QVA149, fomoterol, tiotropium, glycopyrronium,  indacaterol, umeclidinium Introduction Recommendations for COPD treatment are primarily based on the burden of symptoms,  categorized using the modified Medical Research Council and COPD assessment  test questionnaires, and on risks, assessed based on severity of airflow limitation and  history of exacerbations.1 Studies have shown that coadministration of long-acting  muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs) is more effec - tive than treatment with either drug class alone in stable COPD as the combination  offers improvement in airflow obstruction, dynamic hyperinflation, reduction in rescue  medication, and a safety profile that is similar to the components.2–4 LABA/LAMA combinations evaluated in clinical studies include open combina - tions of a LABA such as formoterol (FOR), salmeterol (SAL), or indacaterol (IND) Correspondence: Yogesh Suresh Punekar Value evidence and Outcomes,  GlaxoSmithKline, Stockley Park,  Uxbridge UB11 1BT, UK Tel +44 208 990 4786 Fax +44 208 990 3505 email yogesh.q.punekar@gsk.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Huisman et al Running head recto: UMEC/VI versus other combination bronchodilators in COPD DOI: http://dx.doi.org/10.2147/COPD.S87082",Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
"Available from: http://www.who.int/healthinfo/statistics/GlobalCOD_ method.pd f. Accessed April 16, 2014.",OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
Available  from: http://www.vectura.com/media/press-releases/2013/23-sep-2013.,Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
Available from: http://www.fda.gov/newsevents/newsroom/pres - sannouncements/ucm379057.ht m. 2013.,Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
"Available from: http://trials.boehringer- ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/ results/205/205.269.pd f. Accessed April 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7b/a2/copd-10-1863.PMC4573199.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/46/jpr-8-603.PMC4573200.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 603–606Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  603Case RePo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JPR.S8477 1Resolution of chronic migraine headaches   with intrathecal ziconotide: a case report sachin Narain1 Lama al-Khoury2 eric Chang3–6 1Department of anesthesiology and  Perioperative Care, 2Department  of Neurology, 3Department of  Physical Medicine and Rehabilitation,   4Department of Neurosurgery,   5Department of orthopedics, 6Reeve- Irvine Research Center for spinal  Cord Injury, University of California  Irvine, Irvine, C a, Usa Correspondence: eric Chang   Restore orthropedics & spine Center,  1120 West La Veta ave. suite 300,  orange, Ca 92868, Usa   tel +1 657 210 4096   Fax +1 657 210 4233   email: echang@restoreorthopedics.co mBackground:  Migraine headaches are a common and functionally debilitating disorder affect - ing approximately 17% of women and 5.6% of men.",Non-OADS,/arxiv_data1/oa_pdf/93/46/jpr-8-603.PMC4573200.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/93/46/jpr-8-603.PMC4573200.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/46/jpr-8-603.PMC4573200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 441–449ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  441ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S8635 5abobotulinumtoxina in the management   of cervical dystonia in the United Kingdom:   a budget impact analysis seye abogunrin1 sarah Brand2 Kamal Desai3 Jerome Dinet4 sylvie gabriel5 Timothy harrower6 1Meta Research, Evidera, london, UK;   2health Economics, Evidera, Bethesda,   MD, Usa; 3health Economics, Evidera,   london, UK; 4health Economics  and Outcomes Research (global),   5global Market access and Pricing,   ipsen Pharma, Boulogne-Billancourt,   France; 6Royal Devon and Exeter nhs  Foundation Trust, Exeter, UK Correspondence: seye abogunrin   Meta Research, Evidera, Metro Building,  6th Floor, no 1 Butterwick, london W6  8Dl, UK   Tel +44 20 8576 5049   Fax +44 20 857 5195   Email seye.abogunrin@evidera.co mBackground:  Cervical dystonia (CD) can be effectively managed by a combination of botulinum  neurotoxin A (BoNT -A) and conventional therapy (skeletal muscle relaxants and rehabilitative  therapy), but the costs of different interventions in the UK vary.",Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
"Available  from: http://www.pssru.ac.uk/project-pages/unit-costs/2011/index.ph p.  Accessed December 14, 2012.",Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
Available from: http://www.mhra.gov.uk/home/ groups/par/documents/websiteresources/con108612.pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
Available from: http://www.mhra.gov.uk/home/groups/par/documents/ websiteresources/con208720.pdf.,Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
Available from: http://www.mhra.gov.,Non-OADS,/arxiv_data1/oa_pdf/10/29/ceor-7-441.PMC4573201.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/e0/ceg-8-279.PMC4573202.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 279–284Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  279OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S8641 9The sensitivity, specificity, predictive values, and  likelihood ratios of fecal occult blood test for the  detection of colorectal cancer in hospital settings salah h Elsafi1 norah i alqahtani1 nawaf Y Zakary2 Eidan M al Zahrani3 1Clinical laboratory science  Department, Prince sultan Military  College of health sciences, Dhahran,   2Gastroenterology and Endoscopy  Unit, internal Medicine Department,   King Fahd Military Medical Complex,   Dhahran, 3Prince sultan Military  College of heath sciences, Dhahran,   Kingdom of saudi arabia Correspondence: Salah H Elsafi   Clinical laboratory science Department,  Prince sultan Military College of health  sciences, PO Box 946, Dhahran 31932,  Kingdom of saudi arabia   Tel +966 13 840 5448   Fax +966 13 840 5577   Email salah@psmchs.edu.s aObjectives:  To study the performance of a single test using two fecal occult blood tests with  colonoscopy for the detection of colorectal cancer (CRC) for the first time in Saudi Arabia to  determine possible implications for the anticipated colorectal screening program.",Non-OADS,/arxiv_data1/oa_pdf/7e/e0/ceg-8-279.PMC4573202.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/7e/e0/ceg-8-279.PMC4573202.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/e0/ceg-8-279.PMC4573202.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/74/jpr-8-607.PMC4573203.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 607–618Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  607ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7957 8comparison of single-dose and multiple-dose  pharmacokinetics between two formulations   of hydrocodone bitartrate/acetaminophen:  immediate-release versus biphasic immediate-   release/extended release Krishna Devarakonda1 Kenneth Kostenbader2 Michael J giuliani3 Jim l Y oung4 1Department of clinical Pharmacology,   Mallinckrodt Pharmaceuticals,   hazelwood, MO, Usa; 2independent  Pharmaceuticals Professional,   Mallinckrodt Pharmaceuticals,   hazelwood, MO, Usa; 3Research and  Development, 4clinical affairs and  Program Management, Mallinckrodt  Pharmaceuticals, hazelwood, MO, Usa correspondence: Krishna Devarakonda   Department of clinical Pharmacology,  Mallinckrodt inc., 675 James s McDonnell  Boulevard 302-3-W, hazelwood,   MO 63042, Usa   Tel +1 314 654 3364   Fax +1 314 654 9364   email krishna.devarakonda@mallinckrodt.",Non-OADS,/arxiv_data1/oa_pdf/7f/74/jpr-8-607.PMC4573203.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/7f/74/jpr-8-607.PMC4573203.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/74/jpr-8-607.PMC4573203.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/e0/ijgm-8-293.PMC4573204.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 293–295International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  293Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S8988 6Urinary tract infection caused   by Chromobacterium violaceum Narayan Dutt pant Manisha sharma Department of Microbiology,    Grande International Hospital,    Dhapasi, Kathmandu, Nepal Correspondence: Narayan Dutt pant   Department of Microbiology,   Grande International Hospital,   Dhapasi, Kathmandu, Nepal   tel +977 97 4900 8524   email ndpant1987@gmail.co mAbstract:  Chromobacterium violaceum , a proteobacterium, is a facultative anaerobe, which  is generally present as the normal flora of water and soil in tropical and subtropical regions.",Non-OADS,/arxiv_data1/oa_pdf/d0/e0/ijgm-8-293.PMC4573204.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/d0/e0/ijgm-8-293.PMC4573204.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/e0/ijgm-8-293.PMC4573204.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d7/d3/imcrj-8-189.PMC4573205.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 189–192International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  189Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8671 6Unrecognized clozapine-related constipation  leading to fatal intra-abdominal sepsis – a case  report Vikram oke Frances schmidt Bikash Bhattarai Md Basunia Chidozie agu amrit Kaur Danilo enriquez Joseph Quist Divya salhan Vijay Gayam prajakta Mungikar Department of p ulmonary Medicine,   Interfaith Medical Center, NY, Usa Correspondence: Vikram oke   Interfaith Medical Center, 1545 atlantic  avenue, Brooklyn, NY 11213, Usa   email v ikramoke@gmail.co mAbstract:  Clozapine is the preferred antipsychotic used for the treatment of resistant schizo - phrenia with suicidal ideation.",Non-OADS,/arxiv_data1/oa_pdf/d7/d3/imcrj-8-189.PMC4573205.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/d7/d3/imcrj-8-189.PMC4573205.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/d3/imcrj-8-189.PMC4573205.pdf
Available from: http://www.clozaril.co m. 5.,Non-OADS,/arxiv_data1/oa_pdf/d7/d3/imcrj-8-189.PMC4573205.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/05/3c/main.PMC4573206.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.015 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/05/3c/main.PMC4573206.pdf
"12  (2012)  11  http://www.biomedcentral.com/1471-227X/12/11 [8]  D.  Debnathand,  D.  Valerio,  Atraumatic  rupture  of  the  spleen  in  adults,  J.  R. Coll.",Non-OADS,/arxiv_data1/oa_pdf/05/3c/main.PMC4573206.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c8/ae/main.PMC4573207.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.020 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/ae/main.PMC4573207.pdf
This  is  an  open access article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/7f/main.PMC4573208.pdf
CASE 2 The patient is a 76  year  old  man  with  a  past  history  of  parox- ysmal atrial  ﬁbrillation  and  prostate  cancer  treated  with  open http://dx.doi.org/10.1016/j.ijscr.2015.06.024 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/7f/main.PMC4573208.pdf
This  is  an  open  access  article under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/d8/main.PMC4573209.pdf
This  was  successfully  and  electively  embolised  by http://dx.doi.org/10.1016/j.ijscr.2015.07.001 2210-2612/© 2015  Published  by  Elsevier  Ltd.  on  behalf  of  Surgical  Associates  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/bd/d8/main.PMC4573209.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/d8/main.PMC4573209.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/3b/be/main.PMC4573210.pdf
Now  it  is  time  to  convert  the  three-sided  ﬂap  which  is http://dx.doi.org/10.1016/j.ijscr.2015.06.025 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/be/main.PMC4573210.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/30/35/main.PMC4573211.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.027 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/30/35/main.PMC4573211.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be  found,  in the  online version, at http://dx.doi.org/10.1016/j.ijscr.2015.06.027 References [1] I.  Sucandy,  Y.M.",OADS,/arxiv_data1/oa_pdf/30/35/main.PMC4573211.pdf
"Case  Rep.  29  (April  8)  (2014) 131, http://dx.doi.org/10.1186/1752-1947-8-131 [6]  J.R.  Leavitt,  D.L.",Non-OADS,/arxiv_data1/oa_pdf/30/35/main.PMC4573211.pdf
This  is  an  open access article under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/ce/main.PMC4573212.pdf
The  histology  examination  revealed  a  papillary  lesion composed  of  numorous  papillary  fronds  with  an  acelular  ﬁbro- http://dx.doi.org/10.1016/j.ijscr.2015.07.003 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/ce/main.PMC4573212.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/bd/main.PMC4573214.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.029 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/bd/main.PMC4573214.pdf
"Gutwein,  Amyand’s  hernia:  a  rare  inguinal  hernia,  JSCR  9  (2013) 2 pages,  http://dx.doi.org/10.1093/jscr/rjt043 [17] H.G.",Non-OADS,/arxiv_data1/oa_pdf/b9/bd/main.PMC4573214.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC4573215.pdf
Large  hiatal hernias with  or  without  intrathoracic  gastric  volvu- lus  generally  occur  in  elderly  individuals  and  are  commonly http://dx.doi.org/10.1016/j.ijscr.2015.07.005 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC4573215.pdf
"151  (August  (1))  (2011)  e12–e14,  http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC4573215.pdf
"58  (October  (15))  (2011) 1624–1634, http://dx.doi.org/10.1016/j.jacc.2011.07.0130.1016 .",OADS,/arxiv_data1/oa_pdf/16/e9/main.PMC4573215.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/89/04/main.PMC4573216.pdf
An  UGI  was  negative  followed  by  a  computed  tomography  (CT)  of the  abdomen  showing  free  ﬂuid  suggestive  of  a  leak  or  bleeding http://dx.doi.org/10.1016/j.ijscr.2015.06.028 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/89/04/main.PMC4573216.pdf
http://dx.doi.org/10.1016/j.ajhg.2015.06.011 ./C2112015 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/25/34/main.PMC4573257.pdf
Supplemental Data Supplemental Data include six ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.ajhg.2015.06.011 .,OADS,/arxiv_data1/oa_pdf/25/34/main.PMC4573257.pdf
"Web Resources The URLs for data presented herein are as follows: ExAC Browser, http://exac.broadinstitute.org OMIM, http://www.omim.org PolyPhen-2, http://genetics.bwh.harvard.edu/pph2/ SIFT, http://sift.jcvi.org/ SWISS MODEL, http://swissmodel.expasy.org References 1.Nicholls, T.J., Rorbach, J., and Minczuk, M. (2013).",OADS,/arxiv_data1/oa_pdf/25/34/main.PMC4573257.pdf
This  is  an  open  access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/48/main.PMC4573405.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.002 2210-2612/Published by  Elsevier  Ltd.  on  behalf  of  Surgical  Associates  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/4b/48/main.PMC4573405.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/ by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4b/48/main.PMC4573405.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/00/main.PMC4573406.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.030 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/00/main.PMC4573406.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/3e/main.PMC4573407.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.040 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/3e/main.PMC4573407.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/af/4d/main.PMC4573408.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.031 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/af/4d/main.PMC4573408.pdf
This  is  an  open  access  article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d0/main.PMC4573409.pdf
Here  we  report  a  case http://dx.doi.org/10.1016/j.ijscr.2015.06.039 2210-2612/© 2015  Published  by  Elsevier  Ltd.  on  behalf  of  Surgical  Associates  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/eb/d0/main.PMC4573409.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/d0/main.PMC4573409.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/12/main.PMC4573410.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.036 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/12/main.PMC4573410.pdf
[12] http://www.rch.org.au/clinicalguide/guideline  index/Abdominal  pain/ Open  Access This  article  is  published  Open  Access  at  sciencedirect.com .,Non-OADS,/arxiv_data1/oa_pdf/35/12/main.PMC4573410.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/93/56/main.PMC4573411.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.033 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/93/56/main.PMC4573411.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b5/7a/main.PMC4573412.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.010 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/7a/main.PMC4573412.pdf
"Amna,  R.  Howell,  S.  Raj,  Lymphoma  of  the  cervix  uteri,  BMJ  Case  Rep.  (2009), http://dx.doi.org/10.1136/bcr05.2009.1835 ,  PMCID:  PMC3030160.",Non-OADS,/arxiv_data1/oa_pdf/b5/7a/main.PMC4573412.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC4573413.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.006 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC4573413.pdf
"1)  (2008) 43–51,  http://dx.doi.org/10.1080/10428190802311441 [2]  C.  Haegelen,  L.  Riffaud,  M.  Bernard,  X.  Morandi,  Primary  isolated  lymphoma  of the  fourth  ventricle:  case  report,  J.  Neurooncol.",Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC4573413.pdf
"2013  (2013)  4,  http://dx.doi.org/10.1155/2013/614658 ,  Article  ID  614658.",Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC4573413.pdf
"2014  (2014)  6,  http://dx.doi.org/10.1155/2014/630954 , Article  ID  630954.",Non-OADS,/arxiv_data1/oa_pdf/59/6f/main.PMC4573413.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/62/main.PMC4573414.pdf
"The  result  of  NCS  revealed  that  the  wave  form of  left  hypoglossal  nerve  was  not  recorded,  whereas  the  amplitude http://dx.doi.org/10.1016/j.ijscr.2015.07.007 2210-2612/© 2015  The  Authors.",OADS,/arxiv_data1/oa_pdf/81/62/main.PMC4573414.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/62/main.PMC4573414.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
"Tumour  markers  (CEA,  CA  19.9,  CA  125) http://dx.doi.org/10.1016/j.ijscr.2015.07.009 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
11  (2013)  23  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
"96 (1)  (2004)  77–80  http://dx.doi.org/10.4321/S1130-01082004000100010[6]  A.  Kobayashi,  T.  Hasebe,  Y.  Endo,  S.  Sasaki,  M.  Konishi,  M.  Sugito,  et  al., Primary gastric  choriocarcinoma:  two  case  reports  and  a  pooled  analysis  of  53 cases,  Gastric  Cancer  8  (3)  (2005)  178–185.",Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
"23 (25)  (2005)  6251–6253  http://dx.doi.org/10.1200/JCO.2005.09.011 [9] Z. Liu,  J.L.",Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
"Hayes,  Primary  gastric  chorioadenocarcinoma:  a needle in  a  haystack,  Rare  Tumors  3  (2)  (2011)  e19  http://dx.doi.org/10.4081/ rt.2011.e19 [13]  T.  Krulewski,  L.B.",Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
40  (3)  (2008)  145–150  http://dx.doi.org/10.4143/crt.2008.,Non-OADS,/arxiv_data1/oa_pdf/51/82/main.PMC4573415.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/7a/main.PMC4573416.pdf
The  tibialis  tendon  was  found  to  be  avulsed  from  the  base http://dx.doi.org/10.1016/j.ijscr.2015.06.043 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/7a/main.PMC4573416.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4573417.pdf
The  superﬁcial  gingival  tissues  con- tained  a  haemangioma-like  cluster  of  large  irregular  vessels  with  a http://dx.doi.org/10.1016/j.ijscr.2015.06.041 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/86/9a/main.PMC4573417.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/26/51/main.PMC4573419.pdf
These  screening examinations  allow  diagnosis  on  the  basis  of  typical  imaging http://dx.doi.org/10.1016/j.ijscr.2015.06.042 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/26/51/main.PMC4573419.pdf
"Ultrasound  43  (June  (5)) (2015) 277–282, http://dx.doi.org/10.1002/jcu.22259 [7]  G.  Low,  A.  Panu,  N.  Millo,  E.  Leen,  Multimodality  imaging  of  neoplastic  and nonneoplastic  solid  lesions  of  the  pancreas,  Radiographics  31  (2011)  993–1015.",Non-OADS,/arxiv_data1/oa_pdf/26/51/main.PMC4573419.pdf
"260  (August (2)) (2014) 348–355,  http://dx.doi.org/10.1097/SLA.0000000000000583 [12] G.  Li,  N.H.  Baek,  K.  Yoo,  J.C.  Hwang,  J.H.",Non-OADS,/arxiv_data1/oa_pdf/26/51/main.PMC4573419.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b4/77/main.PMC4573420.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.06.044 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/77/main.PMC4573420.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/7e/main.PMC4573421.pdf
Her http://dx.doi.org/10.1016/j.ijscr.2015.07.012 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/7e/main.PMC4573421.pdf
"275 http://dx.doi.org/10.3345/kjp.2015.58.8.275Korean J Pediatr 2015;58(8):275-282 Nephrotic syndrome: what’s new, what’s hot?",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"According to the Health Insurance Review and Assessment  service (HIRA, http://www.hira.or.kr) of Korea, 4,342 patients younger than 20 years were  treated for NS in 2009, while in 2013 the number of NS patients decreased to 2,795 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"Younger age, male gender, a history of atopy, longer time to first remission, a shorter time from remission  to first relapse, and glucocorticoid receptor gene NR3C1 GR-9beta+TthIII-1 variants have Corresponding author: Hae Il Cheong, MD, PhD Department of Pediatrics, Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel: +82-2-2072-2810Fax: +82-2-743-3455E-mail: cheonghi@snu.ac.kr Received: 22 April, 2015 Accepted: 18 June, 2015 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2015;58(8):275-282 http://dx.doi.org/10.3345/kjp.2015.58.8.275pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
http://dx.doi.org/10.3345/kjp.2015.58.8.275Kang HG and Cheong HI • Nephrotic syndrome update 276been linked to frequent relapse and steroid dependence2-5).,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"Number of patients younger than 20 years old treated for ne- phrotic syndrome from 2009 to 2013, according to the Health Insurance  Review and Assessment service (http://www.hira.or.kr).",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"277 http://dx.doi.org/10.3345/kjp.2015.58.8.275Korean J Pediatr 2015;58(8):275-282 somal recessive nephrotic syndrome), and 9 with FSGS (autoso - mal dominant FSGS, Table 1).",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
http://dx.doi.org/10.3345/kjp.2015.58.8.275Kang HG and Cheong HI • Nephrotic syndrome update 278mentioning.,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
279 http://dx.doi.org/10.3345/kjp.2015.58.8.275Korean J Pediatr 2015;58(8):275-282 Diagnosis 1.,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"Duration of initial oral steroid treatment for steroid-sensitive  NS KDIGO (Kidney Disease: Improving Global Outcomes) publish - ed a guideline on glomerulonephritis in 2012 (http://kdigo.org/ home/glomerulonephritis-gn/) including NS22,23).",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
http://dx.doi.org/10.3345/kjp.2015.58.8.275Kang HG and Cheong HI • Nephrotic syndrome update 280proved growth and reduction of obesity31).,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"281 http://dx.doi.org/10.3345/kjp.2015.58.8.275Korean J Pediatr 2015;58(8):275-282 mellitus, and behavioral disturbances.",Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
http://dx.doi.org/10.3345/kjp.2015.58.8.275Kang HG and Cheong HI • Nephrotic syndrome update 28223.,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
http://dx.doi.org/10.1681/ASN.2014080799.,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
http://dx.doi.org/10.1007/s00467-015-3074-x.,Non-OADS,/arxiv_data1/oa_pdf/dd/85/kjped-58-275.PMC4573440.pdf
"283 http://dx.doi.org/10.3345/kjp.2015.58.8.283Korean J Pediatr 2015;58(8):283-287 Iron and vitamin D status in breastfed infants  and their mothers Yu Sun Kang1, Joon Hwan Kim1, Eun Hee Ahn2, Eun-Gyong Yoo1, Moon Kyu Kim3 Departments of 1Pediatrics and 2Obstetrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Department of 3Pediatrics, Yonsei  University College of Medicine, Seoul, Korea Purpose: We assessed the relationships between iron and vitamin D statuses in breastfed infants and  their mothers and evaluated the determinants of iron and vitamin D deficiencies in breastfed infants.",Non-OADS,/arxiv_data1/oa_pdf/b0/85/kjped-58-283.PMC4573441.pdf
"Previous studies have reported a Corresponding author: Moon Kyu Kim, MD, PhD Department of Pediatrics, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, KoreaTel: +82-2-2228-2050Fax: +82-2-393-9118E-mail: mkkim929@gmail.com Received: 27 June, 2014 Revised: 11 September, 2014Accepted: 21 October, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(8):283-287 http://dx.doi.org/10.3345/kjp.2015.58.8.283pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/b0/85/kjped-58-283.PMC4573441.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.283Kang YS, et al.",OADS,/arxiv_data1/oa_pdf/b0/85/kjped-58-283.PMC4573441.pdf
"285 http://dx.doi.org/10.3345/kjp.2015.58.8.283Korean J Pediatr 2015;58(8):283-287 mothers, 89% (n=62) had VDD and only 1% (n=1) had IDA.",OADS,/arxiv_data1/oa_pdf/b0/85/kjped-58-283.PMC4573441.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.283Kang YS, et al.",OADS,/arxiv_data1/oa_pdf/b0/85/kjped-58-283.PMC4573441.pdf
287 http://dx.doi.org/10.3345/kjp.2015.58.8.283Korean J Pediatr 2015;58(8):283-287  10.,OADS,/arxiv_data1/oa_pdf/b0/85/kjped-58-283.PMC4573441.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.288Lee DK, et al.",OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
"However, not much has been reported on the Corresponding author: Eun Ae Park, MD, PhD Department of Pediatrics, Ewha Womans University Mokdong Hospital, Ewha Womans University School of Medicine, 1071 Anyangcheon­ro, Yangcheon­gu, Seoul 158­710, KoreaTel: +82­2­2650­5275Fax: +82­2­2653­3718E­mail: pea8639@ewha.ac.kr Received: 28 July, 2014 Revised: 28 September, 2014Accepted: 20 October, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(8):288­293 http://dx.doi.org/10.3345/kjp.2015.58.8.288pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
289 http://dx.doi.org/10.3345/kjp.2015.58.8.288Korean J Pediatr 2015;58(8):288-293 topic.,Non-OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.288Lee DK, et al.",OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
291 http://dx.doi.org/10.3345/kjp.2015.58.8.288Korean J Pediatr 2015;58(8):288-293 tion ranged from 0.5 to 5.0 cm.,OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.288Lee DK, et al.",OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
293 http://dx.doi.org/10.3345/kjp.2015.58.8.288Korean J Pediatr 2015;58(8):288-293 tion should be ruled out.,Non-OADS,/arxiv_data1/oa_pdf/3d/ec/kjped-58-288.PMC4573442.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.294Yu J, et al.",OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"The laboratory determination of  the peak luteinizing hormone (LH) concentration during the GnRH stimulation test is  considered the most important diagnostic process, although it had some disadvantages in -Corresponding author: Jae Hyun Kim, MD Department of Pediatrics, Inje University Ilsan Paik Hospital, Inje University College of Medicine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, KoreaTel: +82-31-910-7942Fax: +82-31-910-7108E-mail: pedendo@paik.ac.kr Received: 21 August, 2014 Revised: 12 October, 2014Accepted: 20 October, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(8):294-300 http://dx.doi.org/10.3345/kjp.2015.58.8.294pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
295 http://dx.doi.org/10.3345/kjp.2015.58.8.294Korean J Pediatr 2015;58(8):294-300 cluding time-consuming multiple samples resulting in discom fort  to patients and a low sensitivity despite of its high specificity9).,Non-OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.294Yu J, et al.",OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"297 http://dx.doi.org/10.3345/kjp.2015.58.8.294Korean J Pediatr 2015;58(8):294-300 iterval (CI) for basal LH, basal FSH and basal LH/FSH ratio was  0.766 (0.708–0.825), 0.727 (0.652–0.802), and 0.769 (0.712– 0.825), respectively.",OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.294Yu J, et al.",OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"299 http://dx.doi.org/10.3345/kjp.2015.58.8.294Korean J Pediatr 2015;58(8):294-300 differences of cutoff values may be ethnic differences, body size  differences, interpersonal vari  ations of radiologists and  performance differences among ultrasono  graphic machines.",Non-OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.294Yu J, et al.",OADS,/arxiv_data1/oa_pdf/8f/6a/kjped-58-294.PMC4573443.pdf
"301 http://dx.doi.org/10.3345/kjp.2015.58.8.301Korean J Pediatr 2015;58(8):301-308 Evaluation of three glucometers for whole blood  glucose measurements at the point of care in preterm or low-birth-weight infants Joon Ho Hwang, MD1, Yong-Hak Sohn, MD2, Seong-Sil Chang, MD3, Seung Yeon Kim, MD1 Departments of 1Pediatrics, 2Laboratory Medicine, and 3Occupational & Environmental Medicine, Eulji University School of Medicine, Daejeon, Korea Purpose:  We evaluated three blood glucose self-monitoring for measuring whole blood glucose levels  in preterm and low-birth-weight infants.",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"As  indicated by many studies, although the measured values in the normal to high glucose Corresponding author: Seung Yeon Kim, MD Department of Pediatrics, Eulji University Hospital, Eulji University School of Medicine, 95 Dunsanseo-ro, Seo-gu, Daejeon 302-799, KoreaTel: +82-42-611-3000Fax: +82-42-611-3353E-mail: dunggiduk@eulji.ac.kr Received: 11 June, 2014 Revised: 29 September, 2014Accepted: 21 October, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2015;58(8):301-308 http://dx.doi.org/10.3345/kjp.2015.58.8.301pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.301Hwang JH, et al.",OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"303 http://dx.doi.org/10.3345/kjp.2015.58.8.301Korean J Pediatr 2015;58(8):301-308 were compared with the results from the standard test method (D;  Advia chemical analyzer), the correlation coefficient between  method (D) and test method (A) was 0.888 and the significance  probability was 0.001; thus, no significant difference was ob - served (Fig.",OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.301Hwang JH, et al.",OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
305 http://dx.doi.org/10.3345/kjp.2015.58.8.301Korean J Pediatr 2015;58(8):301-308 3.,Non-OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.301Hwang JH, et al.",OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"307 http://dx.doi.org/10.3345/kjp.2015.58.8.301Korean J Pediatr 2015;58(8):301-308 for each method, the results of portable glucometers (A, B, and C)  were consistent with the NCCLS recommended standards for  glucose levels exceeding 60 mg/dL (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.301Hwang JH, et al.",OADS,/arxiv_data1/oa_pdf/cd/cf/kjped-58-301.PMC4573444.pdf
"309 http://dx.doi.org/10.3345/kjp.2015.58.8.309Korean J Pediatr 2015;58(8):309-312 Successful sulfonylurea treatment in a patient  with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation Sung Yeon Ahn, MD, PhD1, Gu-Hwan Kim, PhD2, Han-Wook Yoo, MD, PhD2,3 1Department of Pediatrics, Ulsan University Hospital, Ulsan, 2Medical Genetics Center, 3Department of Pediatrics, Asan Medical Center Children’s Hospital, University  of Ulsan College of Medicine, Seoul, Korea Permanent neonatal diabetes mellitus refers to diabetes that occurs before the age of 6 months  and persists through life.",Non-OADS,/arxiv_data1/oa_pdf/7f/b3/kjped-58-309.PMC4573445.pdf
"We report a case of PNDM caused by a novel p.H186D heterozygous mutation in the  KCNJ11 gene whose treatment was successfully transitioned from insulin to oral Corresponding author: Sung Yeon Ahn, MD, PhD Department of Pediatrics, Ulsan University Hospital, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 682-714, Korea Tel: +82-52-250-8819Fax: +82-52-250-7065E-mail: zzidol74@empal.com Received: 27 June, 2014 Revised: 11 September, 2014Accepted: 21 October, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(8):309-312 http://dx.doi.org/10.3345/kjp.2015.58.8.309pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/7f/b3/kjped-58-309.PMC4573445.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.309Ahn SY, et al.",OADS,/arxiv_data1/oa_pdf/7f/b3/kjped-58-309.PMC4573445.pdf
311 http://dx.doi.org/10.3345/kjp.2015.58.8.309Korean J Pediatr 2015;58(8):309-312 injection (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7f/b3/kjped-58-309.PMC4573445.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.309Ahn SY, et al.",OADS,/arxiv_data1/oa_pdf/7f/b3/kjped-58-309.PMC4573445.pdf
"313 http://dx.doi.org/10.3345/kjp.2015.58.8.313Korean J Pediatr 2015;58(8):313-316 De novo interstitial deletion of 15q22q23 with  global developmental delay and hypotonia: the first Korean case Ha-Su Kim, MD1, Jin-Yeong Han, MD2, Myo-Jing Kim, MD1  Departments of 1Pediatrics and 2Laboratory Medicine, Dong-A University College of Medicine, Busan, Korea Interstitial deletions involving the chromosome band 15q22q24 are very rare and only nine cases have  been previously reported.",Non-OADS,/arxiv_data1/oa_pdf/a9/2b/kjped-58-313.PMC4573446.pdf
"This is the first case in Korea.Corresponding author: Myo-Jing Kim, MD Department of Pediatrics, Dong-A University Col-lege of Medicine, 32 Daesingongwon-ro, Seo-gu, Busan 602-714, KoreaTel: +82-51-240-2589Fax: +82-51-242-2765E-mail: myojing@dau.ac.kr Received: 10 December, 2013 Revised: 27 May, 2014Accepted: 3 June, 2014 Copyright © 2015 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2015;58(8):313-316 http://dx.doi.org/10.3345/kjp.2015.58.8.313pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr",Non-OADS,/arxiv_data1/oa_pdf/a9/2b/kjped-58-313.PMC4573446.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.313Kim HS, et al.",OADS,/arxiv_data1/oa_pdf/a9/2b/kjped-58-313.PMC4573446.pdf
"315 http://dx.doi.org/10.3345/kjp.2015.58.8.313Korean J Pediatr 2015;58(8):313-316 global developmental delay, hypotonia, sensory neural hearing  loss, frontal bossing, flat nasal bridge, microretrognathia with  normal palate and uvula, thin upper lip with inverted V-shape, a  midline sacral dimple, and severe both calcanovalgus.",Non-OADS,/arxiv_data1/oa_pdf/a9/2b/kjped-58-313.PMC4573446.pdf
"http://dx.doi.org/10.3345/kjp.2015.58.8.313Kim HS, et al.",OADS,/arxiv_data1/oa_pdf/a9/2b/kjped-58-313.PMC4573446.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/17/main.PMC4573456.pdf
The  effect  of  3.0  T  on  quantitative  diffusion  param- eters  in  the  abdomen  in  comparison  with  1.5  T  has  been  rarely http://dx.doi.org/10.1016/j.ejro.2015.08.001 2352-0477/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/main.PMC4573456.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/main.PMC4573456.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/7f/main.PMC4573457.pdf
Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57091 .,OADS,/arxiv_data1/oa_pdf/fb/7f/main.PMC4573457.pdf
http://dx.doi.org/10.1016/j.gdata.2015.08.003 2213-5960/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/fb/7f/main.PMC4573457.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/7f/main.PMC4573457.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/fb/7f/main.PMC4573457.pdf
The validity and accuracy of older and even  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Meeting summaries and other relevant documents for the NCFS are available online at  http://www.facadatabase.gov/  (see Committee 83353) as well as at the official NCFS  website: http://www.justice.gov/ncfs .,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Information on the activities and membership of the NCFS  can be found at http://www.justice.gov/NCFS .,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
"Presentations were also made at the April 2013 forensic laboratory governance meeting on  the FORESIGHT Project, which is an NIJ-funded, West Virginia University-led effort to  benchmark forensic laboratory productivity ( http://www.be.wvu.edu/forensic/foresight.htm )  [22,23].",Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
"Finally, a history of efforts in U.S. laboratory governance changes and challenges  was provided by the National Forensic Science Technology Center ( https://www.nfstc.org/ ).",OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
More information on  NIST research is available at http://www.nist.gov/forensics/research/index.cfm .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
More information is available at  http://www.nist.gov/coe/forensics/ .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
"This group meets at least once a year, typically in April, and consists of about 100  representatives from 35 European countries (see http://www.enfsi.eu/about-enfsi/structure/ working-groups/dna ).",Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
This  data format standard is regularly revised (see http://www.nist.gov/itl/iad/ig/ ansi_standard.cfm ).,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2005; 7 Available at: http://www.fbi.gov/about-us/lab/forensic-science- communications/fsc/jan2005/special_report/2005_special_report.htm .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.law.yale.edu/documents/pdf/alumni_affairs/ stith_edwards_nas_report_forensic_science.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.whitehouse.gov/sites/ default/files/microsites/ostp/forensic-science-subcommittee-charter.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at:  https://www.whitehouse.gov/sites/default/files/sofs_charter_2012_signed.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.whitehouse.gov/sites/default/files/microsites/ostp/forensic- science-accred-cert.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.whitehouse.gov/sites/default/files/microsites/ostp/ forensic-science-stand-pract-prot.pdf 12.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.whitehouse.gov/sites/default/files/microsites/ostp/ forensic-science-education-ethics.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.whitehouse.gov/sites/default/files/ microsites/ostp/forensic-science-rdte.pdfButler Page 21 Forensic Sci Int Genet .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.whitehouse.gov/sites/default/files/microsites/ostp/forensic- science-outreach-comm.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at http://www.bjs.gov/content/pub/pdf/cpffcl09.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.nist.gov/oles/doj-nist-forensic-science021513.cfm  or http:// www.justice.gov/opa/pr/department-justice-and-national-institute-standards-and-technology- announce-launch-national  [accessed 25.03.15] 18.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at http://www.promega.com/products/pm/genetic-identity/ishi- conference-proceedings/25th-ishi-oral-presentations/ 19.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.facadatabase.gov/ download.aspx?fn=Charters/83353_Charter_(2013-05-03-10-42-45).pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.forensicinstitute.nl/about_nfi/ 22.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
January 2013 presentation; 2013.  available at: http://www.swgdam.org/History%20of%20QA%20%20SWGDAM%20Jan %202013.pdf 26.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2000; 2(3) Available at: http://www.fbi.gov/ about-us/lab/forensic-science-communications/fsc/july2000/codispre.htm/codis2a.htm .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2000; 2(3) Available at:  http://www.fbi.gov/about-us/lab/forensic-science-communications/fsc/july2000/codispre.htm/ codis1a.htm .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2000;  2(3) Available at: http://www.fbi.gov/about-us/lab/forensic-science-communications/fsc/july2000/ swgroups.htm .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
[accessed 27.04.15] 2015. website: http://www.nist.gov/forensics/osac/index.cfm 33.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2015. http://www.nist.gov/ forensics/osac/standards-guidelines-catalog.cfm 35.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://rti.connectsolutions.com/p9gbz920bwc 38.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.nist.gov/ manuscript-publication-search.cfm?pub_id=910745 40.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://nvlpubs.nist.gov/ nistpubs/ir/2013/NIST.IR.7928.pdf 41.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.nsf.gov/pubs/2013/nsf13007/nsf13007.pdf 42.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at http://www.nsf.gov/pubs/2013/nsf13120/nsf13120.pdf 43.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.nsf.gov/pubs/2014/nsf14066/nsf14066.pdf 44.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at http://www.interpol.int/ content/download/21910/206602/version/1/file/IFSMSReviewPapers2013.pdf 62.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2015. http://www.nist.gov/forensics/upload/ Annotated-Bibliography-latent-print-analysis.pdf 64.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2015. http://www.justice.gov/sites/default/files/ncfs/pages/attachments/2015/02/25/ scientific_literature_views_document_as_adopted_1_30_15.pdf 66.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2012. http://nist.gov/oles/forensics-2012.cfm 69.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2015. http://www.isfg.org/ Publications/DNA+Commission 73. International Organization for Standardization (ISO).,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
[accessed 04.05.15] 2015. http://www.iec.ch/ 75. International Telecommunications Union (ITU).,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
[accessed 04.05.15] 2015. http://www.itu.int 76.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
[accessed 04.05.15] 2015. http://www.ansi.org 77.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.ansi.org/ essentialrequirements 78.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.iso.org 79.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
[accessed  04.05.15] 2015. http://www.ascld-lab.org/ 80.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
[accessed 04.05.15] 2015. http://anab.org/ 81.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.fbi.gov/about-us/lab/biometric-analysis/ codis 83.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/ Interpretation_Guidelines_January_2010.pdfButler Page 24 Forensic Sci Int Genet .,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/SWGDAM_Validation_Guidelines_APPROVED_Dec_2012.pdf 85.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/SWGDAM %20mtDNA_Interpretation_Guidelines_APPROVED_073013.pdf 86.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/ SWGDAM_Mitochondrial_DNA_Nomenclature_Examples_EB_APPROVED_05052014.pdf 87.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/ SWGDAM%20Training%20Guidelines%20%20APPROVED%20January%2017%202013.pdf 88.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at:  http://swgdam.org/SWGDAM_Guidelines_for_MP_Casework_APPROVED_01092014.pdf 89.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/ SWGDAM_YSTR_Guidelines_APPROVED_01092014_v_02112014_FINAL.pdf 90.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/SWGDAM%20Guidelines%20for%20STR%20Enhanced %20Detection%20Methods%20FINAL%20100614.pdf 91.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://swgdam.org/SWGDAM%20Guidelines%20for %20Biological%20Evidence%20APPROVED%2001152015.pdf 92.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.enfsi.eu/sites/default/files/documents/ recommendations_for_the_training_of_dna_staff_-_v2010_0.pdf 94.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.enfsi.eu/sites/default/files/documents/ dna_contamination_prevention_guidelines_for_the_file_contamantion_prevention_final_- _v2010_0.pdf 95.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.enfsi.eu/sites/default/files/documents/ enfsi_2014_document_on_dna-database_management_0.pdf 96.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at:  http://www.interpol.int/content/download/8993/66934/version/6/file/HandbookPublic2009.pdf 97.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.nist.gov/forensics/evidence-management.cfm 98.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.gov.uk/government/publications/the- interpretation-of-dna-evidence 99.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.gov.uk/government/publications/forensic-science- providers-codes-of-practice-and-conduct-2014 100.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.gov.uk/government/publications/dna-analysis-codes-of-practice- and-conduct 101.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.gov.uk/government/publications/ allele-frequency-databases-and-reporting-guidance-for-the-dna-17-profiling 102.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.gov.uk/government/ publications/dna-contamination-detectionButler Page 25 Forensic Sci Int Genet .,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: https://www.gov.uk/government/publications/forensic-science-providers-validation 104. International Forensic Strategic Alliance.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.enfsi.eu/sites/default/files/documents/IFSA/ ifsa_dna_mrd_2014.pdf  [accessed 04.05.15] 105.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.promega.com/ resources/profiles-in-dna/manufacturing-high-quality-forensic-tools-promega-quality-standards/ 2010Butler Page 26 Forensic Sci Int Genet .,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at:  http://www.promega.com/~/media/files/resources/conference%20proceedings/ishi%2002/oral %20presentations/17.pdf 128.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.promega.com/resources/ profiles-in-dna/2009/expansion-of-the-european-standard-set/ .,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available at: http://www.promega.com/ resources/profiles-in-dna/2012/variability-of-new-str-loci-and-kits-in-us-population-groups/ 135.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
Available  at: https://www-s.nist.gov/srmors/view_cert.cfm?srm=2391C 137.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2015. website: http://www.cstl.nist.gov/strbase/ 139.,OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
2015. http://www.nij.gov/topics/ law-enforcement/investigations/death-investigation/symposium/Pages/welcome.aspx 141.,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
These bibliographies are available at http://www.nist.gov/ forensics/workgroups.cfm#B  [62].,Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
"Date Topic Website July 10–11, 2012 Measurement science  and standards in  forensic firearms  analysishttp://www.nist.gov/oles/forensics_firearms_2012.cfm November 28–30, 2012 Forensics@NIST 2012 http://www.nist.gov/oles/forensics-2012.cfm January 28–30, 2013 ANSI/NIST-ITL  Standard Workshop  2013http://www.nist.gov/itl/iad/ig/ansi_workshop_jan_2013.cfm April 12, 2013 DNA analyst training  on mixture  interpretationhttp://www.nist.gov/oles/forensics/dna-analyst-training-on-mixture-interpretation.cfm April 30–May 1, 2013 Emerging trends in  synthetic drugs  workshophttp://www.nist.gov/oles/synthetic_drugs.cfm June 4–5, 2013 Measurement science  and standards in  forensic handwriting  analysishttp://www.nist.gov/oles/handwriting.cfm November 19–20, 2013 DNA technical leader  summitHeld in Norman, Oklahoma in conjunction with the FBI CODIS Conference (event was not webcast) February 18, 2014 Organization of  Scientific Area  Committees (OSAC)  webcast from AAFShttp://www.nist.gov/forensics/aafswebcast.cfm March 24, 2014 Cloud computing  forensic science  workshophttp://www.nist.gov/itl/forensic-science-workshop.cfm May 28, 2014 NIST DNA analyst  webinar series:  probabilistic  genotyping and  software programs  (Part 1)http://www.nist.gov/forensics/nist-dna-analyst-webinar-series-pt1.cfm June 18, 2014 NIST mobile forensics  workshop and webcasthttp://www.nist.gov/forensics/mobile_forensics2.cfm August 6, 2014 NIST DNA analyst  webinar series:  validation concepts  and resources (Part 1)http://www.nist.gov/forensics/nist-dna-analyst-webinar-series-validation-concepts-and-resources-part-1.cfm September 18, 2014 NIST DNA analyst  webinar series:  probabilistic  genotyping and  software programs  (Part 2)http://www.nist.gov/forensics/dna-analyst-webinar-probabilistic-genotyping-software-programs.cfm December 3–4, 2014 Forensics@NIST 2014 http://www.nist.gov/forensics/forensics-at-nist-2014.cfm January 26–27, 2015 Improving biometric  and forensic  technology: the future  of research datasetshttp://www.nist.gov/forensics/biometric-forensic-technology-webcast.cfm February 16– 17, 2015 Public meetings of the  five OSAC Scientific  Area Committeeshttps://workspace.forensicosac.org/kws/public July 20–24, 2015 International  symposium on  forensic science error  management: http://www.nist.gov/director/international_forensics_home.cfm Forensic Sci Int Genet .",Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
"NIST Author Manuscript NIST Author Manuscript NIST Author ManuscriptButler Page 39 Table 9 Summary of ISFG DNA Commission recommendations, which are available at http://www.isfg.org/ Publications/DNA+Commission .",Non-OADS,/arxiv_data1/oa_pdf/27/d8/nihms714819.PMC4573542.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2f/cf/main.PMC4573597.pdf
A  1.5-cm  incision  is  made http://dx.doi.org/10.1016/j.ijscr.2015.07.015 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/cf/main.PMC4573597.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/78/3f/main.PMC4573598.pdf
"With  these ﬁndings,  a  preliminary  diagnosis  of  duodenum  perforation  with retroperitoneal  abscess  was  made  and  an  emergency  laparotomy http://dx.doi.org/10.1016/j.ijscr.2015.07.013 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/78/3f/main.PMC4573598.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/35/ef/main.PMC4573599.pdf
A  repeat  electrocardiogram  revealed  asystole  and  echocardiogram performed  at  our  hospital  revealed  dense  “jello  like”  soft  tissue echoes  in  the  left  ventricle  extending  upto  the  aortic  valve  consis- http://dx.doi.org/10.1016/j.ijscr.2015.06.045 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/35/ef/main.PMC4573599.pdf
"[11]  D.  Yusef,  A.  Waran,  E.  Vamvakiti,  A  16  year  old  boy  with  emphysematous gastritis  and  oesophageal  candidiasis,  BMJ  Case  Rep.  (2014),  http://dx.doi.org/ 10.1136/bcr-2014-203755 [12]  C.A.",Non-OADS,/arxiv_data1/oa_pdf/35/ef/main.PMC4573599.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/9d/main.PMC4573600.pdf
Chest  tomography  conﬁrmed  a  right  diaphragmatic  her- http://dx.doi.org/10.1016/j.ijscr.2015.07.014 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/9d/main.PMC4573600.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/35/main.PMC4573601.pdf
It  showed  viable  fetus  with  positive  heart  activity http://dx.doi.org/10.1016/j.ijscr.2015.07.019 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/35/main.PMC4573601.pdf
"[5]  S.  Jayaprakash,  L.  Muralidhar,  G.  Sampathkumar,  R.  Sexsena,  Rupture  of bicornuate  uterus,  BMJ  Case  Rep.  28  (October)  (2011),  http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/4d/35/main.PMC4573601.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/16/fc/main.PMC4573602.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.016 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/fc/main.PMC4573602.pdf
This  is  an  open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/bf/main.PMC4573603.pdf
The  long http://dx.doi.org/10.1016/j.ijscr.2015.07.017 2210-2612/Crown Copyright  ©  2015  Published  by  Elsevier  Ltd.  on  behalf  of  Surgical  Associates  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/cb/bf/main.PMC4573603.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ac/48/main.PMC4573604.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.020 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/48/main.PMC4573604.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/49/e1/main.PMC4573605.pdf
Differential http://dx.doi.org/10.1016/j.ijscr.2015.07.022 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/49/e1/main.PMC4573605.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/58/f6/main.PMC4573606.pdf
The density  was  1.697  g/cm2for  his  right  femoral  head  and  0.667  g/cm2 http://dx.doi.org/10.1016/j.ijscr.2015.07.025 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/58/f6/main.PMC4573606.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/5e/main.PMC4573607.pdf
1)  and  entered  into  the  peritoneal  cavity  while http://dx.doi.org/10.1016/j.ijscr.2015.07.023 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/21/5e/main.PMC4573607.pdf
This  is  an  open  access  article  under  the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/21/5e/main.PMC4573607.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f6/ff/main.PMC4573608.pdf
"On  admission,  vital  signs  (blood http://dx.doi.org/10.1016/j.ijscr.2015.07.021 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/f6/ff/main.PMC4573608.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/24/f0/main.PMC4573610.pdf
"The  abdomen  was  without  palpable  pain,  but  with http://dx.doi.org/10.1016/j.ijscr.2015.07.027 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/24/f0/main.PMC4573610.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ce/ae/main.PMC4573611.pdf
"Plain  MRI  of  lower  lum- bosacral  region suggested  L4/L5  block  vertebral  anomaly  of  sacrum with  spina-biﬁda, prominent subcutaneous  fat,  few  rudimentary bony  structures,  muscle  elements  and  a  well  deﬁned  saccular http://dx.doi.org/10.1016/j.ijscr.2015.07.026 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/ce/ae/main.PMC4573611.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/a1/main.PMC4573612.pdf
"A segment  of  greater  saphenous  vein,  already  harvested for  CABG,  was  tailored  to  perform  a  small  patch  repair  of  the  arte- http://dx.doi.org/10.1016/j.ijscr.2015.07.030 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/fe/a1/main.PMC4573612.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b2/ca/main.PMC4573616.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.035 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/b2/ca/main.PMC4573616.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Multi-state outcome analysis of treatments CL Bowden et al 242 Molecular Psychiatry (2016), 237 –242 © 2016 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/a6/36/mp201521a.PMC4573671.pdf
"Omics technologies such as genomics, proteomics,  metabolomics and transcriptomics have made it pos - sible to obtain large amounts of information and to un -  Review article Key Words computational modeling, multi-target drugs, network  pharmacology, systems biology, traditional medicineISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:011-018 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.020    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"Tel: +82-33-730-0673  Fax: +82-33-730-0653 E-mail: jinlee@sangji.ac.kr   ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Physiology, College of Korean Medicine, Sangji University, Wonju, Korea Received:  Aug 19, 2015    Reviewed:  Aug 26, 2015    Accepted:  Aug 31, 2015",Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
012  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):011-018 derstand biological phenomena as a whole.,Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"http://www.journal.ac013  Journal of Pharmacopuncture 2015;18(3):011-018 compounds in northeast Asian traditional medicine (TM- MC), the most recently developed database, has tried to  overcome the shortcomings of earlier databases, such as  redundancy of herbs in a system, and contains medicinal  materials from Korean, Chinese and Japanese pharma - copoeias [16].",Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"There - fore, identifying medical knowledge from clinical data and  collating quantitative biomarkers could become a signifi - cant step to bridge the gap between clinical practice and Database Description URL Reference TCM-ID1,197 prescriptions, 1,104 herbs, 9,862  ingredients, 12,117 compounds, and 4,111  diseaseshttp://bidd.nus.edu.sg/ group/TCMsite/Default.aspx[11] TCMID46,914 prescriptions, 8,159 herbs, 25,210  ingredients, 6,826 drugs, 17,521 related  targets, and 3,791 diseaseshttp://www.megabionet.org/tcmid/ [12] TCM  Database@Taiwan352 herbs, and 37,170 compounds http://tcm.cmu.edu.tw/ [13] TCMGeneDitAssociated information between TCMs  and genes, diseases, effects and ingredientshttp://tcm.lifescience.ntu.edu.tw [40] TCMSP499 herbs, 29,384 ingredients, 3,311  targets, and 837 associated diseaseshttp://sm.nwsuaf.edu.cn/lsp/tcmsp.php [14] TM-MC536 medicinal materials, 14,492  compounds, and 24,154 links between  medicinal materials and compoundshttp://informatics.kiom.re.kr/com - pound/[16] CancerHSP2,349 anticancer herbs, 3,575 anticancer  ingredients and their molecular structures,  and ADME parametershttp://lsp.nwsuaf.edu.cn/CancerHSP .php [17] CEMTDD621 herbs, 4,060 compounds, 2,163 targets,  and 210 diseaseshttp://www.cemtdd.com/index.html [15] TCM-ID, traditional Chinese medicine information database; TCMID, traditional Chinese medicine integrated database; TCMSP , tradi - tional Chinese medicine systems pharmacology database and analysis platform; TM-MC, database of medicinal materials and chemical  compounds in northeast Asian traditional medicine; CancerHSP , anti-cancer herbs database of systems pharmacology; ADME, absorp - tion, distribution, metabolism, and excretion; CEMTDD, Chinese ethnic minority traditional drugs database.Table 1  Traditional medicine databases",OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
014  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):011-018 traditional medical theory [18].,Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"http://www.journal.ac015  Journal of Pharmacopuncture 2015;18(3):011-018 Table 2  Selected network pharmacology studies of traditional medicine Herb/Herbal ingredients/ Herbal prescriptionsRelated diseases/Symptoms/ Target Year Reference Qing-Luo-Yin  (Hot-Cooling herbal formula) Wen-Luo-Yin  (Cold-Warming herbal formula)Cold- and Hot-syndrome- related rheumatoid arthritis2007 [21] Ganoderic acid D  (from Ganoderma lucidum )Cancer 2008 [23] Rhizoma chuanxiong  herb network from  3,865 collaterals-related herbal formulaeAngiogenesis disorder 2010 [20] 676 compounds Type II diabetes mellitus 2011 [24] Yishen Juanbi tablet  (containing the water extracts  of seven herbs)Rheumatoid arthritis 2012 [28] Ligusticum chuanxiong  Hort., Dalbergia odorifera  T.",Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"016  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):011-018 Barabasi AL, Gulbahce N, Loscalzo J.",Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
http://orcid.org/0000-0002-5362-1199.,Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
http://www.journal.ac017  Journal of Pharmacopuncture 2015;18(3):011-018 Rev Genet.,Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
Available from: http://www.koreantk.com/.,Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
Availa - ble from: http://jisik.kiom.re.kr/.,Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"http://www.journal.ac018  Journal of Pharmacopuncture 2015;18(3):011-018 Lee S, Noble P , Ma Y, Earm Y, Noble D, editors.",Non-OADS,/arxiv_data1/oa_pdf/d6/46/2093-6966-v18-n03-011.PMC4573803.pdf
"An elevated serum  CRP level was found to be significantly related to the  incidence of liver metastases, peritonitis carcinomato - sa, pathological lymph node metastases, intravenous  invasion, and survival rate in 120 colorectal cancer pa - Original article Key Words c-reactive protein, erythrocyte sedimentation rate, fi - brinogen, stable disease, treatment period, wheel bal - anced cancer therapyISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:019-031 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.021    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"Tel: +82-42-470-9132  Fax: +82-42-470-9006 E-mail: altyhs@dju.kr ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acEast West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Korea Received:  Apr 15, 2015     Reviewed:  Apr 29, 2015     Accepted:  May 29, 2015",Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
020  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):019-031 tients [3].,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"http://www.journal.ac021  Journal of Pharmacopuncture 2015;18(3):019-031 Characteristic Patients (n = 73) Gender (n, male/female) 40/33 Meanage (years ─ range) 58 (26 ─ 84) Decrease Stable          Increase CRP (n) 15 12 27 ESR (n) 24 9 3 Fibrinogen (n) 3 5 4 ECOG = 0 ECOG  = 1 ECOG  = 2 ECOG grade (n) 2 17 54 Ye s No Unknown Surgical operation (n) 36 36 1Table 1  Clinical characteristics of stage IV cancer patients Table 2  Clinical characteristics of patients according to the treatment period and their genderCRP , C-reactive protein; ESR, erythrocyte sedimentation rate; ECOG, Eastern Cooperative Oncology Group.",Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
022  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):019-031 gery and the non-surgery subgroups.,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"http://www.journal.ac023  Journal of Pharmacopuncture 2015;18(3):019-031 For the Kruskal–Wallis test, CRP , C-reactive protein; ESR, erythrocyte sedimentation rate.",OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"024  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):019-031 For Kruskal–Wallis test, CRP , C-reactive protein; ESR, erythrocyte sedimentation rate.",OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"http://www.journal.ac025  Journal of Pharmacopuncture 2015;18(3):019-031 For Fisher's exact test, CRP , C-reactive protein; ESR, erythrocyte sedimentation rate.",OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
026  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):019-031 3.2.,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"http://www.journal.ac027  Journal of Pharmacopuncture 2015;18(3):019-031 Table 9  Results of cross-analyses of the CRP , ESR and fibrinogen levels in the ≥ 21 day and ≤ 20 day groups for both no-surgery and the  surgery subgroups For Fisher's exact test, CRP , C-reactive protein; ESR, erythrocyte sedimentation rate.",Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
028  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):019-031 group.,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
http://www.journal.ac029  Journal of Pharmacopuncture 2015;18(3):019-031 based on the theory of Korean medicine and is provided  to EWCC inpatients [35].,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
http://orcid.org/0000-0001-7461-1654.,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"http://www.journal.ac030 Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG,  et al .",OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
Available from: http://www.nlm.nih.gov/medline - plus/ency/article/003650.htm.,Non-OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"http://www.journal.ac031 Leipold H, Hefler-Frischmuth K, et al .",OADS,/arxiv_data1/oa_pdf/9e/62/2093-6966-v18-n03-019.PMC4573804.pdf
"These approaches  Original article Key Words apoptosis, condurango extract, cytotoxicity, G0/G1 ar - rest, reactive oxygen speciesISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:032-041 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.022    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"Tel: +91-33-2582-8750   Fax: +91-33-2582-8282 E-mail: prof_arkb@yahoo.co.in  ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acCytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani, India Received:  Apr 23, 2015     Reviewed:  May 17, 2015     Accepted:  Jun 11, 2015Kausik Bishayee, Jesmin Mondal, Sourav Sikdar, Anisur Rahman Khuda-Bukhsh*",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"http://www.journal.ac033 target and rapidly destroy growing cells in the body; how - ever, normal healthy cells are also impacted, thus causing  undesirable side effects [2].",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
034  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):032-041 tometer with the FL-1H filter for annexin V staining and  the FL-2A filter for PI staining.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"http://www.journal.ac035  Journal of Pharmacopuncture 2015;18(3):032-041 Figure 1   (A) For the MTT assay, cells were cultured in a 96-well plate and treated with different doses of CE.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"036  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):032-041 Figure 2   (A) In the cell cycle analysis, cells were treated with CE and after incubation for 24 hours, they were fixed and stained with PI.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"http://www.journal.ac037  Journal of Pharmacopuncture 2015;18(3):032-041 A A B CD ECB Figure 3   (A) For the annexin V assay, cells were harvested and suspended in annexin V buffer.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"038  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):032-041 Figure 5   For the ROS evaluation,cells were harvested and fixed in 70% chilled methanol and 4% PFA for flow cytometry and microscopic study,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
http://www.journal.ac039  Journal of Pharmacopuncture 2015;18(3):032-041 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
http://www.journal.ac040 of this death receptor often go down when tumorigenesis  is in progress.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
http://www.journal.ac041 in HeLa cells through p38-p53 and PI3K/AKT signalling  pathways.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/2093-6966-v18-n03-032.PMC4573805.pdf
"SBV has been report - ed to have fewer allergic responses than BVP; for that  reason, SBV treatment is considered to be as effective,  Original article Key Words bee venom, intravenous injection, melittin, toxicity testISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:049-056 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.024    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
"Tel: +82-33-744-9304  Fax: +82-33-744-9305 E-mail: drkwon5031@daum.net   ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Acupuncture &Moxibustion Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 2 Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 3 Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea 4 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea  Received:  Apr 9, 2015        Reviewed:  Jun 5, 2015        Accepted:  Jun 15, 2015",Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
"050  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):049-056 or better, than BVP treatment [12, 13].",Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
http://www.journal.ac051  Journal of Pharmacopuncture 2015;18(3):049-056 SexGroup / Dose  (mL/animal)No.,Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
052  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):049-056 Table 2  Mean hematology parameters (Sex: Male) (Sex: Female)Group /  Dose (mL/ani - mal)Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
http://www.journal.ac053  Journal of Pharmacopuncture 2015;18(3):049-056 Group /  Dose (mL/ani - mal)Mean S.D.,Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
054  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):049-056 (Sex: Female) Group /  Dose (mL/ani - mal)Mean S.D NALT (U/L)AST (U/L)ALP (U/L)GGT (U/L)Glu (mg/dL)BUN (mg/dL)Crea (mg/dL)T-Bili (mg/dL)T-Chol (mg/dL) G1 (0) Mean 26.2 77.3 564.4 0.51 134 13.3 0.40 0.07 70 S.D  2.4 13.8 139.3 0.32  12  1.2 0.01 0.07 14 N 5 5 5 5 5 5 5 5 5 G2 (0.1) Mean 22.3 72.2 609.9 0.40 134 12.2 0.37 0.04 75 S.D 3.5  5.5 181.2 0.11   6  2.0 0.02 0.01 21 N 5 5 5 5   5  5 5 5 5 G3 (0.5) Mean 23.8 73.7 528.4 0.31 139 12.3 0.39 0.03 74 S.D  2.2 10.1 101.6 0.18  18  1.0 0.03 0.01 9 N  5 5 5 5  5  5 5 5 5 G4 (1.0) Mean 23.6 93.1 477.6 0.41 130 12.6 0.37 0.04 78 S.D 5.3 21.6 114.1 0.11  18  1.6 0.02 0.02 21 N 5 5 5 5  5  5 5 5 5Group /  Dose (mL/an - imal)Mean S.D NTG (mg/dL)TP (mg/dL)Alb (mg/dL)A/G ratioP (mg/dL)Ca (mg/dL)Na (mmol/L)K (mmol/L)CI (mmol/L) G1 (0)Mean 54 5.2 2.2 0.76 8.69 10.0 139 4.7 104 S.D 24 0.1 0.1 0.05 0.14  0.1   2 0.2   1 N 5 5 5 5 5 5   5 5   5 G2 (0.1) Mean 56 5.3 2.3 0.77 8.72 10.3 139 4.6 103 S.D 14 0.1 0.1 0.06 0.41  0.3   0 0.2   1 N 5 5 5 5 5 5   5 5   5 G3 (0.5) Mean 56 5.4 2.2 0.69 8.27 10.3 139 4.4 103 S.D 17 0.1 0.1 0.03 0.51  0.2   1 0.2   2 N 5 5 5 5 5 5   5 5   5 G4 (1.0) Mean 44 5.3 2.3 0.76 8.77 10.2 139 4.6 103 S.D 11 0.2 0.1 0.05 0.48 0.3   1 0.5   2 N 5 5 5 5 5 5   5 5   5 Group /  Dose (mL/an - imal)Mean S.D NTG (mg/dL)TP (mg/dL)Alb (mg/dL)A/G ratioP (mg/dL)Ca (mg/dL)Na (mmol/L)K (mmol/L)CI (mmol/L) G1 (0) Mean 11 5.5 2.4 0.81 7.11 10.0 139 4.5 106 S.D 5 0.3 0.2 0.01 0.37  0.3   1 0.3   2 N 5 5 5 5 5  5   5 5   5 G2 (0.1) Mean 12 5.6 2.5 0.80 7.02 9.9 139 4.6 105 S.D  5 0.2 0.1 0.05 0.71 0.2   1 0.2   1 N 5 5 5 5 5 5   5 5   5 (Continued),Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
http://www.journal.ac055  Journal of Pharmacopuncture 2015;18(3):049-056 Significantly different from control by Dunnett's t-test: *P < 0.01.,Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
"056  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):049-056 Choi YC, Kwon KR, Choi SH.",Non-OADS,/arxiv_data1/oa_pdf/b3/d7/2093-6966-v18-n03-049.PMC4573807.pdf
"These studies concluded  that the lethal doses of GWG and GWG20 were greater  Original article Key Words Guseonwangdo-go  glucose 5%, herbal medicine, intra - venous, pharmacopuncture, toxicity testISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:057-062 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.025    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
"Tel: +82-31-961-9122  Fax: +82-31-961-9009 E-mail: chuckman@dongguk.edu ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.acDepartment of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Dongguk University, Goyang, Korea Received:   Jun 18, 2015      Reviewed:   Jul 17, 2015      Accepted:   Jul 20, 2015",Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
058 http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):057-062,Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
http://www.journal.ac059  Journal of Pharmacopuncture 2015;18(3):057-062 tissues were extracted and fixed in 10% neutral buffered  formalin.,Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
060 http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):057-062 GroupMale Female Control G-0.1 G-0.5 G 4 / 1 Control G-0.1 G-0.5 G 4 / 1 ALT (U/L) 29.1 ± 2.4 25.4 ± 3.2 27.2 ± 2.5 31.7 ± 3.8 23.0 ± 1.6 21.8 ± 2.8 22.5 ± 4.0 20.5 ± 3.5 AST (U/L) 99.7 ± 31.2 85.8 ± 8.6 93.7 ± 19.6102.8 ±  28.286.9 ± 15.7 95.2 ± 9.7 81.4 ± 10.9 86.0 ± 4.1 ALP (U/L)801.5 ±  176.5801.6 ±  108.4756.7 ±  170.4916.4 ±  173.5459.1 ±  97.3525.8 ±  107.9457.6 ±  79.4526.2 ±  146.3 GGT (U/L) 0.45 ± 0.12 0.34 ± 0.13 0.44 ± 0.07 0.37 ± 0.15 0.43 ± 0.16 0.63 ± 0.34 0.60 ± 0.23 0.57 ± 0.11 Glu (mg/dL) 125 ± 21 115 ± 14 116 ± 14 131 ± 8 99 ± 10 0.5 ± 7 107 ± 10 113 ± 13 BUN (mg/dL) 11.0 ± 1.0 11.5 ± 2.7 11.8 ± 1.4 11.3 ± 1.2 13.4 ± 2.5 14.0 ± 3.4 13.4 ± 2.5 116 ± 1.0 Crea (mg/dL) 0.38 ± 0.02 0.40 ± 0.03 0.42 ± 0.02 0.41 ± 0.03 0.45 ± 0.02 0.46 ± 0.03 0.45 ± 0.02 0.44 ± 0.03 T-bili (mg/dL) 0.05 ± 0.02 0.04 ± 0.02 0.04 ± 0.01 0.04 ± 0.01 0.04 ± 0.03 0.02 ± 0.01 0.06 ± 0.07 0.03 ± 0.02 T-Chol (mg/dL) 93 ± 21 85 ± 22 90 ± 19 67 ± 17 70 ± 16 73 ± 12 76 ± 9 65 ± 15 TG (mg/dL) 44 ± 18 50 ± 18 39 ± 20 42 ± 22 11 ± 2 11 ± 3 13 ± 4 11 ± 4 TP (mg/dL) 5.2 ± 0.3 5.1 ± 0.1 5.3 ± 0.2 5.1 ± 0.1 5.3 ± 0.2 5.4 ± 0.3 5.1 ± 0.3 5.4 ± 0.2 Alb (mg/dL) 2.3 ± 0.1 2.3 ± 0.1 2.3 ± 0.1 2.3 ± 0.0 2.5 ± 0.1 2.4 ± 0.1 2.3 ± 0.1 2.5 ± 0.1 A/G ratio 0.77 ± 0.06 0.82 ± 0.07 0.75 ± 0.06 0.81 ± 0.05 0.85 ± 0.030.79* ±  0.040.81 ± 0.01 0.88 ± 0.05 P (mg/dL) 8.79 ± 0.47 8.53 ± 0.47 8.70 ± 0.14 8.93 ± 0.23 7.21 ± 0.68 7.30 ± 0.44 7.26 ± 0.36 7.09 ± 0.39 Ca (mg/dL) 9.8 ± 0.4 9.9 ± 0.3 9.8 ± 0.2 9.7 ± 0.2 9.7 ± 0.3 9.5 ± 0.3 9.5 ± 0.3 9.6 ± 0.3 Na (mmol/L) 139 ± 1 140 ± 1 140 ± 1 139 ± 2 139 ± 1 139 ± 1 139 ± 1 140 ± 2 K (mmol/L) 4.7 ± 0.2 4.5 ± 0.2 4.6 ± 0.3 4.6 ± 0.4 4.5 ± 0.2 4.5 ± 0.2 4.5 ± 0.3 4.4 ± 0.2 Cl (mmol/L) 104 ± 1 103 ± 1 104 ± 1 104 ± 1 106 ± 1 106 ± 1 106 ± 1 107 ± 3Table 3  Biochemical values of SD rats Values are presented as mean ± standard deviation (S.D.).,Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
"http://www.journal.ac061  Journal of Pharmacopuncture 2015;18(3):057-062 Ichikawa H, Wang X, Konishi T. Role of compo - nent herbs in antioxidant activity of shengmai san  - a traditional Chinese medicine formula prevent - ing cerebral oxidative damage in rat.",Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
http://orcid.org/0000-0003-3348-9626.,Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
062  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):057-062 net].,Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
Available from: http://www.law.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/78/b7/2093-6966-v18-n03-057.PMC4573808.pdf
"Drug processing and compatibility are the main  Original article Key Words herbal medicine, oral toxicity, super key (processed sul - fur), toxicity testISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:063-067 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.026    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
"Tel: +82-62-670-6441  Fax: +82-62-670-6767 E-mail: kscndl@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Korean Rehabilitation Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 2 Department of Acupuncture & Moxibustion Medicine, Wonkwang University Gwangju Korean Medical Hospital, Gwangju, Korea 3 Nervous & Muscular System Disease Clinical Research Center of Wonkwang University Gwa ngju Korean Medical Hospital, Gwangju, Korea Received:   Mar 19, 2015      Reviewed:   Jul 21, 2015      Accepted:  Jul 21, 2015",Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
"GroupSuper Key administration (mL/kg)Number of animals (serial numbers) Male Female G1: Control group 0 5 (11001 ─ 11005) 5 (21001 ─ 21005) G2: Low-dose group 500 5 (12001 ─ 12005) 5 (22001 ─ 22005) G3: Mid-dose group 1,000 5 (13001 ─ 13005) 5 (23001 ─ 23005) G4: High-dose group 2,000 5 (14001 ─ 14005) 5 (24001 ─ 24005)Table 1  Groups of animals064 http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):063-067",Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
http://www.journal.ac065  Journal of Pharmacopuncture 2015;18(3):063-067 3.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
066 http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):063-067 Shin HM.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
http://orcid.org/0000-0003-3580-5290.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
http://www.journal.ac067  Journal of Pharmacopuncture 2015;18(3):063-067 Drugs Dermatol.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
Available from: http://lawwizice.wordpress.com/.9.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/2093-6966-v18-n03-063.PMC4573809.pdf
"7,12-dimethyl benz[a] anthracene (DMBA) is a well recognized carcinogen  Original article Key Words breast cancer, electron transport chain complexes, mi - tochondrial lipid peroxidation, mitochondrial antioxi - dant, taurine, tricarboxylic acid cycle enzymes      This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
"Tel: +91-44-24547080  Fax: +91-44-24540709 E-mail: vanithakalappan@gmail.com ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Medical Biochemistry, University of Madras, Taramani Campus, Chennai, India 2 Department of Biomedical Sciences, College of Health Sciences, Arsi University, Asella, Ethiopia Received:   Jun 3, 2015         Reviewed:   Jul 6, 2015         Accepted:  Jul 29, 2015ISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:068-074 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.027",Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
"http://www.journal.ac069 known to induce enormous amounts of free radicals,  which in turn reacts with lipids, causing the release of lipid  peroxides [3].",Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
070  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):068-074 3.,Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
http://www.journal.ac071  Journal of Pharmacopuncture 2015;18(3):068-074 cycle enzymes is shown in Table 4.,Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
072  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):068-074 GST is a group of multifunctional proteins that perform  tasks ranging from catalyzing the detoxification of elec - trophilic compounds to protection against peroxidative  damage [39].,Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
"http://www.journal.ac073 Hansen SH, Andersen ML, Cornett C, Gradinaru R,  Grunnet N. A role for taurine in mitochondrial func - tion.",OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
074  http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):068-074 1948;174:961-77.,Non-OADS,/arxiv_data1/oa_pdf/00/71/2093-6966-v18-n03-068.PMC4573810.pdf
"Brief Report Key Words Mercox, mice, primo nodes, primo vessels, skinISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:075-079 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.028    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
"ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1Department of Animal Morphology, Physiology and Nutrition, Agricultural Faculty, Trakia University, Stara Zagora, Bulgaria 2 Nano Primo Research Center, Advanced Institutes of Convergence Technology, Seoul National University, Seoul, Korea 3 Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received:   May 29, 2015     Reviewed:   Jun 10, 2015     Accepted:  Jun 15, 2015",Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
076 http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):075-079,Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
http://www.journal.ac077  Journal of Pharmacopuncture 2015;18(3):075-079 is 1 ─ 2 mm in diameter [27].,Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
"078 http://www.journal.ac Journal of Pharmacopuncture 2015;18(3):075-079 Shin HS, Johng HM, Lee BC, Cho SI, Soh KS, Baik KY,  et al .",Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
http://orcid.org/0000-0002-4885-5863.,Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
http://www.journal.ac079  Journal of Pharmacopuncture 2015;18(3):075-079 T. Scanning electron microscopy of vascular corrosion  casts – technique and applications.,Non-OADS,/arxiv_data1/oa_pdf/5b/1f/2093-6966-v18-n03-075.PMC4573811.pdf
"The Effects of Sa-am Acupuncture Simpo-jeongkyeok  Treatment on the Blood Pressure, Pulse Rate, and  Body Temperature Woo-Jin Choi1, Yoon-Young Cho2, Seung-Ho Sun2* The original article The Effects of Sa-am Acupuncture  Simpo-jeongkyeok Treatment on the Blood Pressure,  Pulse Rate, and Body Temperature (J Pharmacopunc - ture 2015;18(2):33-41, DOI: http://dx.doi.org/10.3831/ KPI.2015.18.013) by Woo-Jin Choi, Yoon-Young Cho,  Seung-Ho Sun, was published with an incorrect ac - knowledgements due to a production error.",Non-OADS,/arxiv_data1/oa_pdf/45/33/2093-6966-v18-n03-080.PMC4573812.pdf
"Correction Key Words acupuncture, blood pressure, body temperature, hwa  byung, pulse rate, randomized controlled trialISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:080-080 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.029    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/33/2093-6966-v18-n03-080.PMC4573812.pdf
"Tel: +82-33-741-9209   Fax: +82-33-732-2124  E-mail: sunguy2001@hanmail.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac1 Department of Neuropsychiatry, College of Korean Medicine, Sangji University, Wonju, Korea 2  Department of Internal Medicine, College of Korean Medicine, Sangji University, Wonju, Korea Received:   Jan 09, 2015     Reviewed:   Feb 23, 2015     Accepted:  Mar 19, 2015",Non-OADS,/arxiv_data1/oa_pdf/45/33/2093-6966-v18-n03-080.PMC4573812.pdf
"Single-dose Toxicity of Water-soluble Ginseng  Pharmacopuncture Injected Intramuscularly in Rats Junsang Yu1, Seungho Sun2, Kwangho Lee3, Kirok Kwon4* Correction Key Words aqua acupuncture, ginseng, herbal medicine, intramus - cular injection, intramuscular toxicity, pharmacopunc - tureISSN 2093-6966  [Print], ISSN 2234-6856  [Online] Journal of Pharmacopuncture 2015;18[3]:081-081 DOI:    http://dx.doi.org/10.3831/KPI.2015.18.030    This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/c9/2093-6966-v18-n03-081.PMC4573813.pdf
"Tel: +82-33-744-9304   Fax: +82-33-744-9305 E-mail: drkwon5031@daum.net ⓒ 2015 Korean Pharmacopuncture Institute                      http://www.journal.ac 1 Department of Sasang Constitutional Medicine, Sangji University College of Korean Medicine, Wonju, Korea 2  Department of Acupuncture and Moxibustion, Sangji University College of Korean Medicine, Wonju, Korea  3  Department of Internal Medicine, Sangji University College of Korean Medicine, Wonju, Korea  4  Research Center of the Korean Pharmacopuncture Institute, Seoul, Korea Received:   Jan 02, 2015     Reviewed:   Jan 10, 2015     Accepted:  Feb 04, 2015The original article Single-dose Toxicity of Water-soluble  Ginseng Pharmacopuncture Injected Intramuscularly  in Rats (J Pharmacopuncture 2015;18(2):76-85, DOI:  http://dx.doi.org/10.3831/KPI.2015.18.018) by Junsang  Yu, Seungho Sun, Kwangho Lee, and Kirok Kwon, was  published with an incorrect acknowledgements due to  a production error.",Non-OADS,/arxiv_data1/oa_pdf/35/c9/2093-6966-v18-n03-081.PMC4573813.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/28/main.PMC4573848.pdf
A  perforation  of http://dx.doi.org/10.1016/j.ijscr.2015.07.032 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/28/main.PMC4573848.pdf
This  is  an  open access article under the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/03/04/main.PMC4573849.pdf
The  ﬁndings http://dx.doi.org/10.1016/j.ijscr.2015.07.033 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/03/04/main.PMC4573849.pdf
This  is  an  open access article under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/55/d9/main.PMC4573850.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.07.031 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/55/d9/main.PMC4573850.pdf
[Keywords : FANCM; Mph1; Fml1; MHF; BLM; replication fork regression; crossover control]Corresponding author: zhaox1@mskcc.orgArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.266593.115.© 2015 Xue et al.,OADS,/arxiv_data1/oa_pdf/d1/95/1777.PMC4573851.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publi-cation date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d1/95/1777.PMC4573851.pdf
"Aftersix months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d1/95/1777.PMC4573851.pdf
"Corresponding authors: brian_strahl@med.unc.edu, tatiana.kutateladze@ucdenver.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.269977.",Non-OADS,/arxiv_data1/oa_pdf/1b/eb/1795.PMC4573853.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/1b/eb/1795.PMC4573853.pdf
"After six months, it is available under a Creative Commons Li- cense (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/1b/eb/1795.PMC4573853.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.266999.115.© 2015 Arenzana et al.,Non-OADS,/arxiv_data1/oa_pdf/df/c8/1801.PMC4573854.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/df/c8/1801.PMC4573854.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.264036.115.© 2015 Váraljai et al.,Non-OADS,/arxiv_data1/oa_pdf/21/5b/1817.PMC4573855.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-is-sue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/21/5b/1817.PMC4573855.pdf
"After six months, it is available under a Creative Commons Li-cense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/21/5b/1817.PMC4573855.pdf
Functional enrichment analysis Functional annotation of target genes was based on GO biological process or cellular location (http://www.geneontology.org).,OADS,/arxiv_data1/oa_pdf/21/5b/1817.PMC4573855.pdf
Article and publication date are on-line at http://www.genesdev.org/cgi/doi/10.1101/gad.269068.115.,Non-OADS,/arxiv_data1/oa_pdf/cf/69/1835.PMC4573856.pdf
"This article, published in Genes & Development ,i s available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/cf/69/1835.PMC4573856.pdf
"Moreover, Nkx2-1 deletion in KP lung adenocarcinomas was not sufficient to induce the Corresponding author: tjacks@mit.edu Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.267393.115.© 2015 Li et al.",Non-OADS,/arxiv_data1/oa_pdf/99/65/1850.PMC4573857.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue pub-lication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/99/65/1850.PMC4573857.pdf
"Af-ter six months, it is available under a Creative Commons License(Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/99/65/1850.PMC4573857.pdf
"To this end, we analyzed RNA-seq expressiondata for 488 lung adenocarcinoma primary tumors from patients with stage I –IV disease from The Cancer Genome Atlas (TCGA, http://cancergenome.nih.gov).",OADS,/arxiv_data1/oa_pdf/99/65/1850.PMC4573857.pdf
Corresponding author: philippe.soriano@mssm.eduArticle is online at http://www.genesdev.org/cgi/doi/10.1101/gad.264994.115.© 2015 Brewer et al.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/1863.PMC4573858.pdf
"This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issuepublication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).After six months, it is available under a Creative Commons License (At-tribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d2/8d/1863.PMC4573858.pdf
Statistical analysis of mutant inheritance frequencies The χ2 tests were performed using GraphPad QuickCalcs (http://graphpad.com/quickcalcs/chisquared1.cfm) to determine whether observed inheritance frequencies deviated from the pre- dicted 1:2:1 Mendelian genotypic ratio.,OADS,/arxiv_data1/oa_pdf/d2/8d/1863.PMC4573858.pdf
Blood samples were split into serum chemistries and complete blood cell count and shipped to Phoenix Central Laboratories (http://www.pclv.net) for analysis.,OADS,/arxiv_data1/oa_pdf/d2/8d/1863.PMC4573858.pdf
Article and publication date areonline at http://www.genesdev.org/cgi/doi/10.1101/gad.264127.115.© 2015 Nicolay et al.,Non-OADS,/arxiv_data1/oa_pdf/a7/06/1875.PMC4573859.pdf
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-is-sue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a7/06/1875.PMC4573859.pdf
"After six months, it is available under a Creative Commons Li-cense (Attribution-NonCommercial 4.0 International), as described athttp://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a7/06/1875.PMC4573859.pdf
This  is  an  open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/20/main.PMC4573861.pdf
"The  images  demonstrated  incarcer- ated  right  inguinal  hernia  containing  the  distal  ileum,  cecum,  and appendix  together  with  a  small  amount  of  ﬂuid  within  the  hernia http://dx.doi.org/10.1016/j.ijscr.2015.07.038 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/76/20/main.PMC4573861.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/58/main.PMC4573862.pdf
She  had  a  history  of  thrombocytope- nia  26  days  earlier  attributed  to  NSAID  use  and  history  of  a http://dx.doi.org/10.1016/j.ijscr.2015.07.036 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/15/58/main.PMC4573862.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/eb/4e/main.PMC4573863.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.08.009 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/4e/main.PMC4573863.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a0/86/main.PMC4573864.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.08.002 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/86/main.PMC4573864.pdf
"24  (2009) 757–761,  http://dx.doi.org/10.1111/j.1440-1746.2008.05703.x [8] R.A.  Kozar,  J.B.  Moore,  S.E.",Non-OADS,/arxiv_data1/oa_pdf/a0/86/main.PMC4573864.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e0/a7/main.PMC4573865.pdf
"In  the  structure  of  the  distal  phalanx  in  children,  the http://dx.doi.org/10.1016/j.ijscr.2015.08.005 2210-2612/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/e0/a7/main.PMC4573865.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c5/06/main.PMC4573866.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.08.003 2210-2612/© 2015  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/06/main.PMC4573866.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/5b/main.PMC4573867.pdf
http://dx.doi.org/10.1016/j.ijscr.2015.08.007 2210-2612/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/de/5b/main.PMC4573867.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by- nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/96/8e/ezu466.PMC4573977.pdf
"http://www.statistik.at/web_de/statistiken/gesundheit/ index.html (30 October 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/96/8e/ezu466.PMC4573977.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007535).,Non-OADS,/arxiv_data1/oa_pdf/57/37/bmjopen-2014-007535.PMC4574009.pdf
- 141 -Imaging Science in Dentistry 2015; 45: 141-5 http://dx.doi.org/10.5624/isd.2015.45.3.141 Introduction The detection of proximal dental caries is a challenge in  dentistry.,Non-OADS,/arxiv_data1/oa_pdf/81/ea/isd-45-141.PMC4574050.pdf
"(Imaging Sci Dent 2015; 45: 141-5) Key words : Radiography, Dental, Digital; Image Processing, Computer ­Assisted; Image Enhancement; Dental Caries Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/ea/isd-45-141.PMC4574050.pdf
"- 147 -Imaging Science in Dentistry 2015; 45: 147-51 http://dx.doi.org/10.5624/isd.2015.45.3.147 Introduction The application of cone-beam computed tomography  (CBCT) in dentistry has increased rapidly since it was  introduced.1 CBCT has been used as a method for creat- ing three-dimensional radiographs,2 which are one of the  most sensitive imaging modalities for dental diagnostic  purposes, and as a substitute for traditional CT in the  assessment of pathology and dysfunction of the cranio-maxillofacial complex.",Non-OADS,/arxiv_data1/oa_pdf/5a/56/isd-45-147.PMC4574051.pdf
"(Imaging Sci Dent 2015; 45: 147-51) Key words : Cone-Beam Computed Tomography; Tooth Fractures; Artifacts; Sensitivity and Specificity Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/56/isd-45-147.PMC4574051.pdf
"- 153 -Imaging Science in Dentistry 2015; 45: 153-8 http://dx.doi.org/10.5624/isd.2015.45.3.153 Introduction External root resorption (ERR) is defined as the loss of   mineralized dental tissue, such as cementum, dentin, and  even alveolar bone, as the result of various factors leading  to alterations in osteoclastic activity.",Non-OADS,/arxiv_data1/oa_pdf/36/00/isd-45-153.PMC4574052.pdf
"(Imaging Sci Dent 2015; 45:  153-8 ) Key words : Root Resorption; Cone­Beam Computed Tomography; Dental Digital Radiography Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/00/isd-45-153.PMC4574052.pdf
"- 159 -Imaging Science in Dentistry 2015; 45: 159-68 http://dx.doi.org/10.5624/isd.2015.45.3.159 Introduction Magnetic resonance imaging (MRI) is an important di- agnostic method that has the ability to improve soft tissue  contrast without using ionizing radiation.1,2Artifacts are one of the most important features of MRI  images.",Non-OADS,/arxiv_data1/oa_pdf/77/e8/isd-45-159.PMC4574053.pdf
"(Imaging  Sci Dent 2015; 45: 159-68) Key words : Magnetic Resonance Imaging; Orthodontic Brackets; Artifacts; Orthodontic Wires Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/77/e8/isd-45-159.PMC4574053.pdf
- 169 -Imaging Science in Dentistry 2015; 45: 169-74 http://dx.doi.org/10.5624/isd.2015.45.3.169 Introduction Restoring edentulous spaces in the mouth with endosse­ ous dental implants is increasingly common.,Non-OADS,/arxiv_data1/oa_pdf/99/36/isd-45-169.PMC4574054.pdf
"(Imaging Sci Dent 2015; 45: 169-74 ) Key woRds : Dental Implants; Maxillary Sinus; Cone­Beam Computed Tomography; Radiography, Panoramic Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/36/isd-45-169.PMC4574054.pdf
- 175 -Imaging Science in Dentistry 2015; 45: 175-80 http://dx.doi.org/10.5624/isd.2015.45.3.175 Introduction Recent technological advances have significantly im- pacted the practice of dentistry.,Non-OADS,/arxiv_data1/oa_pdf/c2/73/isd-45-175.PMC4574055.pdf
"(Imaging Sci Dent 2015; 45: 175-80) Key words : PACS (Radiology); Radiography, Dental, Digital; Radiography, Panoramic Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/73/isd-45-175.PMC4574055.pdf
- 181 -Imaging Science in Dentistry 2015; 45: 181-5 http://dx.doi.org/10.5624/isd.2015.45.3.181 Amelogenesis imperfecta is characterized by inherited  defects in the enamel that can be qualitative or quantita­ tive.,Non-OADS,/arxiv_data1/oa_pdf/c3/1a/isd-45-181.PMC4574056.pdf
"(Imaging Sci Dent 2015; 45: 181-5 ) KEy woRds : Amelogenesis Imperfecta; Cone­Beam Computed Tomography; Dental Enamel; Kidney Disease Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/1a/isd-45-181.PMC4574056.pdf
- 187 -Imaging Science in Dentistry 2015; 45: 187-92 http://dx.doi.org/10.5624/isd.2015.45.3.187 Cleidocranial dysplasia (CCD) is a rare autosomal domi­ nant skeletal disorder.,Non-OADS,/arxiv_data1/oa_pdf/60/94/isd-45-187.PMC4574057.pdf
"(Imaging Sci Dent 2015; 45: 187-92) Key woRds : Cleidocranial Dysplasia; Cone­Beam Computed Tomography; Odontoma; Tooth, Supernumerary Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/94/isd-45-187.PMC4574057.pdf
"- 193 -Imaging Science in Dentistry 2015; 45: 193-8 http://dx.doi.org/10.5624/isd.2015.45.3.193 The term ‘noma’ is derived from the Greek word nomein ,  meaning ‘to devour,’ which is an allusion to the rapidly  destructive course of gangrene.1,2 Hippocrates first des­ cribed noma in the fifth century BC, and the dis ease con­ tinued to be reported throughout Europe until World War II.",Non-OADS,/arxiv_data1/oa_pdf/78/d5/isd-45-193.PMC4574058.pdf
"(Imaging Sci Dent 2015; 45: 193-8) Key woRds : Noma; Jaw Diseases; Tomography, X­ray Computed Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non­Commercial License (http://creativecommons.org/licenses/by­nc/3.0)   which permits unrestricted non­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/d5/isd-45-193.PMC4574058.pdf
"- 199 -Imaging Science in Dentistry 2015; 45: 199-203 http://dx.doi.org/10.5624/isd.2015.45.3.199 Multiple myeloma is a systemic clonal proliferation of  plasma cells in the bone marrow that characteristically se- crete a monoclonal immunoglobulin.1 Multiple myeloma  is one of the three clinically distinct plasma cell disorders, as well as solitary plasmacytoma of the bone and extra - medullary plasmacytoma.",Non-OADS,/arxiv_data1/oa_pdf/18/e5/isd-45-199.PMC4574059.pdf
"(Imaging Sci Dent 2015; 45: 199-203 ) Key woRds : Multiple Myeloma; Bisphosphonate-Associated Osteonecrosis of the Jaw; Tooth Extraction Copyright ⓒ 2015 by Korean Academy of Oral and Maxillofacial Radiology This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)   which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/e5/isd-45-199.PMC4574059.pdf
/C211The Author(s) 2015 Reprints and permission: http://www.sagepub.com/journalsPermissions.nav DOI: 10.1177/0272989X15577362Supplementary material for this article is available on the Medical Decision Making Web site at http://mdm.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/0f/1e/10.1177_0272989X15577362.PMC4574086.pdf
Available from: URL: http://www.euroqol.org/fileadmin/user_ upload/Documenten/PDF/Folders_Flyers/EQ-5D-3L_UserGuide_2013_v5.0_October_2013.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/0f/1e/10.1177_0272989X15577362.PMC4574086.pdf
Available from: URL:http://www.nice.org.uk/article/pmg 9/resources/non-guidance-guide- to-the-methods-of-technology-appraisal-2013-pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/0f/1e/10.1177_0272989X15577362.PMC4574086.pdf
Available from: URL: http://archive.ahrq.gov/professionals/clinicians-providers/resour ces/rice/EQ5Dscore.html 29.,OADS,/arxiv_data1/oa_pdf/0f/1e/10.1177_0272989X15577362.PMC4574086.pdf
Availablefrom: URL: http://meps.ahrq.gov/data_files/publications/mr15/ mr15.pdf 30.,OADS,/arxiv_data1/oa_pdf/0f/1e/10.1177_0272989X15577362.PMC4574086.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/ed/rjv123.PMC4574196.pdf
(Cell Mol Gastro- enterol Hepatol 2015;1:462 –476; http://dx.doi.org/10.1016/ j.jcmgh.2015.06.010 ) Keywords: Inﬂammatory Bowel Disease; Very Early Onset In- ﬂammatory Bowel Disease; Whole Exome Sequencing; Mucosal Immunology.,Non-OADS,/arxiv_data1/oa_pdf/1f/68/main.PMC4574301.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1f/68/main.PMC4574301.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2015.06.010,OADS,/arxiv_data1/oa_pdf/1f/68/main.PMC4574301.pdf
"REFERENCES  1) http://www.stat.go.jp/data/jinsui/index.htm  2) Amano J, Kuwano H, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2011, Annual report  by The Japanese Association for Thoracic Surgery.",OADS,/arxiv_data1/oa_pdf/14/c9/2186-3326-77-3-0389.PMC4574326.pdf
"According to the International Standard Classification of Occupation-08 by the International Labor Organization (available at http://www.ilo.org/public/english/bureau/stat/isco/), all civil servants were categorized into the following six major occupational groups; managers, professionals, technicians and associate professionals, clerical support workers, plant and machine operators, and elementary occupations.",OADS,/arxiv_data1/oa_pdf/00/f7/2186-3326-77-3-0417.PMC4574329.pdf
"Gazette of the State Council of the People’s Republic of China,  2003; 26.  http://www.gov.cn/gongbao/content/2003/content_62342.htm (Accessed on April 20, 2015)  9) Gertler P, Gaag Jvd.",Non-OADS,/arxiv_data1/oa_pdf/01/cc/2186-3326-77-3-0465.PMC4574334.pdf
http://www.who.int/topics/millennium_development_goals/child_mortality/en/.,Non-OADS,/arxiv_data1/oa_pdf/01/cc/2186-3326-77-3-0465.PMC4574334.pdf
"Gazette of the State Council of the People’s Republic of China, 2009; 11. http://www.lawinfochina.",Non-OADS,/arxiv_data1/oa_pdf/01/cc/2186-3326-77-3-0465.PMC4574334.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/40/main.PMC4574508.pdf
"Biochemical assessment of the line, clone 3B2, revealed that these cells are highly resistant toContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2015.08.013 2405-5808/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/81/40/main.PMC4574508.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/40/main.PMC4574508.pdf
"Sequences were then compared to one another (to resolve strain-speci ﬁc polymorphisms) as well as to the annotated genome (TriTrypDB, http://tritrypdb.org/tritrypdb/ ).",OADS,/arxiv_data1/oa_pdf/81/40/main.PMC4574508.pdf
"To de- termine if the 3B2 line had a similar defect, the OST open reading frames encoded by the TbSTT3 genes were cloned and sequenced from the genomes of both parental and mutant lines and com- pared to one another and to reference T. brucei genomes (http://tritrypdb.org/tritrypdb/ ).",Non-OADS,/arxiv_data1/oa_pdf/81/40/main.PMC4574508.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2015.08.013 .,OADS,/arxiv_data1/oa_pdf/81/40/main.PMC4574508.pdf
"34Dement Geriatr Cogn Disord Extra 2015;5:32–41  DOI: 10.1159/000370307 EXTRA  Kirkevold and Selbæk: The Agreement between the MMSE and IQCODE Tests in a  Community-Based Sample of Subjects Aged ≥70 Receiving In-Home Nursing  www.karger.com/dee© 2015 S. Karger AG, Basel service or in-home nursing, and about 130,000 (74%) of them wer e  ≥ 75 years old (Statistics  Norway http://ssb.no/).",Non-OADS,/arxiv_data1/oa_pdf/9d/18/dee-0005-0032.PMC4574614.pdf
30 ICD-10 version 2010. http://apps.who.int/classifications/ic d10/browse/2010/en#/F04.,Non-OADS,/arxiv_data1/oa_pdf/9d/18/dee-0005-0032.PMC4574614.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 3, Pages:1092-1094,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/20/17/epj-07-1092.PMC4574693.pdf
http://www.ephysician.ir Page10948.,Non-OADS,/arxiv_data1/oa_pdf/20/17/epj-07-1092.PMC4574693.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 3,Pages:1095-1101,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/epj-07-1095.PMC4574694.pdf
"http://www.ephysician.ir Page1096measure that can lead to complications, such as hematoma, ischemia, arteriovenous fistula, and, occasionally, life - threatening infections (2 -4).",Non-OADS,/arxiv_data1/oa_pdf/bf/0c/epj-07-1095.PMC4574694.pdf
"http://www.ephysician.ir Page1098significant correlation (correlation coefficient = 0.950, p < 0.001).",OADS,/arxiv_data1/oa_pdf/bf/0c/epj-07-1095.PMC4574694.pdf
http://www.ephysician.ir Page1100model.,Non-OADS,/arxiv_data1/oa_pdf/bf/0c/epj-07-1095.PMC4574694.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 3, Pages:1102-1107,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/ee/6f/epj-07-1102.PMC4574695.pdf
http://www.ephysician.ir Page1104medical records).,Non-OADS,/arxiv_data1/oa_pdf/ee/6f/epj-07-1102.PMC4574695.pdf
http://www.ephysician.ir Page1106examined further.,Non-OADS,/arxiv_data1/oa_pdf/ee/6f/epj-07-1102.PMC4574695.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 3, Pages:1108-1113,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/61/a9/epj-07-1108.PMC4574696.pdf
http://www.ephysician.ir Page1110(11).,Non-OADS,/arxiv_data1/oa_pdf/61/a9/epj-07-1108.PMC4574696.pdf
http://www.ephysician.ir Page1112reportedthat they had experienced mental disorders .,Non-OADS,/arxiv_data1/oa_pdf/61/a9/epj-07-1108.PMC4574696.pdf
"1979; 9 (01): 139-45. doi: http://dx.doi.org/10.1017/S0033291700021644, PMID: 424481.",Non-OADS,/arxiv_data1/oa_pdf/61/a9/epj-07-1108.PMC4574696.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 3, Pages:1114-1120,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/5b/d1/epj-07-1114.PMC4574697.pdf
http://www.ephysician.ir Page11163.,Non-OADS,/arxiv_data1/oa_pdf/5b/d1/epj-07-1114.PMC4574697.pdf
http://www.ephysician.ir Page1118Table3.Ten-year overall survival rate according to univariate and multivariate analysis Factor Univariate analysis Multivariate analysis HRa(95% CIb) p-valueHR (95% CI) p-value Gender 1.14(0.35-1.82)0.83 1.80 (0.72 -2.90)0.74 Age≥ 40 3.33(1.52-5.01) 0.02 0.55 (0.31 -0.80) 0.01 Oligodendroglioma/ Astrocytoma 0.52 (0.18 -1.14) 0.03 2.21 (0.54 -4.12) 0.03 Mixed oligoastrocytoma/ Astrocytoma 0.79(0.42-1.21) 0.11 1.26(0.58-2.06) 0.10 Tumor  size ≥5 cm 2.02(0.47-3.69) 0.01 2.09 (1.23 -3.98) 0.00 Headache at diagnosis 1.08(0.62-1.47) 0.45 1.14 (0.58 -1.46) 0.50 Seizure at diagnosis 1.31 (0.71 -1.92) 0.10 1.13 (0.36 -1.77) 0.26 Motor or sensory deficit at diagnosis 1.32 (0.22 -2.41) 0.05 1.47 (0.93 -2.30) 0.08 KPS greater than 70 0.38 (0.16 -0.61) 0.01 1.34 (0.70 -2.00) 0.33 Subtotal resection/Gross -total resection 1.87 (0.82 -2.87) 0.02 1.20 (1.59 -2.57) 0.02 Biopsy (no surgery)/Gross -total resection 3.16 (0.12 -5.88) 0.01 2.88 (0.93 -5.44) 0.00 Radiation therapy at progre ssion/Adjuvant radiotherapy1.17 (0.57 -1.52) 0.09 1.20 (0.42 -1.90) 0.08 aHR: hazard ratio;bCI: confidence interval 4.,Non-OADS,/arxiv_data1/oa_pdf/5b/d1/epj-07-1114.PMC4574697.pdf
"http://www.ephysician.ir Page11203)Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP.",OADS,/arxiv_data1/oa_pdf/5b/d1/epj-07-1114.PMC4574697.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volu me: 7, Issue: 3, Pages:1121-1125,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/7f/a3/epj-07-1121.PMC4574698.pdf
"http://www.ephysic ian.ir Page1122morbidity and mortali ty, increase healthcare costs, and cause physical and functional deficits, such as interference with mastication, swallowing, speech, breathing, and interacting with others; they also cause cosmetic problems, which, in turn, can cause psychological problem s (2, 3).",Non-OADS,/arxiv_data1/oa_pdf/7f/a3/epj-07-1121.PMC4574698.pdf
http://www.ephysic ian.ir Page1124conscious (12-15).,Non-OADS,/arxiv_data1/oa_pdf/7f/a3/epj-07-1121.PMC4574698.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir Year: 2015, Volume: 7, Issue: 3, Pages:1126-1134,DOI: 10.14661/2015.",Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
http://www.ephysician.ir Page11282.3.,Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
"http://www.ephysician.ir Page1130and p = 0.041, respectively).",Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
"http://www.ephysician.ir Page1132In another st udy, researchers used the DPOAE test with 33 participants.",Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
Available from: https://www.iso.org/obp/ui/#iso:std:iso:8996:ed -2:v1:en.,Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
"Available from: http://emedicine.medscape.com/ article/835943 -overview, updated 15 June 2012; Accessed 20 September 2012.",Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
Available from: https://www.iso.org/obp/ui/#iso:std:iso:9612:ed -2:v1:en.,Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
"http://www.ephysician.ir Page113426)De Kleine E, Wit HP, van D ijk P, Avan P. The behavior of spontaneous otoacoustic emissions during and after postural changes.",OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
"(RR840) ,available from: http://www.hse.gov.uk/research/rrpdf/rr840.pdf.",Non-OADS,/arxiv_data1/oa_pdf/07/8f/epj-07-1126.PMC4574699.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052092.115.© 2015 Parrish et al.,OADS,/arxiv_data1/oa_pdf/34/b9/1691.PMC4574747.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/34/b9/1691.PMC4574747.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.HYPOTHESIS RNA 21:1691 –1703; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1691",Non-OADS,/arxiv_data1/oa_pdf/34/b9/1691.PMC4574747.pdf
This bioinformatic analysis was performed using Galaxy (https://usegalaxy.org).,OADS,/arxiv_data1/oa_pdf/34/b9/1691.PMC4574747.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.051268.115.© 2015 Zafrir and Tuller This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/9a/e5/1704.PMC4574748.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS 1704 RNA 21:1704 –1718; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/9a/e5/1704.PMC4574748.pdf
2002; http://www.rna.,Non-OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.051144.115.© 2015 Doris et al.,OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 21:1719 –1730; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1719",Non-OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
2002) (http://www.rna.icmb.utexas.edu).Our refined data set represents a Full-Length Organismal rRNA Alignment (FLORA) that represents a broad distribu- tion of organisms from the tree of life (Supplemental Fig.,OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
FLORA is publicly available at http://apollo.chemistry.gatech.edu/FLORA.html.,OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
"Identification of conserved nucleotide elements (CNEs) in the large ribosomal subunit within each domain of life Previously, the degree of conservation of each nucleotide within RNA has been quantified (http://www.rna.icmb.",OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
"The dsCNEs agree well with data of individual nucle-otide conservation compared between each of the three domains of life (http://www.rna.icmb.utexas.edu/SAE/2A/ nt_Frequency/SB/index.php), but no comment was madeearlier about dsCNEs as a class.",OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
2007) (http://www.arb-silva.de/projects/) andcurated to create the Full-Length Organismal rRNA Alignment(FLORA) database for 23S –28S rRNA sequences.,OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
2002) (http://www.rna.icmb.utexas.edu).,OADS,/arxiv_data1/oa_pdf/4f/23/1719.PMC4574749.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052472.115.© 2015 Addepalli et al.,OADS,/arxiv_data1/oa_pdf/d3/79/1746.PMC4574751.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d3/79/1746.PMC4574751.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/d3/79/1746.PMC4574751.pdf
"MATERIALS AND METHODS Designing synthetic gene and cloning Using the MC1 amino acid sequence as a template, a synthetic gene with the natural codon bias of E. coli was designed using the codon optimization tool (Fuglsang 2003) at Integrated DNA Technologies (IDT; http://www.idtdna.com/CodonOpt).",OADS,/arxiv_data1/oa_pdf/d3/79/1746.PMC4574751.pdf
"The spray voltage was 4 kV,the capillary temperature was 275°C, the capillary voltage was−23 V and the tube lens was set to −80 V. The theoretical m/z(mass/charge) values of putative digestion products (both U-specific and nonspecific) and the correspondingcollision-induced dissociated (CID) fragment ions were computedusing Mongo Oligo (http://mods.rna.albany.edu/masspec/Mongo-Oligo).",OADS,/arxiv_data1/oa_pdf/d3/79/1746.PMC4574751.pdf
The dock- ing calculations were performed on docking server (http://www.dockingserver.com) (Huey et al.,OADS,/arxiv_data1/oa_pdf/d3/79/1746.PMC4574751.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049940.115.© 2015 Bohjanen et al.,OADS,/arxiv_data1/oa_pdf/e0/ba/1757.PMC4574752.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e0/ba/1757.PMC4574752.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/e0/ba/1757.PMC4574752.pdf
"2006), ZNF678 (http://www.proteinatlas.org/search/), ZMAT3(Parikh et al.",OADS,/arxiv_data1/oa_pdf/e0/ba/1757.PMC4574752.pdf
"A pathway analysis of CELF1 target transcripts in malignant T-cell lines was performed with the Ingenuity Pathway Analysis software(IPA, Ingenuity Systems, http://www.ingenuity.com).",OADS,/arxiv_data1/oa_pdf/e0/ba/1757.PMC4574752.pdf
"Forward andReverse primers were designed to each mRNA of interest, usingPrimer-Blast software from National Center for BiotechnologyInformation, and posted in Supplemental Table 2 (http://www.ncbi.nlm.nih.gov/tools/primer-blast/).",OADS,/arxiv_data1/oa_pdf/e0/ba/1757.PMC4574752.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052555.115.© 2015 Schwer et al.,OADS,/arxiv_data1/oa_pdf/dd/cb/1770.PMC4574753.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/dd/cb/1770.PMC4574753.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/dd/cb/1770.PMC4574753.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052084.115.© 2015 Szempruch et al.,OADS,/arxiv_data1/oa_pdf/04/a7/1781.PMC4574754.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/04/a7/1781.PMC4574754.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052712.115.© 2015 Apostolidi et al.,OADS,/arxiv_data1/oa_pdf/41/1a/1790.PMC4574755.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/41/1a/1790.PMC4574755.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/41/1a/1790.PMC4574755.pdf
"Based on previous reports and using data from the MODOMICS database (http://modomics.genesilico.pl/sequences/list/), it is evident that the ability of the tRNA Gly(UCC)to discriminate among the four codons might also be affected by the presence of a 5′-carboxymethylamino- methyluridine modification in the first position of the antico- don.",Non-OADS,/arxiv_data1/oa_pdf/41/1a/1790.PMC4574755.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052126.115.© 2015 Van Bortle et al.,OADS,/arxiv_data1/oa_pdf/be/a4/1807.PMC4574756.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/be/a4/1807.PMC4574756.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052225.115.© 2015 Galicia-Vázquez et al.,OADS,/arxiv_data1/oa_pdf/34/04/1826.PMC4574758.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/34/04/1826.PMC4574758.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/34/04/1826.PMC4574758.pdf
"This clone, des-ignated eIF4AII em1JP(for the first endo- nuclease-induced mutation [em1] of the eIF4AII gene produced in the JP laboratory) (http://www.informatics.jax.org/mgihome/nomen/gene.shtml#endim) was chosen forfurther characterization.",Non-OADS,/arxiv_data1/oa_pdf/34/04/1826.PMC4574758.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.052613.115.© 2015 Gerasimova et al.,OADS,/arxiv_data1/oa_pdf/5d/91/1834.PMC4574759.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 1834 RNA 21:1834 –1843; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/5d/91/1834.PMC4574759.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/93/sar-6-103.PMC4574796.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 103–111Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  103ORiginAl ReSeARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S8936 1Motivation to maintain sobriety among residents  of sober living recovery homes Douglas l Polcin Rachael Korcha Alcohol Research group, Public  health institute, emeryville, cA, USA correspondence: Douglas l Polcin   Alcohol Research group, Public health   institute, 6475 christie Avenue, Suite   400, emeryville, cA 94608-1010, USA   Tel +1 510 597 3440   Fax +1 510 985 6459   email dp olcin@arg.or gBackground:  The study of motivation in the substance abuse field has typically examined the  extent to which substance users want to quit or reduce substance use.",Non-OADS,/arxiv_data1/oa_pdf/df/93/sar-6-103.PMC4574796.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/df/93/sar-6-103.PMC4574796.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/93/sar-6-103.PMC4574796.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/e2/opth-9-1655.PMC4574797.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1655–1664Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1655Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8864 7Clinical and visual outcomes of patients with  uveitis in the mid-atlantic United states asima Bajwa1 Chang sup lee1 Jim Patrie2 Wenjun Xin2 ashvini K reddy1 1Department of Ophthalmology,   2Department of Public health  sciences, University of Virginia,   Charlottesville, V a, UsaPurpose:  To report the clinical outcomes of uveitis patients at the University of Virginia.",Non-OADS,/arxiv_data1/oa_pdf/9d/e2/opth-9-1655.PMC4574797.pdf
"In most Correspondence: ashvini K reddy Department of Ophthalmology,  University of Virginia, 1300 Jefferson Park  avenue, Charlottesville, Va 22908, Usa Tel +1 434 243 5890 Fax +1 434 924 5180 email ash.vee.knee@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bajwa et al Running head recto: Clinical outcomes of uveitis in Virginia DOI: http://dx.doi.org/10.2147/OPTH.S88647",Non-OADS,/arxiv_data1/oa_pdf/9d/e2/opth-9-1655.PMC4574797.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9d/e2/opth-9-1655.PMC4574797.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/e2/opth-9-1655.PMC4574797.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/4f/tcrm-11-1371.PMC4574798.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1371–1381Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1371ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8829 7aldehyde dehydrogenase-2 protects against  myocardial infarction-related cardiac fibrosis  through modulation of the Wnt/ β-catenin  signaling pathway Xinjun Zhao,1,2,* Yue  hua,1,2,* hongmei Chen,1,2,*  haiyu Yang,3,* Tao Zhang,1,2,*  guiqiong huang,4,* huijie  Fan,1,2 Zhangbin Tan,1,2  Xiaofang huang,1,2 Bin liu,5  Yingchun Zhou1,2 1The Key Laboratory of Molecular  Biology, state administration of  Traditional Chinese Medicine, school of  Traditional Chinese Medicine, southern  Medical University, guangdong,  Guangzhou, People’s Republic of China;  2nanfang hospital, southern Medical  University, guangdong, guangzhou,  People’s Republic of China; 3Jiangmen  Wuyi Traditional Chinese Medicine  hospital, guangdong, Jiangmen,  People’s Republic of China; 4huizhou  hospital of Traditional Chinese  Medicine, Huizhou, People’s Republic of  China; 5The second affiliated hospital  of guangzhou Medical University,  guangdong, guangzhou, People’s  Republic of China *These authors contributed equally  to this workBackground:  Aldehyde dehydrogenase-2 (ALDH2) has a protective effect on ischemic  heart disease.",Non-OADS,/arxiv_data1/oa_pdf/5a/4f/tcrm-11-1371.PMC4574798.pdf
"Keywords:  myocardial infarction, aldehyde dehydrogenase, cardiac fibrosis, Wnt signaling Introduction Cardiovascular disease is the leading cause of mortality and morbidity in developed  countries.1,2 All over the world, the incidence of death from cardiovascular disease  has risen by one-third between 1990 and 2010.3 Furthermore, according to the report  of WHO, the amount of cardiovascular disease has been achieved to 17 million in  2008.4 The Wnt/ β-catenin signaling pathway is a conserved pathway that plays a criti - cal role in most physiological and pathological processes, including tissue and organ Correspondence: Yingchun Zhou nanfang hospital, southern Medical  University, guangzhou avenue north   no 1838, guangdong, guangzhou  510515, People’s Republic of China email zhychun@126.co m  Bin liu The Second Affiliated Hospital of  guangzhou Medical University, Chang  gang Road 250, haizhu District,  guangzhou City, guangdong, guangzhou  510260, People’s Republic of China email liubbingz@yeah.ne tJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Zhao et al Running head recto: ALDH2 inhibits cardiac fibrosis via Wnt/ β-catenin pathway DOI: http://dx.doi.org/10.2147/TCRM.S88297",Non-OADS,/arxiv_data1/oa_pdf/5a/4f/tcrm-11-1371.PMC4574798.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/5a/4f/tcrm-11-1371.PMC4574798.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5a/4f/tcrm-11-1371.PMC4574798.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/4f/tcrm-11-1371.PMC4574798.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/2d/copd-10-1917.PMC4574799.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1917–1923International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1917OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9168 4Effect of indacaterol on lung deflation improves  cardiac performance in hyperinflated COPD  patients: an interventional, randomized, double- blind clinical trial Pierachille santus1,2 Dejan radovanovic1,2 silvia Di Marco3 Vincenzo Valenti4,5 rita raccanelli1,2 Francesco Blasi6,7 stefano Centanni8,9 Maurizio Bussotti3 1Department of health sciences,   University of Milan, 2Pulmonary  rehabilitation Unit, Fondazione  salvatore Maugeri scientific Institute  of Milan-IrCCs, 3Cardiological  rehabilitation Unit, Fondazione  salvatore Maugeri rehabilitation  Institute of Milan-IrCCs,   4Department of Biomedical sciences  for health, University of Milan,   5respiratory Unit, Policlinico san  Donato-IrCCs, san Donato Milanese,   6Department of Pathophysiology  and Transplantation, University of  Milan, 7IrCCs Fondazione Ospedale  Maggiore Policlinico Cà granda Milan,   8Department of health sciences,   University of Milan, 9respiratory Unit,   Ospedale san Paolo, Milan, ItalyBackground:  COPD is often associated with cardiovascular comorbidity.",Non-OADS,/arxiv_data1/oa_pdf/ed/2d/copd-10-1917.PMC4574799.pdf
"COPD is often associated with various comorbidi - ties, mainly cardiovascular and metabolic in nature, and ranks third among the causes  of death worldwide.1Correspondence: Pierachille santus Department of health sciences,  University of Milan, Pulmonary  rehabilitation Unit, Fondazione salvatore  Maugeri, Istituto Scientifico di Milano  IrCCs, Via Camaldoli, 64 – 20138 Milan,  Italy Tel +39 02 5072 5122 Fax +39 02 5072 5240 email pierachille.santus@unimi.i t Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Santus et al Running head recto: COPD lung deflation and cardiac performance DOI: http://dx.doi.org/10.2147/COPD.S91684",Non-OADS,/arxiv_data1/oa_pdf/ed/2d/copd-10-1917.PMC4574799.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ed/2d/copd-10-1917.PMC4574799.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/2d/copd-10-1917.PMC4574799.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/5e/copd-10-1907.PMC4574800.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1907–1916International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1907OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8976 3Vitamin D deficiency is associated with the  severity of COPD: a systematic review and  meta-analysis Biyuan Zhu1,* Biqing Zhu2,* Chaolie Xiao3 Zhiwen Zheng1 1The Fifth Internal Medicine  Department, 2Department  of Laboratory Medicine, 3Department  of Intensive Care Unit, Dongguan  Hospital of Traditional Chinese  Medicine, Guangzhou University  of Chinese Medicine, Dongguan City,   People’s Republic of China *These authors contributed equally  to this workPurpose:  To explore the association between host serum 25-hydroxyvitamin D (25(OH)D)  and the susceptibility and severity of COPD.",Non-OADS,/arxiv_data1/oa_pdf/5a/5e/copd-10-1907.PMC4574800.pdf
"While it has been widely accepted that tobacco Correspondence: Zhiwen Zheng The Fifth Internal Medicine Department,  Dongguan Hospital of Traditional Chinese  Medicine, Guangzhou University of  Chinese Medicine, Songshan Lake Avenue  22, Dongcheng District, Dongguan  City, Guangdong Province 523000,  People’s Republic of China Tel +86 769 2638 8923 Fax +86 769 2638 8923 email zhengzhiwen2014@163.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Zhu et al Running head recto: Meta-analysis for vitamin D and COPD DOI: http://dx.doi.org/10.2147/COPD.S89763",Non-OADS,/arxiv_data1/oa_pdf/5a/5e/copd-10-1907.PMC4574800.pdf
"Available from : http://www.medicine.mcgill.ca/rtamblyn/ Readings/The%20Newcastle%20-%20Scale%20for%20assessing%20 the%20quality%20of%20nonrandomised%20studies%20in%20meta- analyses.pd f. Accessed August 31, 2015.",Non-OADS,/arxiv_data1/oa_pdf/5a/5e/copd-10-1907.PMC4574800.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/5a/5e/copd-10-1907.PMC4574800.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/5e/copd-10-1907.PMC4574800.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/c5/ott-8-2519.PMC4574801.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2519–2526OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2519Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8300 4association between promoter polymorphisms  of matrix metalloproteinase-1 and risk of gastric  cancer Qisong Peng Y ong Xu Department of laboratory Medicine,   The affiliated Jiangning hospital of  nanjing Medical University, nanjing,   People’s republic of chinaAbstract:  Growing evidences show that matrix metalloproteinase-1 ( MMP1 ) plays important  roles in tumorigenesis and cancer metastasis.",Non-OADS,/arxiv_data1/oa_pdf/2c/c5/ott-8-2519.PMC4574801.pdf
"The expression level of  MMP1  gene is at low level in normal cells under physiological conditions;8,9 how - ever, MMP1  expression is dramatically increased in many malignancies.5,10 It has  been reported that the promoter of MMP1  can regulate MMP1  gene transcription, correspondence: Yong Xu Department of laboratory Medicine,   The Affiliated Jiangning Hospital  of nanjing Medical University,  no 168 gushan road, Jiangning  District, nanjing, Jiangsu 211100,  People’s republic of china email 1553278952@qq.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Peng and Xu Running head recto: MMP1 promotor SNP and gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S83004",Non-OADS,/arxiv_data1/oa_pdf/2c/c5/ott-8-2519.PMC4574801.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2c/c5/ott-8-2519.PMC4574801.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/c5/ott-8-2519.PMC4574801.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/opth-9-1683.PMC4574802.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1683–1687Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1683Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8778 8Clinical and imaging characteristics of orbital  metastatic lesions among egyptian patients Mohammed a eldesouky Molham a elbakary Oculoplastic Unit, Faculty of Medicine,   Tanta University, Tanta, egyptPurpose:  The aim of the study was to review the demographic, clinical, and imaging features  of Egyptian patients with orbital metastases.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/opth-9-1683.PMC4574802.pdf
"The study adhered to the principles of the Declaration of Helsinki  and Correspondence: Molham a elbakary Department of Ophthalmology,  Oculoplastic Unit, Faculty of Medicine,  Tanta University, Postal no 31527,  Tanta, egypt Tel +20 11 4828 2205 Fax +20 40 340 7734 email melbakary75@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Eldesouky and Elbakary Running head recto: Orbital metastatic lesions among Egyptians DOI: http://dx.doi.org/10.2147/OPTH.S87788",Non-OADS,/arxiv_data1/oa_pdf/b0/56/opth-9-1683.PMC4574802.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/opth-9-1683.PMC4574802.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/56/opth-9-1683.PMC4574802.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1703–1713Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1703Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8326 3Efficacy and safety of olopatadine hydrochloride  0.77% in patients with allergic conjunctivitis using  a conjunctival allergen-challenge model gail T orkildsen1 abhijit narvekar2 Mark Bergmann3 1andover eye associates, andover,   Ma, 2alcon research ltd, Fort Worth,   TX, 3apex eye, Cincinnati, Oh, UsaBackground:  Symptom relief for the duration of 24 hours after treatment would benefit patients  with allergic conjunctivitis.",Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
"Correspondence: gail Torkildsen andover eye associates, 138 haverhill  street – suite 104, andover, Ma 01810,  Usa Tel +1 978 475 0705 Fax +1 978 475 0008 email mdlasik@comcast.ne t Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Torkildsen et al Running head recto: Olopatadine 0.77% for allergic conjunctivitis DOI: http://dx.doi.org/10.2147/OPTH.S83263",Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
"Available  from: http://www.fda.gov/downloads/AdvisoryCommittees/Commit - teesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAd - visoryCommittee/UCM170900.pd f. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
"Available from: http://www.fda.gov/downloads/drugs/develop - mentapprovalprocess/developmentresources/ucm434580.pd f. Accessed  May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/97/49/opth-9-1703.PMC4574803.pdf
"Quality check was done via fastqc (v. 0.10.0,Babraham Bioinformatics http://www.bioinformatics.bab-raham.ac.uk/).",OADS,/arxiv_data1/oa_pdf/02/b5/acn30002-0875.PMC4574806.pdf
For functional analysis gene ontology enrichment was tested accounting for genelength via R-package goseq http://www.bioconductor.org.,OADS,/arxiv_data1/oa_pdf/02/b5/acn30002-0875.PMC4574806.pdf
A search using BLASTP program of the nonredundant protein database (http://blast.ncbi.nlm.nih.gov) indicatedthat none of the 312 TCR sequences found in L-IIImatched any sequence in the database.,OADS,/arxiv_data1/oa_pdf/02/b5/acn30002-0875.PMC4574806.pdf
"Statistical analyses and bioinformatics Whole genome associations were calculated with PLINK (allelic chi-square test without covariates, and by logisticregression with age, sex, and AD-pathology as co-variateshttp://pngu.mgh.harvard.edu/purcell/plink/).",OADS,/arxiv_data1/oa_pdf/eb/43/acn30002-0920.PMC4574809.pdf
"First, SPTBN1 is known to be expressed in the brain and neu-rons, whereas C2ORF73 exhibits a restricted expression pattern; based on the expressed sequence tag and RNA sequencing data the highest expression levels is found intestis and fetus (https://www.ebi.ac.uk/gxa/experiments/E-MTAB-513).",Non-OADS,/arxiv_data1/oa_pdf/eb/43/acn30002-0920.PMC4574809.pdf
Nor were such variants (with frequency of >2%) reported in the whole SPTBN1 gene in the Exome Aggregation Con- sortium database (http://exac.broadinstitute.org/).,Non-OADS,/arxiv_data1/oa_pdf/eb/43/acn30002-0920.PMC4574809.pdf
"In addition this work was supported by a Research Grant from the Department of Defense, W81XWH-09-2-0128.Portions of this study utilized the high-performance com-putational capabilities of the Biowulf Linux cluster at theNational Institutes of Health, Bethesda, MD, U.S.A. (http://biowulf.nih.gov).",OADS,/arxiv_data1/oa_pdf/eb/43/acn30002-0920.PMC4574809.pdf
"(http://surfer.nmr.mgz.harvard.edu); technical aspects have been described elsewhere.12–15The obtained measures of CTh and surface-based volumetric measurements by gray/white/cerebrospinal ﬂuid boundaries were used for furtheranalysis, but correction of the standard pipeline wasneeded.",OADS,/arxiv_data1/oa_pdf/7d/a0/acn30002-0932.PMC4574810.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/75/ott-8-2503.PMC4574812.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2503–2507OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2503Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8722 2Treatment and survival analyses of completely  resected thymic carcinoma patients Yanjiao Mao shixiu Wu Department of radiotherapy  Oncology, hangzhou cancer hospital,   hangzhou, People’s republic of chinaPurpose:  To investigate the impact of chemotherapy and/or radiotherapy on disease-free survival  (DFS) and overall survival (OS) rates of patients with thymic carcinoma after complete resection.",Non-OADS,/arxiv_data1/oa_pdf/31/75/ott-8-2503.PMC4574812.pdf
"correspondence: shixiu Wu Department of radiotherapy Oncology,  hangzhou cancer hospital, hangzhou  310022, People’s republic of china Tel +86 571 6588 2999 Fax +86 571 6588 2996 email wushixiuhangzhou@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Mao and Wu Running head recto: Analyses of thymic carcinoma patients DOI: http://dx.doi.org/10.2147/OTT.S87222",Non-OADS,/arxiv_data1/oa_pdf/31/75/ott-8-2503.PMC4574812.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/31/75/ott-8-2503.PMC4574812.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/75/ott-8-2503.PMC4574812.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/05/copd-10-1931.PMC4574813.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1931–1934International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1931Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S9281 2Does roflumilast induce phagocytic activity  in COPD patients?,Non-OADS,/arxiv_data1/oa_pdf/3d/05/copd-10-1931.PMC4574813.pdf
DOI: http://dx.doi.org/10.2147/COPD.S92812,Non-OADS,/arxiv_data1/oa_pdf/3d/05/copd-10-1931.PMC4574813.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/3d/05/copd-10-1931.PMC4574813.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/05/copd-10-1931.PMC4574813.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 1475–1477Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1475Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S9306 8Potential underdiagnosis of osteoporosis in repeated   vertebral augmentation for new vertebral  compression fractures Birkan I.lhan Fatih tufan Gülistan Bahat Mehmet Akif Karan Division of Geriatrics, Department  of Internal Medicine, Istanbul  Medical School, Istanbul University,   Istanbul,  turkeyDear editor We read with great interest the article by Liang et al “Repeated vertebral augmenta - tion for new vertebral compression fractures of postvertebral augmentation patients:  a nationwide cohort study”.1 In their study, the authors investigated the factors possibly associated with new  vertebral compression fractures in patients who previously had vertebral augmentation  procedures.",Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
"In the elderly, one of the important factors underlying falls  may be overtreatment of HT leading to hypotension and/or orthostatic hypotension  and consequent falls.3,4 Consideration of patients with low blood pressure levels or  clinically significant orthostatism on antihypertensive medications would help the  authors to interpret this association.Correspondence: Birkan l.lhan Division of Geriatrics, Department  of Internal Medicine, Istanbul Medical  School, Istanbul University, PB 34093  Sehremini Istanbul turkiye email birkanilhan@hotmail.co mJournal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2015 Volume: 10 Running head verso: İlhan et al Running head recto: Potential underdiagnosis of osteoporosis in repeated vertebral augmentation DOI: http://dx.doi.org/10.2147/CIA.S93068",Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
Available from: http://nof.org/files/nof/public/content/file/2791/ upload/919.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
Available from: http://www.who.int/ chp/topics/Osteoporosis.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
Available from: http://nof.org/files/nof/public/content/file/2791/ upload/919.pdf .,Non-OADS,/arxiv_data1/oa_pdf/49/01/cia-10-1475.PMC4574814.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/e3/opth-9-1651.PMC4574815.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1651–1653Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1651Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OPTH.S8983 1Visual outcomes of age-related macular  degeneration patients undergoing intravitreal  ranibizumab monotherapy in an urban population:  letter to the editor Michael W Stewart Department of Ophthalmology, Mayo  Clinic Florida, Jacksonville, FL, USADear editor In their recently published manuscript entitled “Visual outcomes of age-related  macular degeneration patients undergoing intravitreal ranibizumab monotherapy in  an urban population” Basheer et al1 reported on the prospectively acquired results  of 123 eyes (106 patients) treated for 2 years with ranibizumab as needed.",Non-OADS,/arxiv_data1/oa_pdf/34/e3/opth-9-1651.PMC4574815.pdf
"Maintenance of VA (loss of ,15 letters)  Correspondence: Michael W Stewart 4500 San Pablo rd, Department of  Ophthalmology, Mayo Clinic Florida,  Jacksonville, FL 32224, USA tel +904 953 2232 Fax +904 953 7040 email stewart.michael@mayo.ed u Journal name: Clinical Ophthalmology Article Designation: Letter Y ear: 2015 Volume: 9 Running head verso: Stewart Running head recto: Visual outcomes of age-related macular degeneration patients DOI: http://dx.doi.org/10.2147/OPTH.S89831 Table 1  the major visual acuity outcomes of the Basheer et al1 study compared with those  from three pivotal ranibizumab trials Visual outcomes Present   studyCATT   trial2ANCHOR   trial4MARINA   trial3 12 months Maintained vision: loss of ,15   etDrS letters (% of eyes)91.8 96.0 (P=0.03)96.4 (P=0.03)94.6 (P=0.24) Improved vision: gain of $15   etDrS letters (% of eyes)20.3 25.0 (P=0.25)40.3 (P=0.00004)33.8 (P=0.003) 24 months Maintained vision: loss of ,15   etDrS letters (% of eyes)88.6 93.0 (P=0.08)89.9 (P=0.64)90.0 (P=0.65) Improved vision: gain of $15   etDrS letters (% of eyes)19.7 33.0 (P=0.002)41.0 (P=0.00001)35.0 (P=0.0007) Abbreviation:  etDrS, early treatment Diabetic retinopathy Study.",Non-OADS,/arxiv_data1/oa_pdf/34/e3/opth-9-1651.PMC4574815.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/34/e3/opth-9-1651.PMC4574815.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/e3/opth-9-1651.PMC4574815.pdf
Competing Interests The author has completed the Uni ﬁed Competing Inter- est form at http://www.icmje .org/coi_disclosure.pdf (available on request from the author) and declaredPDY is an employee and shareholder of GlaxoSmithKline.,Non-OADS,/arxiv_data1/oa_pdf/10/a5/bcp0080-0372.PMC4574823.pdf
Available at http://www.gsk-clinicalstudyregister.com (lastaccessed 8 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/10/a5/bcp0080-0372.PMC4574823.pdf
Available at http://www.ginasthma.org (last accessed 8 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/10/a5/bcp0080-0372.PMC4574823.pdf
Available at https://www.medicines.org.uk/emc (last accessed 8 March 2015).,Non-OADS,/arxiv_data1/oa_pdf/10/a5/bcp0080-0372.PMC4574823.pdf
Available at http://www.accessdata.,Non-OADS,/arxiv_data1/oa_pdf/10/a5/bcp0080-0372.PMC4574823.pdf
Competing Interests All authors have completed the Uni ﬁed Competing Inter- est form at http://www.icmj e.org/coi_disclosure.pdf (available on request from the corresponding author).,Non-OADS,/arxiv_data1/oa_pdf/fe/96/bcp0080-0381.PMC4574824.pdf
Available at http://cks.nice.org.uk/analgesia-mild-to- moderate-pain#!topicsummary (last accessed 1 December2014).,Non-OADS,/arxiv_data1/oa_pdf/fe/96/bcp0080-0381.PMC4574824.pdf
Available at http://www.arthritis.ca/d ocument.doc?id=341 (last accessed 1 December 2014).,Non-OADS,/arxiv_data1/oa_pdf/fe/96/bcp0080-0381.PMC4574824.pdf
2009; Available at: http://www.gmc-uk.org/about/research/25056.asp (last accessed 23 September 2013).,Non-OADS,/arxiv_data1/oa_pdf/c3/70/bcp0080-0415.PMC4574827.pdf
"Competing Interests All authors have completed the Uni ﬁed Competing Inter- est form at http://www.icmje .org/coi_disclosure.pdf (available on request from the corresponding author) and declare FT, CC, MJ, ML, JR, SS, and APT had supportfrom Novartis for the submitted work, FT, CC, MJ, ML were employees of Camurus and JR, SS and APT were employees of Novartis in the p revious 3 years.",OADS,/arxiv_data1/oa_pdf/7a/2a/bcp0080-0460.PMC4574831.pdf
Available at: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/7a/2a/bcp0080-0460.PMC4574831.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/8d/ott-8-2493.PMC4574847.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2493–2502OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2493Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8552 0association between the polymorphisms of  urokinase plasminogen activation system and  cancer risk: a meta-analysis Zhen Xu1,* li-li Meng2,* Jizong lin3 Yunbiao ling3 shu-xian chen3 nan lin3 1Department of infectious Diseases,   The Third affiliated hospital,   sun Yat-sen University, 2Department  of gynecology and Obstetrics,   sun Yat-sen Memorial hospital,   3Department of hepatobiliary  surgery, The Third affiliated hospital,   sun Yat-sen University, guangzhou,   People’s  republic of china *These authors contributed equally  to this studyPurpose:  The present study aimed to investigate the potential association between the urokinase  plasminogen activation (uPA) system polymorphisms (rs4065, rs2227564, and rs344781) and  cancer risk.",Non-OADS,/arxiv_data1/oa_pdf/5c/8d/ott-8-2493.PMC4574847.pdf
"The effects of uPA/uPAR on plas - minogen activation are regulated by their specific inhibitors PAI-1 and PAI-2.3,11–13correspondence: Jizong lin Department of hepatobiliary surgery,  The Third Affiliated Hospital of Sun  Yat-sen University, guangzhou, 510630  People’s republic of china email imlinjz@126.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xu et al Running head recto: uPA system and cancer risk DOI: http://dx.doi.org/10.2147/OTT.S85520",Non-OADS,/arxiv_data1/oa_pdf/5c/8d/ott-8-2493.PMC4574847.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/5c/8d/ott-8-2493.PMC4574847.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/8d/ott-8-2493.PMC4574847.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1935–1949International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1935RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7756 2Gastroesophageal reflux disease in COPD: links  and risks Annemarie L Lee1–3 Roger S Goldstein1,2,4 1West Park Healthcare Centre,   2Department of Physical Therapy,   University of T oronto, T oronto, ON,   Canada; 3Institute for Breathing and  Sleep, Austin Hospital, Melbourne, VIC,   Australia; 4Department of Medicine,   University of T oronto, T oronto, ON,   CanadaAbstract:  COPD is a long-term condition associated with considerable disability with a clinical  course characterized by episodes of worsening respiratory signs and symptoms associated with  exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
"Gastroesophageal reflux disease (GERD) develops when the reflux of gastric  contents results in troublesome symptoms or complications.6 It is a common upper  gastrointestinal condition, affecting up to 33% of the general population7 and may  be associated with either esophageal or extra-esophageal syndromes.6 Refluxate may  be acidic or nonacidic (alkaline), liquid, or gaseous.8 The frequency and duration of  episodes of reflux as well as the destination of the gastroesophageal refluxate affect  the impact of GERD.Correspondence: Annemarie L Lee Department of Respiratory Medicine,  West Park Healthcare Centre, 82  Buttonwood Avenue, Toronto, ON,  Canada M6M 2J5 Tel +1 416 243 2653 Fax +1 416 243 3747 email annemarie.lee@westpark.or g Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Lee and Goldstein Running head recto: GERD in COPD DOI: http://dx.doi.org/10.2147/COPD.S77562",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
"Available from: http://www.goldcop d. Accessed 24 February,  2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
"Available  from: https://www.nice.org.uk/guidance/cg101/chapter/1-guidanc e.  Accessed 24 February, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b4/a2/copd-10-1935.PMC4574848.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/8a/ott-8-2527.PMC4574849.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2527–2533OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2527Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8885 7The clinical analysis of acute pancreatitis  in colorectal cancer patients undergoing  chemotherapy after operation Yanlei Ji1 Zhen han2 limei shao1 Yunling li1 long Zhao1 Yuehuan Zhao1 1Department of special Diagnosis,   shandong cancer hospital and  institute, Jinan, People’s republic  of china; 2Department of internal  Medicine, Jinan second People’s  hospital, Jinan, People’s republic  of chinaAbstract:  Acute pancreatitis is a rare complication in postoperative colorectal cancer patients  after FOLFOX6 (oxaliplatin + calcium folinate +5-FU [5-fluorouracil]) chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/99/8a/ott-8-2527.PMC4574849.pdf
"This  combined method is called FOLFOX6 and XELOX regimens.2–4 In 1999, the FOLFOX6  (oxaliplatin + leucovorin +5-FU) chemotherapy program was first confirmed to have  good results for the second-line treatment of advanced colorectal cancer, which has  been gradually applied in the domestic medical fields.5–7 At the target point, Oxalip - latin could easily covalently combine with the G DNA chain and may form intrachain correspondence: Yuehuan Zhao Department of special Diagnosis,  shandong cancer hospital and institute,  440 Jiyan road, Jinan 250117, shandong  Province, People’s republic of china Tel +86 531 6762 6239 Fax +86 531 6762 6239 email yuehuanxczhao@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ji et al Running head recto: Analysis of acute pancreatitis in colorectal cancer patients DOI: http://dx.doi.org/10.2147/OTT.S88857",Non-OADS,/arxiv_data1/oa_pdf/99/8a/ott-8-2527.PMC4574849.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/99/8a/ott-8-2527.PMC4574849.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/8a/ott-8-2527.PMC4574849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/8c/copd-10-1951.PMC4574850.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1951–1956International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1951OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8811 4Factors associated with the prescription of inhaled  corticosteroids in gOlD group a and B patients  with COPD – subgroup analysis of the Taiwan  obstructive lung disease cohort Correspondence: Ping-hung Kuo Department of Internal Medicine, national Taiwan  University hospital, no 7, Chung-shang south  road, Taipei 100, Taiwan Tel +886 2 2312 3456 ext 65445 Fax +886 2 2358 2867 email kph712@ntuh.gov.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wei et al Running head recto: ICS overprescription in COPD patients DOI: http://dx.doi.org/10.2147/COPD.S88114 Yu-Feng Wei,1 Ping- hung  Kuo,2 Ying-huang Tsai,3  Chi-Wei Tao,4 shih-lung  Cheng,5,13 Chao-hsien lee,6  Yao-Kuang Wu,7 ning-hung  Chen,8 Wu-huei hsu,9 Jeng- Yuan hsu,10 Ming-shian lin,11  Chin-Chou Wang12 1Department of Internal Medicine, e-Da  hospital/I-shou University, Kaohsiung, Taiwan;   2Department of Internal Medicine, national  Taiwan University hospital, Taipei, Taiwan;   3Department of Internal Medicine, Chang gung  Memorial hospital, Chiayi, Taiwan; 4Department  of Internal Medicine, Cheng- hsin general  hospital, Taipei, Taiwan; 5Division of Thoracic  Medicine, Department of Internal Medicine,   Far eastern Memorial hospital, Taipei, Taiwan;   6Division of Pulmonary and Critical Care  Medicine, Mackay Memorial hospital, Taipei,   Taiwan; 7Division of Pulmonary Medicine,   Department of Internal Medicine, Taipei Tzu  Chi hospital, Taipei, Taiwan; 8Department of  Pulmonary and Critical Care Medicine, Chang  gung Memorial hospital, linkou, Taiwan;   9Division of Pulmonary and Critical Care  Medicine, Department of Internal Medicine,   China Medical University and China Medical  University hospital, Taichung, Taiwan; 10Division  of Chest Medicine, Taichung Veterans general  hospital, Taichung, Taiwan; 11Division of  Pulmonary and Critical Care Medicine, Chia-Yi  Christian hospital, Chiayi, Taiwan; 12Division  of Pulmonary and Critical Care Medicine,   Kaohsiung Chang gung Memorial hospital and  Chang gung University College of Medicine,   Kaohsiung, Taiwan; 13Department of Chemical  engineering and Materials science, Yuan-Ze  University, Taoyuan, TaiwanBackground and objective:  The overprescription of inhaled corticosteroids (ICS) in the  current Global Initiative for Chronic Obstructive Lung Disease (GOLD) group A and B patients  with chronic obstructive pulmonary disease (COPD) is not uncommon in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/fc/8c/copd-10-1951.PMC4574850.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/fc/8c/copd-10-1951.PMC4574850.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/8c/copd-10-1951.PMC4574850.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/10/7a/opth-9-1689.PMC4574851.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1689–1695Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1689Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S8436 7a Department-of-anesthesiology-based  management protocol for perioperative  corneal abrasions Jessica r lichter1 lawrence B Marr2 Dennis e schilling3 Mark e hudson4 robert h Boretsky5 roxana F Barad6 Jacques e Chelly1–3 1Division of Clinical research,  Department of anesthesiology,  University of Pittsburgh, 2University  of Pittsburgh Physicians, Department  of anesthesiology, UPMC shadyside  hospital, 3UPMC shadyside hospital,  4University of Pittsburgh Physicians,  Department of anesthesiolgy,  University of Pittsburgh Medical  Center, 5Department of anesthesiology,  UPMC shadyside, 6Department of  Ophthalmology, UPMC shadyside,  University of Pittsburgh Medical  Center, Pittsburgh, P a, UsaIntroduction:  Corneal abrasions (CAs) are the most prevalent ocular injuries in the perioperative  period.",Non-OADS,/arxiv_data1/oa_pdf/10/7a/opth-9-1689.PMC4574851.pdf
"Hence, to lessen the time  between symptom onset and treatment – and in turn patient suffering and dissatisfac - tion – an anesthesiology-based protocol for the management of minor CAs identified Correspondence: Jacques e Chelly Department of anesthesiology,  University of Pittsburgh Medical Center,  Posner Pain Center, 532 south aiken  avenue, suite 407, Pittsburgh,   Pa 15232, Usa Tel +1 412 623 6904 Fax +1 412 623 4188 email chelje@anes.upmc.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Lichter et al Running head recto: Anesthesiology management of corneal abrasions DOI: http://dx.doi.org/10.2147/OPTH.S84367",Non-OADS,/arxiv_data1/oa_pdf/10/7a/opth-9-1689.PMC4574851.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/10/7a/opth-9-1689.PMC4574851.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/10/7a/opth-9-1689.PMC4574851.pdf
Available from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/10/7a/opth-9-1689.PMC4574851.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/6b/opth-9-1665.PMC4574852.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1665–1673Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1665Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S8535 8acute hemorrhagic conjunctivitis: anti-coxsackievirus  a24 variant secretory immunoglobulin a in acute  and convalescent tear Marlyn p Langford edwin a anders Maxwell a Burch Department of Ophthalmology,   Louisiana state University Health  sciences Center, shreveport,    La, UsaPurpose:  The purpose of this paper is to present the clinical course of a laboratory-acquired  case of acute hemorrhagic conjunctivitis (AHC) caused by coxsackievirus A24 variant (CA24v).",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/opth-9-1665.PMC4574852.pdf
"AHC is endemic in several  countries where sporadic cases occur annually and local outbreaks and epidemics Correspondence: Marlyn p Langford Department of Ophthalmology, Louisiana  state University Health sciences Center,  1501 Kings Highway, pO Box 33932,  shreveport, La 71130, Usa tel +1 318 675 5018 Fax +1 318 675 6000 email mlangf@lsuhsc.ed u Journal name: Clinical Ophthalmology Article Designation: Case Report Y ear: 2015 Volume: 9 Running head verso: Langford et al Running head recto: Acute hemorrhagic conjunctivitis DOI: http://dx.doi.org/10.2147/OPTH.S85358",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/opth-9-1665.PMC4574852.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/opth-9-1665.PMC4574852.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/6b/opth-9-1665.PMC4574852.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/62/copd-10-1925.PMC4574853.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 1925–1930International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1925OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S8565 9sonographic evaluation of diaphragmatic  dysfunction in COPD patients nadine scheibe natalia sosnowski alina Pinkhasik sandy Vonderbank andreas Bastian Department of Pneumonology,   Marienkrankenhaus Kassel,   Kassel,  germanyBackground:  Diaphragmatic dysfunction is an important reason for dyspnea in COPD patients.",Non-OADS,/arxiv_data1/oa_pdf/90/62/copd-10-1925.PMC4574853.pdf
"There are various sonographic methods: for example, measurement  of the increasing thickening of the diaphragm in the lung apposition zone during Correspondence: andreas Bastian Department of Pneumonology,  Marienkrankenhaus Kassel, Marburger  street 85, 34127 Kassel, germany Tel +49 561 8073 1212 email a.bastian@marienkrankenhaus- kassel.d e Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Scheibe et al Running head recto: Sonographic evaluation of diaphragmatic dysfunction DOI: http://dx.doi.org/10.2147/COPD.S85659 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/90/62/copd-10-1925.PMC4574853.pdf
Or use: http://youtu.be/8K1CADk4a4 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/90/62/copd-10-1925.PMC4574853.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/90/62/copd-10-1925.PMC4574853.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/62/copd-10-1925.PMC4574853.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/78/opth-9-1697.PMC4574854.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 1697–1702Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1697Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6859 5Targeting interleukin-6 for noninfectious uveitis Phoebe Lin Casey eye institute, Oregon Health  and Science University, Portland, OR,   USAAbstract:  Interleukin-6 (IL-6) is a pleiotropic cytokine implicated in the pathogenesis of many  immune-mediated disorders including several types of non-infectious uveitis.",Non-OADS,/arxiv_data1/oa_pdf/25/78/opth-9-1697.PMC4574854.pdf
"Specifically, IL-6  plays a critical role in differentiation of CD4-positive T helper (Th) cells into Th17  cells which have been strongly implicated in the pathogenesis of immune-mediated  diseases including noninfectious uveitis.1,2 IL-6 can also induce differentiation of  CD8-positive cells into cytotoxic T-cells.2,3 IL-6 inhibits transforming growth factor  β-mediated regulatory T-cell development, which is important in downregulating  inflammatory responses.2,4 Additionally, IL-6 may be important in the pathogenesis  of certain types of cancers, such as multiple myeloma.5 IL-6 signals in an autocrine and paracrine fashion by binding to the transmembrane  cell surface IL-6 receptor as well as soluble IL-6 receptor.2,6 The IL-6 receptor includes  the IL-6 binding domain (known as the IL-6 receptor) and the signal transduction  chain, or gp130 (Figure 1A).7 Gp130 is common to other IL-6 family cytokines includ - ing interleukin-27 (IL-27), interleukin-35 (IL-35), interleukin-11 (IL-11), leukemia  inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor (CNTF),  cardiotrophin 1 (CTF1), and cardiotrophin-like cytokine (CLC).8 Activation of the IL-6 receptor requires a hexameric structure consisting of two  molecules each of the IL-6 receptor, IL-6, and gp130.7 Activated gp130 results in  activation of Janus kinase (JAK) and signal transducer and activator of transcription 3  (STAT3) pathways.2,6,8,9 SH2-domain containing tyrosine phosphatase-2 and mitogen  activated protein kinases (MAPK) are also activated.8 IL-6 responsive genes include Correspondence: Phoebe Lin Casey eye institute, Oregon Health and  Science University, 3375 Sw Terwilliger  Blvd, Portland, OR 97239, USA Tel +1 503 494 0007 Fax +1 503 494 6875 email linp@ohsu.ed u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lin Running head recto: Targeting IL-6 for noninfectious uveitis DOI: http://dx.doi.org/10.2147/OPTH.S68595",Non-OADS,/arxiv_data1/oa_pdf/25/78/opth-9-1697.PMC4574854.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/25/78/opth-9-1697.PMC4574854.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/78/opth-9-1697.PMC4574854.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/ott-8-2509.PMC4574856.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2509–2517OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2509Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9170 8The expression and clinical significance of HDGF  in osteosarcoma Zhiguo chen1 shenghai Qiu2 Xiaofei Lu3 1Department of Orthopedics, Linyi  People’s Hospital, Linyi City, Shandong  Province, People’s Republic of China;   2Department of Orthopedics, People’s  Hospital of Taiyuan, Taiyuan City,   Shanxi Province, People’s Republic  of China; 3Department of General  Surgery, Jinan Central Hospital  affiliated to Shandong University,   Jinan City, Shandong Province,   People’s Republic of ChinaAim:  To investigate the expression of hepatoma-derived growth factor (HDGF) in osteosarcoma  (OS) and the correlation with clinicopathologic factors, prognosis, and tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/1f/cc/ott-8-2509.PMC4574856.pdf
"Thanks to the application of  chemotherapy in OS treatment, the OS survival rate has significantly improved from  less than 20% up to 70%–80% in patients without clinically evident metastatic disease  at the time of presentation in high-grade OS,3 which accounts for 80%–90% of all OS.4  However, despite the important progresses made by chemotherapy implementation,  the survival rates of OS continue to be unsatisfactory in metastatic and relapse cases  and new chemotherapy targets are still urgently needed.5Correspondence: Xiaofei Lu Department of General Surgery,  Jinan Central Hospital affiliated to  Shandong University, 105 Jiefang Road,   Jinan City, 250013, Shandong,  People’s Republic of China Tel +86 153 1881 6768 email sduly2015@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Chen et al Running head recto: Clinical significance of HDGF in osteosarcoma DOI: http://dx.doi.org/10.2147/OTT.S91708",Non-OADS,/arxiv_data1/oa_pdf/1f/cc/ott-8-2509.PMC4574856.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/1f/cc/ott-8-2509.PMC4574856.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/cc/ott-8-2509.PMC4574856.pdf
Transcription 2014; 5:e28726;   http://dx.doi.org/10.4161/trns.28726,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nat Struct Mol Biol 2006; 13:815- 22; PMID:16921380 ; http://dx.doi.org/10.1038/ nsmb1135 2.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Genome Res   2012 ; 22:1616 -25; PMID:22955974 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Mol Cell Biol   2003 ; 23:5768 -79; PMID:12897147 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nat Rev Mol Cell Biol  2013 ; 14:153- 65; PMID:23385723 ; http://dx.doi.org/10.1038/ nrm3525 5.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature  2010 ; 465:53-9; PMID:20445623 ;  http://dx.doi.org/10.1038/nature09000 6.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
IUBMB Life  2012 ; 64:809- 16; PMID:22941908 ; http://dx.doi.org/10.1002/ iub.1075 7.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Mol Cell   2007 ; 26:867-81; PMID:17588520 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Trends Biochem Sci  2010 ;  35:497-504; PMID:20418102 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Genet Res Int  2011 ; 2011 :309865 ; PMID:22567350 ;  http://dx.doi.org/10.4061/2011/309865 10.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Mol Cell  2012 ; 45:459- 69; PMID:22264826 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
"Proc Natl Acad Sci U S A  2004 ; 101:2270 - 4; PMID:14982999 ; http://dx.doi.org/10.1073/ pnas.0308133100 12. de la Mata  M, Alonso  CR, Kadener  S, Fededa   JP, Blaustein  M, Pelisch  F, Cramer  P, Bentley  D,  Kornblihtt  AR.",OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Mol Cell  2003 ; 12:525- 32; PMID:14536091 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Genome Res  2011 ; 21:390- 401; PMID:21163941 ; http://dx.doi.org/10.1101/ gr.111070.110 14.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Cell  2011 ; 144:16-26; PMID:21215366 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Science  2010 ;  327:996-1000 ; PMID:20133523 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Trends Genet   2012 ; 28:285-94; PMID:22465610 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Cell 2007 ; 128:693-705; PMID:17320507 ;  http://dx.doi.org/10.1016/j.cell.2007.02.005 20.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nat Struct Mol Biol  2009 ; 16:996-1001 ;  PMID:19684599 ; http://dx.doi.org/10.1038/ nsmb.1658 22.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nat Struct  Mol Biol  2012 ; 19:998-1004 ; PMID:22961379 ;  http://dx.doi.org/10.1038/nsmb.2373 24.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nat Struct Mol Biol   2011 ; 18:337-44; PMID:21358630 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
EMBO J  2013 ; 32:2264 -74; PMID:23892457 ;  http://dx.doi.org/10.1038/emboj.2013.167 26.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Proc Natl Acad Sci U S A  2009 ; 106:4325 - 30; PMID:19251664 ; http://dx.doi.org/10.1073/ pnas.0810666106 27.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature  2011 ; 479:74-9; PMID:21964334 ;  http://dx.doi.org/10.1038/nature1044228.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature  2012 ; 485:376- 80; PMID:22495300 ; http://dx.doi.org/10.1038/ nature11082 29.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Annu Rev Genomics Hum Genet   2013 ; 14:67-84; PMID:23875797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature  2009 ; 462:58- 64; PMID:19890323 ; http://dx.doi.org/10.1038/ nature08497 31.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Genome Res  2011 ; 21:697- 706; PMID:21471403 ; http://dx.doi.org/10.1101/ gr.111153.110 32.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Cell 2012 ; 148:84-98; PMID:22265404 ;  http://dx.doi.org/10.1016/j.cell.2011.12.014 35.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature  2013 ;  498:516-20; PMID:23728302 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Transcription  2012 ; 3:181-6; PMID:22771987 ;  http://dx.doi.org/10.4161/trns.20720 38.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Mol Cell  2002 ;  10:1453 -65; PMID:12504019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
EMBO J   2007 ; 26:2041 -51; PMID:17380126 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Cell 2012 ; 149:1233 - 44; PMID:22682246 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Science  2012 ; 338:671- 5; PMID:23019609 ; http://dx.doi.org/10.1126/ science.1224350 45.,Non-OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Curr  Opin Genet Dev  2014 ; 25C:30-7; PMID:24434548 ;  http://dx.doi.org/10.1016/j.gde.2013.11.01646.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature   2010 ; 467:430-5; PMID:20720539 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Nature   2011 ; 473:43-9; PMID:21441907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
Cell 2013 ; 153:1281 - 95; PMID:23706625 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a6/d1/tran-5-e28726.PMC4574877.pdf
"Transcription 2014; 5:e28869; PMID: 24802894; http://dx.doi.org/10.4161/trns.28869Activation and reactivation of the   RNA polymerase II trigger loop for intrinsic   RNA cleavage and catalysis Pavel  Čabart1, huiyan  Jin1, Liangtao  Li2 and c raig D  Kaplan1,* 1Department of Biochemistry and Biophysics; Texas a &M University; c ollege s tation, TX; 2Department of Pathology; University of Utah s chool of Medicine; s alt Lake c ity, UT U sa Keywords:  gene expression, general transcription factors, intrinsic cleavage, RNA synthesis, trigger loop In addition to RN a synthesis, multisubunit RN a polymerases (msRN aPs) support enzymatic reactions such as intrinsic  transcript cleavage.",Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Supplementary Material Supplementary material may be found here:   https://www.landesbioscience.com/journals/transcription/article/28869/ References 1.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Transcription 2012; 3:115-8; PMID:22771945 ;  http://dx.doi.org/10.4161/trns.19887 2.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Proc Natl Acad Sci U S  A 1996; 93:12914-9;  PMID:8917519 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
J Biol Chem 1996; 271:21549- 58; PMID:8702941 ; http://dx.doi.org/10.1074/ jbc.271.35.215496.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Proc Natl Acad Sci U S A  1995; 92:4596-600;  PMID:7538676 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Cell 2006; 127:941-54; PMID:17129781 ;  http://dx.doi.org/10.1016/j.cell.2006.11.023 8.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Nat  Struct Mol Biol 2010; 17:99-104; PMID:19966797 ;  http://dx.doi.org/10.1038/nsmb.1732 9.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
PLoS Genet 2012; 8:e1002627; PMID:22511879 ;  http://dx.doi.org/10.1371/journal.pgen.1002627 10.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Biochim Biophys Acta  2013; 1829:39-54;  PMID:23022618 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Cell  2005; 120:183-93;  PMID :15680325 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Elife 2013; 2:e00971;   PMID:24066225 ; http://dx.doi.org/10.7554/ eLife.00971 13.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Biophys J 2010; 99:2577-86; PMID:20959099 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Proc Natl Acad Sci U S A 2012; 109:6555-60;   PMID:22493230 ; http://dx.doi.org/10.1073/ pnas.1200939109,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Mol Cell 2008; 30:547-56; PMID:18538653 ;  http://dx.doi.org/10.1016/j.molcel.2008.04.023 16.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Mol Cell 2008; 30:557- 66; PMID:18538654 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
BMC Biol 2010; 8:54; PMID:20459653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Nucleic Acids Res 2013; 41:7048-59;   PMID:23737452 ; http://dx.doi.org/10.1093/nar/ gkt433 19.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Nat Struct Mol Biol  2009; 16:212-8;  PMID:19151724 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Chem Rev 2013; 113:8400-22; PMID:24074222 ;  http://dx.doi.org/10.1021/cr400006b 23.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Chem Rev 2013;  113:8546-66;  PMID:23987500 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Biochim  Biophys Acta 2010; 1799:575-87; PMID:20478425 ;  http://dx.doi.org/10.1016/j.bbagrm.2010.05.002 25.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Science 2009; 324:1203- 6; PMID:19478184 ; http://dx.doi.org/10.1126/ science.1168729 26.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Science 2006;  313:518-20;  PMID:16873663 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Proc Natl Acad Sci U S A 2010; 107:10878- 83; PMID:20534498 ; http://dx.doi.org/10.1073/ pnas.0914424107 28.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
J Biol Chem 2013;  288:6688-703;  PMID:23283976 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Nucleic Acids Res 2011; 39:4352-9;  PMID:21266474 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Science 1977; 198:513-4; PMID:910143 ;  http://dx.doi.org/10.1126/science.910143 34.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Biochim  Biophys Acta 2013; 1829:2-8; PMID:23000482 ;  http://dx.doi.org/10.1016/j.bbagrm.2012.09.003 35.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Trends  Biochem Sci 2013; 38:603-11; PMID:24120742 ;  http://dx.doi.org/10.1016/j.tibs.2013.09.002 36.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Nature 2013; 493:437- 40; PMID :23151482 ; http://dx.doi.org/10.1038/ nature11715 37.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Cell  2013; 154:775-88;  PMID:23932120 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Genetics 2006;  172:2201-9;  PMID:16510790 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
J Mol Biol 2013; 425:697- 712; PMID:23238253 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
J  Biol Chem 2003; 278:50101-11; PMID:14506279 ;  http://dx.doi.org/10.1074/jbc.M307590200 42.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Transcription 2013; 4:4; PMID:24270513 ;  http://dx.doi.org/10.4161/trns.27062 43.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Proc Natl Acad Sci U S A 2011; 108:15786-91;   PMID:21896726 ; http://dx.doi.org/10.1073/ pnas.1104591108 46.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Mol Cell Biol 2008; 28:3757-66; PMID:18362165 ;  http://dx.doi.org/10.1128/MCB.02272-07 47.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Cell Rep  2013; 4:974-84;  PMID:23994471 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
EMBO J 2003; 22:2234- 44; PMID:12727889 ; http://dx.doi.org/10.1093/ emboj/cdg193 50.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Science 1994; 266:2022- 5; PMID:7528445 ; http://dx.doi.org/10.1126/ science.7528445 51.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Mol Cell Biol 2012; 32:12- 25; PMID:22025674 ; http://dx.doi.org/10.1128/ MCB.06242-11 52.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Mol Cell 2005; 19:101- 10; PMID :15989968 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Mol Cell Biol 2002; 22:6979- 92; PMID:12242279 ; http://dx.doi.org/10.1128/ MCB.22.20.6979-6992.2002 54.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Biochem J 2008; 409:139- 47; PMID:17848138 ; http://dx.doi.org/10.1042/ BJ20070751 55.,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Methods  2001; 24:218-29;  PMID:11403571 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Science 2010; 327:206-9; PMID:19965383 ;  http://dx.doi.org/10.1126/science.1182015,Non-OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Methods  Enzymol 2003; 371:233-51; PMID:14712704 ;  http://dx.doi.org/10.1016/S0076-6879(03)71017-9 59.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Yeast 1995; 11:53-5;  PMID:7762301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
Methods Enzymol 1987;  154:164-75;  PMID:3323810 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/37/0b/tran-5-e28869.PMC4574878.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/f4/ndt-11-2323.PMC4574879.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2323–2329Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2323OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8335 0Periodic limb movements during reM sleep  in multiple sclerosis: a previously undescribed  entity christian Veauthier1 gunnar gaede2,3 helena radbruch2 Joern-Peter sieb4,5 Klaus-Dieter Wernecke6,7 Friedemann Paul2,8 1interdisciplinary center of sleep  Medicine, charité University Medicine  Berlin, germany; 2Neuro cure  clinical research center, charité  University Medicine Berlin, germany;   3Department of Neurology, st Joseph  hospital Berlin-Weissensee, Berlin,   germany; 4Department of Neurology,   heliOs hanseklinikum stralsund,   stralsund, germany; 5Department of  Neurology, University hospital Bonn,   Bonn, germany; 6crO sOsTaNa  gmbh, Berlin, germany; 7institute  of Medical Biometry, charité  University Medicine Berlin, Berlin,   germany; 8clinical and experimental  Multiple sclerosis research center,   Department of Neurology, charité  University Medicine Berlin, Berlin,   germanyBackground:  There are few studies describing periodic limb movement syndrome (PLMS)  in rapid eye movement (REM) sleep in patients with narcolepsy, restless legs syndrome, REM  sleep behavior disorder, and spinal cord injury, and to a lesser extent, in insomnia patients and  healthy controls, but no published cases in multiple sclerosis (MS).",Non-OADS,/arxiv_data1/oa_pdf/66/f4/ndt-11-2323.PMC4574879.pdf
"If the periodic limb movement index (PLMI; the number of PLMs per hour of sleep)  exceeds 15 per hour of sleep (in adults) and leads clinically to sleep disturbances, it  is called PLMD.1 Approximately 70%–80% of patients with RLS show PLMS in a correspondence: christian Veauthier interdisciplinary center of sleep  Medicine, charité University Medicine  Berlin, charitéplatz 1, 10117 Berlin,  germany Tel +49 17 4430 9430 Fax +49 321 2282 8668 email cveauthier@web.d e Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Veauthier et al Running head recto: PLMs during REM sleep in MS DOI: http://dx.doi.org/10.2147/NDT.S83350",Non-OADS,/arxiv_data1/oa_pdf/66/f4/ndt-11-2323.PMC4574879.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/66/f4/ndt-11-2323.PMC4574879.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/f4/ndt-11-2323.PMC4574879.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/c1/rmhp-8-151.PMC4574880.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 151–156Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  151ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S8753 2Accountability, Italian style: how to reply to  government pressure?",Non-OADS,/arxiv_data1/oa_pdf/d3/c1/rmhp-8-151.PMC4574880.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/d3/c1/rmhp-8-151.PMC4574880.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/c1/rmhp-8-151.PMC4574880.pdf
Available from http://www.normattiva.,Non-OADS,/arxiv_data1/oa_pdf/d3/c1/rmhp-8-151.PMC4574880.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1279–1291Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1279Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8128 4Review of predialysis education programs: a need  for standardization Judith van den Bosch1 D Simone warren1 Peter A Rutherford2 1Pallas Health Research and  Consultancy B v, Rotterdam, the  Netherlands; 2Baxter Healthcare SA,   Zürich, SwitzerlandAbstract:  To make an informed decision on renal replacement therapy, patients should receive  education about dialysis options in a structured program covering all modalities.",Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
"In-center HD is performed by trained nursing Correspondence: Peter A Rutherford Quintiles, 500 Green Park, Reading,  RG2 6UU, UK Tel +44 118 450 1847 email peter.rutherford@quintiles.co m Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Van den Bosch et al Running head recto: Predialysis education: need for standardization DOI: http://dx.doi.org/10.2147/PPA.S81284",Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Availale from: https://www.renalreg.org/ wp-content/uploads/2014/09/01-Chap-01.pd f. Accessed 7 Aug 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://www.slideshare.net/Sammy17/ ckd-educatio n. Accessed 7 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from:  http://ispd.org/NAC/wp-content/uploads/2010/11/CKD-Education- Glickman-April-2011-Notes.pd f. Accessed 7 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://users.hunterlink.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: https://stgrenal.org.au/sites/default/files/upload/Annual- Report-2011.pd f. Accessed 7 August 2015.,OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available  from: http://homedialysis.org.au/health-professional/educating-patients/ treatment-options-teaching-patients /.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://www.kamsc.org.au/renal/downloads/ renalpresentations/predialysis_role.pd f. Accessed 7 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Avail - able from: http://www.renalnetwork.on.ca/common/pages/UserFile.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://www.turner-white.com/pdf/hp_aug03_care.pd f.  Accessed 7 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://www.satellitehealth.com/medical_community/ satellite_wellbound/wellness_classes.ph p. Accessed 7 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available  from: http://www.renal.org/guidelines/modules/planning-initiating- and-withdrawal-of-renal-replacement-therapy#sthash.ZpW4QQaN.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://www.advancedrenaleducation.com/Litera - ture/PDServeConnectionPastArticles/PreESRDANecessity/tabid/347/ Default.asp x. Accessed 7 August 2015.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
Available from: http://www.kidney.org.au/LinkClick.aspx?fileticket=   4u5Qky3opAc%3D&tabid=635&mid=159 0.,Non-OADS,/arxiv_data1/oa_pdf/4d/65/ppa-9-1279.PMC4574882.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f6/86/ndt-11-2331.PMC4574883.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2331–2338Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2331OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7486 1Augmentation of light therapy in difficult-to-treat  depressed patients: an open-label trial in both  unipolar and bipolar patients giovanni camardese1 Beniamino leone1 riccardo serrani1 coco Walstra1 Marco Di Nicola1 giacomo Della Marca2 Pietro Bria1 luigi Janiri1 1institute of Psychiatry and  Psychology, 2institute of Neurology,   catholic University of the sacred  heart, rome, italyObjectives:  We investigated the clinical benefits of bright light therapy (BLT) as an adjunct  treatment to ongoing psychopharmacotherapy, both in unipolar and bipolar difficult-to-treat  depressed (DTD) outpatients.",Non-OADS,/arxiv_data1/oa_pdf/f6/86/ndt-11-2331.PMC4574883.pdf
"Up to 15% of cases will remain significantly depressed  even after multiple pharmacological approaches,2 with a negative impact on clinical  course.3 Since a partial response to treatment represents a widespread condition among  depressed patients and should be readily identified to decide the most appropriate treat - ment plan, many helpful systems for staging levels of treatment resistance have been  proposed for major depression.4 In this way, Rush et al described “difficult-to-treat  depression”as a clinical condition which includes both those patients who do not respond correspondence: Beniamino leone institute of Psychiatry and Psychology,  catholic University of the sacred  heart, largo a. gemelli, No 8, 00168  rome, italy Tel +39 06 3015 5539 Fax +39 06 2331 2407 email beniaminoleone@yahoo.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Camardese et al Running head recto: Light therapy in DTD unipolar and bipolar depressed patients DOI: http://dx.doi.org/10.2147/NDT.S74861",Non-OADS,/arxiv_data1/oa_pdf/f6/86/ndt-11-2331.PMC4574883.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f6/86/ndt-11-2331.PMC4574883.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f6/86/ndt-11-2331.PMC4574883.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/7e/ndt-11-2339.PMC4574884.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2339–2348Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2339OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8733 5Predicting functional remission in patients with  schizophrenia: a cross-sectional study of symptomatic  remission, psychosocial remission, functioning, and  clinical outcome Marcelo Valencia1 ana Fresán2 Y oram Barak3 Francisco Juárez1 raul escamilla4 ricardo saracco4 1Division of epidemiological and  Psychosocial research, 2Division  of clinical research, National institute  of Psychiatry ramón de la Fuente,   Mexico city, Mexico; 3Psychiatry  Department, sackler school of  Medicine, T el aviv University, T el aviv,   israel; 4schizophrenia clinic, National  institute of Psychiatry ramón de la  Fuente, Mexico city, MexicoBackground:  New approaches to assess outcome in schizophrenia include multidimensional  measures such as remission, cognition, psychosocial functioning, and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/2c/7e/ndt-11-2339.PMC4574884.pdf
"Unfortunately, full functional recovery is rarely attained and even  less frequently maintained, even after symptoms have remitted.2 Profound impairments correspondence: Marcelo Valencia Division of epidemiological and  Psychosocial research, National  institute of Psychiatry ramón de la  Fuente, calzada México Xochimilco  No 101, colonia san lorenzo huipulco,  Delegación Tlalpan, 14370 Mexico city,  Mexico Tel +52 55 4160 5164 email valencm@imp.edu.m x Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Valencia et al Running head recto: Predicting functional remission in patients with schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S87335",Non-OADS,/arxiv_data1/oa_pdf/2c/7e/ndt-11-2339.PMC4574884.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/2c/7e/ndt-11-2339.PMC4574884.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/7e/ndt-11-2339.PMC4574884.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2315–2322Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2315OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8633 4Identification of two novel mutations, PSEN1   e280K and PRNP  G127S, in a Malaysian family gaik-siew ch’ng1,* seong soo a an2,* sun Oh Bae2 eva Bagyinszky2 sangYun Kim3,4 1Department of Genetics, Kuala  Lumpur Hospital, Kuala Lumpur,   Malaysia; 2Department of Bionano  T echnology, Gachon University,   3Department of  Neurology, Seoul  National University College of  Medicine, 4Department of Neurology,   Seoul National University Bundang  Hospital, Seongnam-si, Gyeonggi-do,   south Korea *These authors contributed equally  to this workAbstract:  Alzheimer’s disease (AD) is the most common form of dementia, which can be  categorized into two main forms: early onset AD and late onset AD.",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"At  least three causative genes have been reported for EOAD: amyloid precursor protein  (APP), presenilin 1 ( PSEN1 ), and presenilin 2 ( PSEN2 ; http://www.alzforum.org/ mutation s).1 The causative mutations in APP for EOAD were found in exons 16 and  17, which were near the cleavage sites of beta and gamma secretases.",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"In EOAD, the majority of mutations revealed a correspondence: sangYun Kim Department of Neurology, Seoul  National University College of Medicine,  Seoul National University Bundang  Hospital, 300 Gumidong, Bundang-gu,  Seongnam-si, Gyeonggi-do 463-707,  south Korea Tel +82 31 787 7462 Fax +82 31 719 6815 email neuroksy@snu.ac.k r  eva Bagyinszky Department of Bionano Technology,  Gachon Bionano Research Institute,  Gachon University, 1342 Sungnam-daero,  Sujung-gu, Seongnam-si, Gyeonggi-do  461-701, South Korea Tel +82 10 39129444 email navigator120@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Ch’ng et al Running head recto: Novel PSEN1 (E280K) and novel prion mutation (G127S) mutation in a Malaysian family DOI: http://dx.doi.org/10.2147/NDT.S86334",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"However, several EOAD cases  were described without any family history, suggesting de  novo  cases for EOAD.2,3 At least 30 pathogenic mutations have been described for  the prion gene ( PRNP ; http://www.federationofscientists.org/ pmpanels/TSE/Priprogene.as p), which could also be involved  in different disease phenotypes, such as Creutzfeldt–Jakob  disease, familial fatal insomnia, Gerstmann–Straussler– Scheinker disease, or kuru.4 Pathological similarities were  found between AD and prion disease, as neurodegenerative  diseases may be based on the aggregation of abnormal pro - teins.",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
Sequences were aligned by  NCBI BLAST ( http://blast.ncbi.nlm.nih.gov/Blast.cg i) and  screened with DNA Baser software ( http://www.dnabaser.,OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
Mutations and sequence variants were identified and  compared against the NCBI Gene ( http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
gov/gen e) and UniProt ( http://www.uniprot.or g) databases.,OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"HumVar data should be used in the  diagnosis of Mendelian disorders, which requires the differ - entiation of highly damaging mutations from less damaging  variants.16 Sorting intolerant from tolerant (SIFT) algorithm  (http://sift.jcvi.org /) predicts the potential effects of amino  acid substitution on protein function.",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"This  algorithm identified ~80% of the nonneutral variants with the  accuracy of 77%.18 The three-dimensional (3-D) structures of  normal and mutant PSEN1  were constructed by the Raptor  X web server ( http://raptorx.uchicago.edu /), a protein struc - ture prediction server using amino acid sequences.",OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
This mutation did not appear in the  AD and FTD mutation database ( http://www.molgen.ua.ac.,OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"be/ADMutations /) nor in the Alzheimer’s Research Forum  (http://www.alzforum.org/mutation s), which supported this  mutation as a novel variant in PSEN1 .",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"PSEN1  (chromosome  14, 73, 603, 142–173, 690, 399) E280K was also checked  in the database of Korea Centers for Disease Control and Prevention ([KCDC]; http://www.cdc.go.k r) and the Exome  Aggregation Consortium ([ExAC]; http://exa c.broadinstitute.",OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"This is likely a novel mutation, since it did appear neither  in the KCDC, neither in nor in the prion mutation data - base ( http://www.federationofscientists.org/pmpanels/tse/ priprogene.as p) or in the Entrez database.",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/76/ndt-11-2315.PMC4574885.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/e7/ppa-9-1293.PMC4574886.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1293–1301Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1293OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8792 8Patients’ preferences for attributes related to  health care services at hospitals in Amhara  region, northern ethiopia: a discrete choice  experiment Adugnaw Berhane1 Fikre enquselassie2 1college of health sciences, Debre  Berhan University, 2school of Public  health, Addis Ababa University, Addis  Ababa, ethiopiaBackground:  Information from the patient’s point of view is essential in policy and clinical  decisions.",Non-OADS,/arxiv_data1/oa_pdf/c4/e7/ppa-9-1293.PMC4574886.pdf
"Previous reports have shown that correspondence: Adugnaw Berhane college of health sciences, Debre Berhan  University, PO Box 100796, Addis Ababa,  ethiopia Tel +251 91 139 1111 email adugnawmph@yahoo.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Berhane and Enquselassie Running head recto: Patient preferences for health care services DOI: http://dx.doi.org/10.2147/PPA.S87928",Non-OADS,/arxiv_data1/oa_pdf/c4/e7/ppa-9-1293.PMC4574886.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c4/e7/ppa-9-1293.PMC4574886.pdf
Conjoint and Dis - crete Choice Experiments Available from: https://www.google.com/ url?sa=t&rct=j&q=&esrc=s&source=web&cd=4&cad=rja&uact=8 &ved=0CDoQFjADahUKEwiqp_OO9tLHAhWHn3IKHYjMAYs& url=http%3A%2F%2Fstatmath.wu.ac.at%2Fpeople%2Ftislam%2F Vienna%2520presentations%2Fweek%2520of%2520July%25203% 2FConjoint%2520and%2520Discrete%2520Choice%2520Analysis.,OADS,/arxiv_data1/oa_pdf/c4/e7/ppa-9-1293.PMC4574886.pdf
"Here, we will focus oninsights into how the TEP as a guidancesignal may link and coordinate theKeywords: apical-basal polarity, cell polar- ization, extracellular electrical signal, NaC/ KC-ATPase, transepithelial potential difference © 2015 Crown Copyright *Correspondence to: Jin Pu; E-mail: jin.pu@abdn.ac.uk Submitted: 01/16/2015Revised: 03/24/2015 Accepted: 03/27/2015 http://dx.doi.org/10.1080/21688370.2015.1037417 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproduction in any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Ann Rev Cell Dev Biol 2012; 28:655-85; PMID:22881460; http://dx.doi.org/10.1146/annurev-cellbio-092910-154033 2.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Biol 2008; 183:625-33; PMID:19001128; http://dx.doi.org/10.1083/jcb.200807121 3.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Mol Biol Cell 2001;12:3717-32; PMID:11739775; http://dx.doi.org/ 10.1091/mbc.12.12.3717 4.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Sci 2014;127:3233-9; PMID:24928904; http://dx.doi.org/ 10.1242/jcs.146357 5.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Sci 2009; 122:4267-76; PMID:19923270; http://dx.doi.org/ 10.1242/jcs.023564 6.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Biol 1989; 109:179-89; PMID:2568363; http://dx.doi.org/10.1083/jcb.109.1.179 7.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Clin Invest 1959;38:435-42; PMID:13631076; http://dx.doi.org/ 10.1172/JCI103818 8.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Faseb J 2005;19:379-86; PMID:15746181; http://dx.doi.org/ 10.1096/fj.04-2325com 9.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Gut 1972; 13:559-65; PMID:5069733; http://dx.doi.org/10.1136/gut.13.7.559 10.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Semin Cell DevBiol 2009; 20:674-82; PMID:19146969; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Dev Biol 1988; 128:290-9;PMID:2456234; http://dx.doi.org/10.1016/0012-1606 (88)90292-8 13.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
"Erickson CA, Nuccitelli R. Embryonic ﬁbroblast motility and orientation can be inﬂuenced by physi- ological electric ﬁ e l d s .JC e l lB i o l1 9 8 4 ;9 8 : 2 9 6 - 307; PMID:6707093; http://dx.doi.org/10.1083/ jcb.98.1.296 14.",OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Exp Cell Res 1983; 147:195-201; PMID:6617761; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
EMBO Rep 2013; 14:184-90; PMID:23328740; http://dx.doi.org/ 10.1038/embor.2012.215 16.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Stem Cell Rev 2015; 11:75-86; PMID:25096637; http://dx.doi.org/10.1007/s12015-014-9524-1.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Neurocytol 2001; 30:45-57; PMID:11577245; http://dx.doi.org/10.1023/A:1011917424450 18.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Exp Neurol 2008; 211:585-7; PMID:18396278; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Neurology 1992; 42:1375-88; PMID:1620349; http://dx.doi.org/10.1212/WNL.42.7.1375 20.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Genes Dev 2001; 15:639-51; PMID:11274050; http://dx.doi.org/10.1101/gad.886801 21.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Neurology 1996; 47:331-9; PMID:8757001; http://dx.doi.org/10.1212/ WNL.47.2.331 22.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Biol 1985; 101:2023-7;PMID:3905820; http://dx.doi.org/10.1083/ jcb.101.6.2023 23.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Ann Rev Cell Dev Biol 2006; 22:207-35;PMID:16771626; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
PloS One 2013; 8: e61509; PMID:23585907; http://dx.doi.org/10.1371/ journal.pone.0061509 26.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
"Cell 2004;116:457-66; PMID:15016379; http://dx.doi.org/ 10.1016/S0092-8674(04)00114-X 27. ten Klooster JP, Jansen M, Yuan J, Oorschot V, Begthel H, Di Giacomo V, Colland F, de Koning J, Maurice MM, Hornbeck P, et al.",OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Dev Cell 2009; 16:551-62; PMID:19386264; http://dx.doi.org/10.1016/j.devcel.2009.01.016 28.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Dev Cell 2006; 10:379-90; PMID:16516840; http://dx.doi.org/10.1016/j.devcel.2006.01.013 29.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Ann Rev Cell Dev Biol 2004; 20:781-810; PMID:15473860; http://dx.doi.org/10.1146/annurev.cellbio.20.010403.113126 30.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Cancer Res 2005; 65:9142-6; PMID:16230369; http://dx.doi.org/10.1158/0008- 5472.CAN-05-1710 31.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
BJU Int 2013;111:505-13; PMID:22882496; http://dx.doi.org/10.1111/j.1464-410X.2012.11421.x 32.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Sci 2004; 117:397-405; PMID:14679307; http://dx.doi.org/10.1242/ jcs.00868 33.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Science 1989; 245:718-25; PMID:2672330; http://dx.doi.org/ 10.1126/science.2672330 35.,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Nat Cell Biol 2001; 3:140-9; PMID:11175746; http://dx.doi.org/10.1038/ 35055042 37.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Cell Mol Life Sci 2011; 68:3081- 93; PMID:21207103; http://dx.doi.org/10.1007/s00018-010-0608-z 38.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Sci 2005; 118:1117-28; PMID:15728257; http://dx.doi.org/10.1242/jcs.01646 39.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
97; PMID:17254974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
Cell M otil Cytoskeleton 2001; 50:207-17; PMID:11807941; http://dx.doi.org/ 10.1002/cm.1000942.,OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
J Cell Sci 2006; 119:1723-35; PMID:16595546; http://dx.doi.org/ 10.1242/jcs.02896 www.tandfonline.com e1037417-7 Tissue Barriers,Non-OADS,/arxiv_data1/oa_pdf/55/b4/ktib-03-03-1037417.PMC4574889.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/lra-8-071.PMC4574900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pLocal and Regional Anesthesia 2015:8 71–77Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  71ORiginAL  ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S8447 6Lidocaine versus ropivacaine for postoperative  continuous paravertebral nerve blocks   in patients undergoing laparoscopic bowel  surgery: a randomized, controlled, double-   blinded, pilot study Daniela ghisi1,3 Andrea Fanelli1,2 Julie Jouguelet-Lacoste1 Luca La colla1,4 Anne-sophie Auroux1,5 Jacques e chelly1 1Department of Anesthesiology,   University of Pittsburgh Medical  center, Pittsburgh, PA, UsA;   2Anesthesia and intensive care Unit,   Policlinico s.Orsola-Malpighi, Bologna,   italy; 3Department of Anesthesia  and Postoperative intensive care,   istituto Ortopedico Rizzoli, Bologna,   italy; 4Department of Anesthesia,   intensive care and Pain Therapy,   Università degli studi di Parma,   Parma, italy 5institut des sciences  Pharmaceutiques et Biologiques- Faculté de Pharmacie de Lyon  Université claude Bernard Lyon,   France correspondence: Jacques e chelly   Acute interventional Perioperative Pain  service, University of Pittsburgh Medical  center, Aiken Medical Building, 532 s  Aiken Avenue, suite 407, Pittsburgh PA,  15232, UsA   T el +1 412 623 6904   Fax +1 412 623 4188   email chelje@anes.upmc.ed uBackground and objectives:  Lidocaine could provide many advantages in continuous  regional anesthesia techniques, including faster onset, greater titratability, and lower cost than  long-acting local anesthetics.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/lra-8-071.PMC4574900.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/d5/36/lra-8-071.PMC4574900.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/36/lra-8-071.PMC4574900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2349–2354Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2349Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S8750 3Alzheimer’s disease and its treatment costs: case  study in the Czech Republic Hana Mohelska1 Petra Maresova2 Martin valis3 Kamil Kuca4,5 1Department of Management,   2Department of economy, Faculty  of informatics and Management,   University of Hradec Králové,   3Department of Neurology, Charles  University in Prague, Faculty of  Medicine in Hradec Králové and  University Hospital Hradec Králové,   4Biomedical Research Centrum,   University Hospital Hradec Králové,   5Center for Basic and Applied  Research, Faculty of informatics and  Management, University of Hradec  Králové, Hradec Králové, Czech  RepublicAbstract:  This paper deals with the analysis of the costs, applied, for example, when treating  specific diseases – an important aid in prioritizing the process of resource allocation.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"In the age group over 90  years, every second person suffers from it.1 The number of people suffering from  dementia in Prague is almost 19,000, which is logical as the capital city has the oldest Correspondence: Kamil Kuca Biomedical Research Centrum, University  Hospital Hradec Králové, Sokolská 581,  Hradec Králové 50005, Czech Republic Tel +420 603 289 166 Fax +420 495 835 200 email kamil.kuca@fnhk.c z Martin valis Department of Neurology, Charles  University in Prague, Faculty of Medicine  in Hradec Králové and University  Hospital Hradec Králové, Sokolská 581,  Hradec Králové 50005, Czech Republic Tel +420 495 835 251 Fax +420 495 835 200 email valismar@seznam.c zJournal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Mohelska et al Running head recto: Alzheimer’s disease and its treatment costs DOI: http://dx.doi.org/10.2147/NDT.S87503",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"Available from: http://www.fnhk.cz/neuro ,6 Korabecny M. Pharmacotherapy  of Alzheimer’s disease: current state and future perspectives.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"Available from: http://www.fnhk.cz/neuro ,6 and own calculations.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"Available from: http://www.fnhk.cz/neuro ,6 and own calculations (CZK/eUR, exchange  rate is based on data from the european Central Bank, accessed April 14, 2015).20 *ICD Alzheimer’s Disease codes.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
[online]  Available from: http://www.vzp.cz/uploads/document/vzp-rocenka-2013.pdf .,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
Available from: http://www.uzis.cz/cz/mkn/index.htm l  3.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
[online]  Available from: http://www.vzp.cz/uploads/document/vzp-rocenka- 2013.pd f. Czech.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"Available from: http://www.fnhk.cz/neur o. Accessed January 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
Available  from: http://www.mzcr.cz/Legislativa/dokumenty/vyhlaska-c324/2014- sb-o-stanoveni-hodnot-boduvyse-uhrad-hrazenych-sluzeb-a_9871_11.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
Available from: https://www.czso.cz/csu/ czso/vysledky-zdravotnickych-uctu-cr-2000-az-2012-efsq7vjww i.  Czech.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
[Online] Available from: http://www.zdrav.cz/modules.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
Available from:  http://www.alzheimer.cz/alzheimerova-choroba-v-cr/zverejnena- zprava-o-stavu-demence-2014 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
"[Online]  Available from: https://www.ecb.europa.eu/stats/exchange/eurofxref/ html/index.en.htm l. Accessed: April 14, 2015.",Non-OADS,/arxiv_data1/oa_pdf/c6/4b/ndt-11-2349.PMC4574902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/f4/eb-6-001.PMC4574956.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpEye and Brain 2014:6 (Suppl 1) 1–4Eye and Brain Dove press submit your manuscript | www.dovepress.co m Dove press  1EDITORIALopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/EB.S6401 6Current research on the organization   and function of the visual system in primates Jon H Kaas Pooja Balaram Department of Psychology, Vanderbilt  University, Nashville, TN, USA Correspondence: Pooja Balaram   Department of Psychology, Vanderbilt  University,  301 Wilson Hall,111  21st  Avenue South, Nashville, TN  37203, USA   Tel +1 508 314 3030  Fax +1 615 343 8449  Email pooja.balaram@vanderbilt.ed uAll primates, including humans, are highly visual creatures.1–3 We rely heavily on  visual cues for basic adaptive behaviors such as finding food, mates, and shelter; as  well as more complex behaviors such as parental care and the formation of social hier - archies.",Non-OADS,/arxiv_data1/oa_pdf/90/f4/eb-6-001.PMC4574956.pdf
"Eye and Brain Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/eye-and-brain-journal  Eye and Brain is an international, peer-reviewed, open access journal   focusing on clinical and experimental research in the field of  neuro-ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/90/f4/eb-6-001.PMC4574956.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/f4/eb-6-001.PMC4574956.pdf
http://seer.cancer.gov/faststats/.,Non-OADS,/arxiv_data1/oa_pdf/5c/46/kjhbps-16-89.PMC4575002.pdf
http://www.who.int/hiv/data/fast_facts/en/ .,OADS,/arxiv_data1/oa_pdf/ab/d1/40121_2015_Article_71.PMC4575289.pdf
https://www.cadth.ca/fr .,Non-OADS,/arxiv_data1/oa_pdf/ab/d1/40121_2015_Article_71.PMC4575289.pdf
2009. http://www.statcan.gc.ca/pub/ 84f0209x/84f0209x2009000-eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ab/d1/40121_2015_Article_71.PMC4575289.pdf
https://www.healthinfo.moh.gov.on.ca/ formulary/index.jsp .,Non-OADS,/arxiv_data1/oa_pdf/ab/d1/40121_2015_Article_71.PMC4575289.pdf
http://aidsinfo.nih.gov/co ntentﬁles/lvguidelines/ adultandadolescentgl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ab/d1/40121_2015_Article_71.PMC4575289.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit332 Infect Dis Ther (2015) 4:321–335",Non-OADS,/arxiv_data1/oa_pdf/7f/89/40121_2015_Article_86.PMC4575290.pdf
Atlanta:Centers for Disease Control and Prevention; 2001. http://www.cdc.gov/reprod uctivehealth/Products Pubs/PDFs/Strategies_taged.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7f/89/40121_2015_Article_86.PMC4575290.pdf
https://www.dshs.state.tx.us/ chs/vstat/annrpts.shtm .,Non-OADS,/arxiv_data1/oa_pdf/7f/89/40121_2015_Article_86.PMC4575290.pdf
2008;5(1):Article 5. http://digitalscholarship.unlv.edu/njph/vol7/iss1/4 .,Non-OADS,/arxiv_data1/oa_pdf/7f/89/40121_2015_Article_86.PMC4575290.pdf
Susceptibilities were assessed using breakpoints established by the Clinical Laboratory Standards Institute (CLSI; http://www.clsi.org ).,OADS,/arxiv_data1/oa_pdf/e0/6c/40121_2015_Article_72.PMC4575293.pdf
"In view of the limited clinical data available, the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http://www.eucast.org ) has published the epi- demiological cutoff values of 4 mg/L for both E. faecalis and E. faecium .",Non-OADS,/arxiv_data1/oa_pdf/e0/6c/40121_2015_Article_72.PMC4575293.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/77/ae/40121_2015_Article_77.PMC4575294.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/eb/a9/40121_2015_Article_78.PMC4575296.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/45/96/40121_2015_Article_87.PMC4575297.pdf
http://www.cdc.gov/nchs/ fastats/pneumonia.htm .,Non-OADS,/arxiv_data1/oa_pdf/45/96/40121_2015_Article_87.PMC4575297.pdf
2015.https://www.whitehouse.gov/the-press-ofﬁce/2015/ 06/02/fact-sheet-over-150-animal-and-health-stake holders-join-white-house-effo .,Non-OADS,/arxiv_data1/oa_pdf/45/96/40121_2015_Article_87.PMC4575297.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/b9/5b/13300_2015_Article_126.PMC4575298.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/b9/5b/13300_2015_Article_126.PMC4575298.pdf
Available from: http://www.health.govt.,Non-OADS,/arxiv_data1/oa_pdf/a8/51/13300_2015_Article_116.PMC4575300.pdf
"This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/cf/f6/13300_2015_Article_125.PMC4575301.pdf
https://clinicaltrials.gov/ct2/show/ NCT01787318 .,Non-OADS,/arxiv_data1/oa_pdf/cf/f6/13300_2015_Article_125.PMC4575301.pdf
http://www.idf.org/sites/ default/ﬁles/EN_6E_Atlas_Full_0.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/1c/13300_2015_Article_119.PMC4575302.pdf
2009. http://www.nice.org.uk/ guidance/ta203/resources/nice-recommends-liraglu tide-for-type-2-diabetes-mellitus4 .,Non-OADS,/arxiv_data1/oa_pdf/81/1c/13300_2015_Article_119.PMC4575302.pdf
2010. http://www.nice.org.uk/guidance/ ta203/resources/guidance-liraglutide-for-the-treatm ent-of-type-2-diabetes-mellitus-pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/1c/13300_2015_Article_119.PMC4575302.pdf
"This article is distributed under the terms of the Creative CommonsAttribution-NonCommercial 4.0 International License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
Available from: http://www.fda.gov/drugs/drugsafety/ucm22 6214.htm .,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
Availablefrom: http://www.fda.gov/Drugs/DrugSafety/Drug SafetyPodcasts/ucm259489.htm .,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
2014.Available from: https://www.takeda.com/news/ 2014/20140829_6714.html .,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/doc ument_library/EPAR_-_Summary_for_the_public/ human/002322/WC500136025.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
Available from: http://www.azpicentral.com/ xigduo/pi_xigduoxr.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/000285/WC500021386.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e7/e2/13300_2015_Article_128.PMC4575305.pdf
2011. http://www.idf.org/diabetesatlas/news/ﬁfth- edition-release .,Non-OADS,/arxiv_data1/oa_pdf/20/dd/13300_2015_Article_120.PMC4575306.pdf
http://www.idf.org/sites/default/ ﬁles/Global_Diabetes_Plan_Final.pdf .,Non-OADS,/arxiv_data1/oa_pdf/df/19/13300_2015_Article_121.PMC4575307.pdf
"License ( http://creativecommons.org/licenses/ by-nc/4.0/ ), which permits any noncommer- cial use, distribution, and reproduction in any medium, provided you give appropriate creditto the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6e/22/13300_2015_Article_127.PMC4575308.pdf
"METHODS Data Source Electronic medical records from the South Central Veterans Affairs Health Care Network, Veterans Integrated Service Network (VISN) 16 (http://www.visn16.va.gov/ ) were used in this retrospective observational study.",OADS,/arxiv_data1/oa_pdf/a9/91/13300_2015_Article_122.PMC4575310.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/92/f1/40258_2015_Article_186.PMC4575351.pdf
http://www.hhs.gov/about/budget/fy2015/budget- in-brief/cms/medicare/index.html .,Non-OADS,/arxiv_data1/oa_pdf/92/f1/40258_2015_Article_186.PMC4575351.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/44/9d/40273_2015_Article_319.PMC4575359.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/71/e6/40258_2015_Article_191.PMC4575361.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/9d/09/40258_2015_Article_190.PMC4575365.pdf
Available from http://www.nice.org.uk/guidance/mtg15 .,Non-OADS,/arxiv_data1/oa_pdf/9d/09/40258_2015_Article_190.PMC4575365.pdf
Available from http://www.nice.org.uk/ guidance/mtg15/documents .,Non-OADS,/arxiv_data1/oa_pdf/9d/09/40258_2015_Article_190.PMC4575365.pdf
2014. http://www.oncallmedical supplies.co.uk .,Non-OADS,/arxiv_data1/oa_pdf/9d/09/40258_2015_Article_190.PMC4575365.pdf
Available from https://www.gov.uk/government/collections/nhs- reference-costs .,Non-OADS,/arxiv_data1/oa_pdf/9d/09/40258_2015_Article_190.PMC4575365.pdf
Available from https://www.nice.org.uk/about/what- we-do/our-programmes/nice-guidance/nice-medical-technologies-guidance .,Non-OADS,/arxiv_data1/oa_pdf/9d/09/40258_2015_Article_190.PMC4575365.pdf
Acknowledgments This research was partly funded by a grant from the European FP7-Health Programme; see also http://www.fp7- improved.eu .,Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
http://www.dhsspsni.gov.uk/ cesdi_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
Available at: http://data.worldbank.org/indicator/PA.NUS.,OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
2010; Available at: http://www.nice.org.uk/ guidance/cg107/chapter/1-recommendations#reducing-the-risk-of-hypertensive-disorders-in-pregnancy .,Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
2013; Available at: http://www.europeristat.com/reports.html .,Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
2013; Available at: http://www.who.int/topics/maternal_health/en/ .,Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
2013; Available at: http://www.un.org/ millenniumgoals/maternal .,Non-OADS,/arxiv_data1/oa_pdf/f6/a7/40273_2015_Article_291.PMC4575369.pdf
"This is illustrated using R-code, which can also be found at http://www.erim.eur.nl/ ecmc .",Non-OADS,/arxiv_data1/oa_pdf/e5/de/40271_2015_Article_118.PMC4575371.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/78/2e/40271_2015_Article_137.PMC4575373.pdf
April 8 2015. http://aidsinfo.nih.gov/contentﬁles/ lvguidelines/adultandadolescentgl.pdf .,Non-OADS,/arxiv_data1/oa_pdf/78/2e/40271_2015_Article_137.PMC4575373.pdf
Amgen (2014) Prolia® EU Summary of Product Characteristics [Available at: https://www.medicinesorguk/ema/medicine/23127 ].,Non-OADS,/arxiv_data1/oa_pdf/de/6e/198_2015_Article_3164.PMC4575374.pdf
Institut national d ’assurance maladie-invalidité (2014) Liste des spécialités pharmaceutiques remboursables : les catégories de remboursement [ http://www.inami.fgov .be/fr/themes/cout- remboursement/par-mutualite/medicament-produits-sante/ remboursement/specialites/Pages/liste-specialites-pharmaceutiques-remboursables-categories-remboursement.aspx#.,Non-OADS,/arxiv_data1/oa_pdf/de/6e/198_2015_Article_3164.PMC4575374.pdf
Prolia: EPAR - Product information (2014) http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/f3/05/198_2015_Article_3253.PMC4575381.pdf
"SCB, Statistics Sweden (2013) http://www.scb.se (Accessed July 30 2013) 19.",Non-OADS,/arxiv_data1/oa_pdf/f3/05/198_2015_Article_3253.PMC4575381.pdf
http://www.york.ac.uk/inst/crd/pdf/ Systematic_Reviews.pdf (Accessed April 14 2014).,Non-OADS,/arxiv_data1/oa_pdf/f3/05/198_2015_Article_3253.PMC4575381.pdf
Available at http://www.who.int/csr/resources/ publications/dengue_9789241547871/en/ (accessed 7 July 2009).,Non-OADS,/arxiv_data1/oa_pdf/9a/de/emi201524a.PMC4575393.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/sVCAM-1 in dengue B Liao et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/de/emi201524a.PMC4575393.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/MERS-CoV antigen detection assay Y Chen et al.",Non-OADS,/arxiv_data1/oa_pdf/2d/c2/emi201526a.PMC4575394.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 26166 - http://dx.doi.org/10.3402/jev.v4.26166 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/67/1a/JEV-4-26166.PMC4575417.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26166 - http://dx.doi.org/10.3402/jev.v4.26166",OADS,/arxiv_data1/oa_pdf/67/1a/JEV-4-26166.PMC4575417.pdf
"Long-term cell cultures Cells that internalized LDEV, cells that had been exposedto LDEV in culture that did not internalize them andcells that were not exposed to LDEV (control) wereplated in 6-well plastic culture plates and cultured inDMEM-glutamax supplemented with 15% foetal bovine serum, 1% PS and recombinant murine stem cell factorMarrow expression of pulmonary epithelial genes Citation: Journal of Extracellular Vesicles 2015, 4: 26166 - http://dx.doi.org/10.3402/jev.v4.26166 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/67/1a/JEV-4-26166.PMC4575417.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26166 - http://dx.doi.org/10.3402/jev.v4.26166",OADS,/arxiv_data1/oa_pdf/67/1a/JEV-4-26166.PMC4575417.pdf
"Y-axis, CFSE (FITC); X-axis, forward scatter (FSC).Marrow expression of pulmonary epithelial genes Citation: Journal of Extracellular Vesicles 2015, 4: 26166 - http://dx.doi.org/10.3402/jev.v4.26166 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/67/1a/JEV-4-26166.PMC4575417.pdf
